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WELCOME AND CALL TO ORDER  .............................................................................................................................................
SESSION A: Stephen B. Thacker Opening Session ........................................................................................................................  8:30–10:15 am
 
CONCURRENT SESSION B1: Vaccine-Preventable Diseases  ................................................................................................ 10:45 am–12:10 pm
 
CONCURRENT SESSION B2: Chronic Disease Prevention and Health Disparities .................................................................. 10:45 am–12:10 pm
 
LUNCH (on your own) ..............................................................................................................................................................  12:15–1:30 pm
 
SESSION C: J. Virgil Peavy Memorial Award Finalists ......................................................................................................................  1:45–3:30 pm
 
EIS Recruitment Information Session  ......................................................................................................................................  3:30–4:30 pm
 
SESSION D1: Zoonotic Diseases .....................................................................................................................................................  3:45–5:10 pm
 
SESSION D2: Reproductive Health ................................................................................................................................................  3:45–5:10 pm
  
SESSION D3: Global Health: Treatment and Safety ........................................................................................................................  3:45–5:10 pm 




CONCURRENT SESSION E1: STDs and HIV .................................................................................................................................  8:30–9:55 am 

CONCURRENT SESSION E2: Occupational Safety and Health ......................................................................................................  8:30–9:55 am
 
SESSION F: Donald C. Mackel Memorial Award Finalists  ........................................................................................................ 10:15 am–12:00 pm 

LUNCH (on your own)/SPECIAL SESSION 1: Epidemiologic Investigations of Environmental Exposures .................................  12:05–1:20 pm
 
POSTER SYMPOSIUM I  .............................................................................................................................................................  1:30–2:45 pm
 
SESSION G: Laboratory Leadership Service Presentations  ..............................................................................................................  1:30–2:45 pm
 
CONCURRENT SESSION H1: Global Health: Epidemiology and Disease Prevention ......................................................................  3:00–4:45 pm 

CONCURRENT SESSION H2: Notes from the Field ......................................................................................................................  3:00–4:45 pm
 
PREDICTION RUN ................................................................................................................................................................................. 6:00 pm 

SESSION I: FETP International Night – Poster Presentations ............................................................................................................  6:00–8:30 pm
 
CONCURRENT SESSION J1: Emerging Infections ......................................................................................................................  8:30–10:15 am
 
CONCURRENT SESSION J2: Injury ...........................................................................................................................................  8:30–10:15 am
 
POSTER SYMPOSIUM II  ........................................................................................................................................................  10:30–11:45 am 

LUNCH (on your own)/SPECIAL SESSION 2: Zika Virus Infection .................................................................................... 11:50 am–1:05 pm 

CONCURRENT SESSION K1: Healthcare-Associated Outbreaks ....................................................................................................  1:15–3:00 pm
 
CONCURRENT SESSION K2: Environmental Health ....................................................................................................................  1:15–3:00 pm 

CONCURRENT SESSION L: Alexander D. Langmuir Lecture .........................................................................................................  3:15–4:45 pm 

EIS CAREER NETWORKING NIGHT  ..........................................................................................................................................  5:15–7:00 pm 

SESSION M: FETP International Night – Oral Presentations ............................................................................................................  6:30–9:00 pm
 
CONCURRENT SESSION N1: Respiratory Diseases  .....................................................................................................................  8:30–9:55 am
 
CONCURRENT SESSION N2: Hepatitis and Tuberculosis ..............................................................................................................  8:30–9:55 am
 
CONCURRENT SESSION O1: Foodborne Outbreaks............................................................................................................ 10:15 am–12:00 pm
 
CONCURRENT SESSION O2: Child Health ......................................................................................................................... 10:15 am–12:00 pm
 
LUNCH (on your own) ..............................................................................................................................................................  12:05–1:30 pm
 
CONCURRENT SESSION P1: Drug-Related Illness ......................................................................................................................  1:35–3:20 pm
 
CONCURRENT SESSION P2: Water-Related Illness ......................................................................................................................  1:35–3:20 pm
 
SESSION Q: Awards and Late-Breaking Reports .............................................................................................................................  3:35–5:15 pm
 
CLOSING REMARKS AND ADJOURNMENT ............................................................................................................................. 5:15–5:25 pm
 
POSTCONFERENCE EIS SATIRICAL REVIEW  ...................................................................................................................................... 7:30 pm
 
Awards presented during session. 
Disclaimer: The findings and conclusions of the reports presented at the 66th Annual EIS Conference are those of the authors and do not necessarily represent the official position of the Centers for 
Disease Control and Prevention (CDC). Use of trade names and commercial sources is for identification only and does not imply endorsement by the Division of Scientific Education and Professional 
Development; Center for Surveillance, Epidemiology, and Laboratory Services; CDC; or the Public Health Service. Published April 2017. 
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Welcome to the 2017 annual Epidemic Intelligence Service (EIS) conference. 
So what?
I think many of you will appreciate that this year’s conference theme is, Science That Makes a Difference: Anticipating the, “So What?”
CDC takes pride in its pledge to use the highest quality scientific data to directly inform decisions to protect our communities. With
this theme in mind, we welcome you to continually challenge the EIS presentations this year with your practical questions of “So 
what?” As an EIS community, your comments help our officers think in actionable, impactful, and policy-relevant ways. I also urge you
to review our annual EIS update, which highlights more examples of how the work of our EIS officers makes an impact and is critical to
generating key actions that protect health and save lives. 
No one exemplifies a focus on making sure that work is impactful and policy-relevant more than this year’s Langmuir lecturer,  
Dr. Sandro Galea! Sandro Galea is a physician, epidemiologist, and dean at the Boston University School of Public Health. He
has long championed the tenets of “consequential epidemiology” to emphasize the importance of ensuring that our work focuses on
questions that lead directly to actions to improve population health. He was named one of TIME magazine’s epidemiology innovators
and listed by Thomson Reuters as one of the “world’s most influential scientific minds” for the Social Sciences category. The “So what?”
concept of his talk will have us thinking about how we move from conducting epidemiologic studies to making broad impacts in 
quantitative population health science. Mark your calendars, as the Alexander D. Langmuir lecture will take place on Wednesday from
3:15 p.m.–4:45 p.m. 
I also encourage you to attend our Laboratory Leadership Service (LLS) presentations. LLS is modeled after the EIS program. LLS
officers have made a substantial impact in improving the operational effectiveness, quality and safety of our laboratories and in helping
coordinate laboratory and epidemiologic work through their involvement in multiple field investigations. Please attend this session as 
they work to communicate the importance of their findings to an epidemiologically-oriented audience, and to further build bridges 
between laboratory and epidemiology sciences at CDC. The LLS presentations will take place on Tuesday from 1:25 p.m.–2:40 p.m. 
Two special sessions are being held this year; the first is on using advanced molecular tools to direct public health action
(Tuesday, 12:05 p.m.–1:20 p.m.) and the second is on the Zika virus outbreak (Wednesday, 11:50 a.m.–1:05 p.m.). 
As we have done since I became the chief of the EIS program, in the past year we focused heavily on our internal strategic planning 
and incorporating your comments and suggestions to continually improve this legacy fellowship. This new conference venue, with
its improved space for recruitment and networking, was selected as a result of your prior feedback. We welcome your feedback as we
continue to learn, grow, and improve the EIS conference experience. 
I again encourage you to take a good look at the annual EIS update, which includes a description of the very talented incoming EIS 
class, as well as details on the amazing work of our current EIS officers.  You will also find examples of how the EIS program works to





continually improve its processes. I am extremely proud of the behind-the-scenes dedication and effort of the operational and scientific 
staff in the Epidemiology Workforce Branch. None of this would happen without them. Please seek us out with any comments or
questions that you might have—they are most welcome! 
I also want to thank all of you for your support and advice the past three conferences. I treasure my experience as lead for the EIS 
program and working in the Center for Surveillance, Epidemiology, and Laboratory Services—it is truly a place where promising 
young (and not so young) scientists receive full support from leadership to pursue their personal dreams and undertake work that has 
meaningful impact on public health workforce development.  
CAPT Joshua A. Mott, EIS '98 
Chief, EIS Program 
DSEPD, CSELS, CDC 
United States Public Health Service 
"Supposing is good, but finding out is better."
— Mark Twain 














The EIS Alumni Association (EISAA) represents more than 3,000 alumni working on the front lines of public health at local, state,
federal, and global levels, both public and private sectors. The association was first established in the 1960s by a group of alumni 
interested in fostering a sense of loyalty to the EIS program through various activities, including sponsoring several prestigious awards, 
hosting alumni networking events, and carrying-on treasured EIS traditions throughout conference week. 
EISAA supports the Alexander D. Langmuir Prize, named in honor of the beloved founder of the EIS Program and awarded to an
outstanding manuscript completed during EIS; the Distinguished Friend of EIS Award honoring an individual who has provided 
exceptional mentoring and support to EIS Officers; the Donald C. Mackel Memorial Award recognizing the EIS investigation that best 
exemplifies collaborative work between epidemiology and laboratory science; the J. Virgil Peavy Memorial Award named in honor of
a distinguished CDC statistician and EIS mentor and recognizing the investigation that most effectively uses innovative statistics and 
epidemiologic methods; and the EIS Champion Award initiated in 2013 in honor of Dr. Steven B. Thacker, an inspirational leader who 
championed the EIS program and its officers throughout his career. Each year, EISAA also provides competitive travel scholarships for 
prospective applicants to attend the EIS Conference through the David J. Sencer Scholarship Award. This year, EISAA had the pleasure
of receiving more than 50 applications and awarding 8 travel scholarships. EISAA also provides funding for food and beverages 
between scientific sessions and helps support EIS Conference events such as the Prediction Run and Satirical Review. 
We are grateful to the de Beaumont Foundation for a grant received last year to help strengthen EISAA and mobilize our alumni base. 
Their support is allowing us this year to launch a new, user-friendly website (www.eisalumni.org) and alumni portal that will allow
EIS alumni, officers, and potential recruits to find each other and connect based on geographic location or interest. The interactive
database and improved communication infrastructure will provide a platform for alumni to network, share career experiences, 
advocate for important public health issues, promote public health events, and provide feedback on how to improve the EISAA. The 
grant has also allowed EISAA to mobilize broader recruitment support for the EIS program by assisting with the development of
new recruitment materials, sponsoring regional recruitment events, and utilizing our diverse alumni pool to speak at local residencies, 
academic institutions, and national conferences. 
If you haven’t already made a contribution to EISAA this year, please consider doing so TODAY!  Your support can help your EIS 
class achieve victory in our competitive class competition. Here’s how you can get involved: 
• Join Now! Renew your membership or make a contribution online (http://www.eisalumni.org) or at the EISAA table. 
• Stay Connected! Look for alumni portal launch information coming soon. This information will guide you on how to log-on to
our new website (http://www.eisalumni.org) alumni portal and update your contact information and alumni profile.
• Learn More! Join us at our Annual meeting on Monday, April 24 at 5:15 p.m. on Floor 203 Room AB and stop by the EISAA 
table in the main reception area of the Conference. 
EISAA is driven by an important purpose — to bring alumni and friends together to connect professionally and personally.  We hope
you will join us in building our alumni community and supporting the premier public health training program in the world! 
Sincerely, 
Steve Waterman, MD, MPH 
President, EIS Alumni Association, EIS ‘10 
Diana Robelotto 
Director of Alumni Affairs/EISAA Liaison, CDC Foundation 
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Scientific Program Committee
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Acknowledgments/Disclaimers 
The EIS Program extends a special thank you to the EIS
Alumni Association and the Council of State and Territorial
Epidemiologists for their generous support of the 66th Annual
EIS Conference. The EIS Program gratefully acknowledges
the valuable assistance and cooperation of the editorial and
support staff of all CDC administrative units participating in
the EIS Conference. 
Abstracts in this publication were edited and officially cleared 
by the respective national centers. Therefore, the EIS Program 
is not responsible for the content, internal consistency, or
editorial quality of this material. Use of trade names throughout
this publication is for identification only and does not imply
endorsement by the U.S. Public Health Service or the U.S. 
Department of Health and Human Services. 
The findings and conclusions in these reports are those of the 
authors and do not necessarily represent the official position of
the Centers for Disease Control and Prevention. 
Purpose Statement 
The primary purpose of the EIS Conference is to provide a 
forum for EIS officers to give scientific presentations (oral or
poster), increase their knowledge of recent investigations and 
the significance to public health, and maintain and increase
their skills in determining the appropriateness of epidemiologic 
methods, presenting and interpreting results clearly, and 
developing appropriate conclusions and recommendations. 
Overall Conference Goals 
• To provide a forum for EIS officers, alumni, and other 

public health professionals to engage in the scientific 

exchange of current epidemiologic topics.
 
• To highlight the breadth of epidemiologic investigations
at CDC. 
• To provide a venue for recruitment of EIS graduates into
leadership positions at CDC and state and local 
departments of health. 
Staff are available at the conference registration desk. Check-in
and onsite registration are available Monday–Wednesday,
7:00 am–5:00 pm. Please wear your conference badge at all
times during the conference. Conference staff are wearing 
purple badges and are available to assist if you need additional 
information or misplace your badge. 
Cyber Café/Message Center 
All participants are welcome to drop by the complimentary
Cyber Café to check emails, conduct meetings and prep for 
conference activities throught the conference week. Please
limit computer time to 10 minutes per session to allow other 
conference attendees an opportunity to use the system as well. 
The Cyber Café will be open Monday–Wednesday,  
8:00 am–5:30 pm and Thursday from 8:00 am–4:00 pm. 
Environmental Considerations 
Smoking is not permitted in any of the conference sessions, 
hallways, or meeting rooms. As a courtesy to presenters and 
all meeting attendees, please mute cellular phones during
conference sessions. Please limit use of cellular phones to public 
areas outside the meeting rooms. 
Lactation Room 
Please visit the EIS information table near the registration area
to sign up for lactation room access. A schedule and key will be
available at the table Monday–Thursday, 8:00 am–5:00 pm. 
Communications App 
Preregistered attendees have immediate access to find, 
communicate, and network with other conference  
participants, speakers and staff. You can also upload a picture 
of yourself to facilitate easy identification. Please see conference 
staff for assistance if you have any questions about the 
Communications App.
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How to Obtain Continuing Education
 
Continuing Education for this conference is only available through the CDC Training and Continuing Education Online system (CDC
TCEO).  Please follow the instructions provided below. You must complete the online evaluation by May 29, 2017 to receive your 
Continuing Education or your certificate of completion. 
To complete online evaluation: 
• Go to CDC TCEO at https://www.cdc.gov/tceonline/.  
Select Participant Login to login. If you are new to
TCEO, select New Participant to create a user ID and 
password. 
• Once logged on to CDC TCEO, the Participant Services
page will display.  Select the Search and Register link. 
Select the CDC Courses link at the bottom right of the 
search page. 
• The next page will ask for the CDC Center/Course 
Code. The code for this course is EISCONF17. Enter 
the course code and select View. 
• Click on the conference name, and the conference 
information page will display.  Scroll down to Register
Here. Select the type of CE that you would like to receive
and then select Submit. 
• The next page requests demographic information.  	New 
participants are required to answer the demographic 
questions.  Returning participants please verify this 
information and select Submit. 
• A message will display thanking you for registering for 
the conference. You will then be prompted to select the 
sessions that you would like to attend. 
• After attending your selected conference sessions return to
CDC TCEO. Select Participant Login
to login.  
• The Participant Services page will display. Select the 
Evaluations and Tests link. Select Conferences. The 
conference will be listed with the sessions you selected. 
You may Add/Edit Sessions until you have completed the 
evaluation for a particular session.  After completing all of
the session evaluations you will be prompted to complete 
the overall conference evaluation.  
• A record of your conference completion and your CE 
certificate will be posted in the Transcript and Certificate
section, located on the Participant Services page. 
• If you have any questions or problems, please contact  




JOIN THE EPIDEMIC 
INTELLIGENCE SERVICE (EIS) 
A life-changing career experience! 
The application period for the 
2018 EIS Class opens May 1, 2017
and closes June 30, 2017. 
JOIN THE LABORATORY 
LEADERSHIP SERVICE (LLS)
Become a future public health laboratory leader! 
The application period for the 
2018 LLS Class opened April 20  
and closes July 17, 2017. 






66th Annual EIS Conference Schedule 
Monday, April 24, 2017 
7:00 	 Registration Desk Opens 
8:15 	 Welcome and Call to Order  ................................................................................................................. Frieden Plenary 
Moderator: Joshua Mott
Presentation of Stephen B. Thacker EIS Champion Award 
8:30–10:15 SESSION A: Stephen B. Thacker Opening Session  ............................................................................. Frieden Plenary 
Moderators: Anne Schuchat and Michael Iademarco 
8:35 	 Prevalence of Human Papillomavirus Before and After Vaccine Introduction — National Health and 
Nutrition Examination Surveys, United States, 2003–2014. Sara Elizabeth Oliver 
8:55 	 Raw Deal: Multistate Outbreak of Salmonella Virchow Infections Linked to a Powdered Meal Replacement 
Product — United States, 2015–2016. Kelly Gambino-Shirley 
9:15 	 Sexual Orientation Discordance and Suicidal Ideation and Suicide Attempt Among U.S. High School
Students — United States, 2015. Francis Annor 
9:35 	 Knowledge, Attitudes, and Practices Rapid for Assessment To Improve Yellow Fever Vaccine Uptake Among 
Men During an Outbreak — Luanda, Angola, 2016. Mariel Asbury Marlow 
9:55 	 Special Education Outcomes Among Children Born with Neonatal Abstinence Syndrome — Tennessee,
2008–2011. Mary-Margaret Anne Fill 
10:15 	BREAK
10:45–12:10 	 CONCURRENT SESSION B1: Vaccine-Preventable Diseases ............................................................ Fri eden Plenary 
Moderators: Nancy Messonnier and Sam Posner 
10:50 	 Epidemiology of a Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting and Use of a Third 
Dose of Measles-Mumps-Rubella Vaccine (MMR) for Outbreak Control — Iowa, July 2015–May 2016.  
Minesh Pradyuman Shah 
11:10 	 Measles Outbreak at a United States Immigration and Customs Enforcement Facility — Arizona, May–June 
2016. Heather Venkat 
11:30 	 Impact of Sociodemographic Factors on Implementation of the Standards for Adult Immunization
Practice — United States, 2016. Neil C. Murthy 
11:50 	 Risk Factors for Meningococcal Disease Among Adults Experiencing Homelessness in Boston — 
Massachusetts, 2016. John O. Otshudiema 
10:45–12:10 	 CONCURRENT SESSION B2: Chronic Disease Prevention and Health Disparities  ........Concurrent Session Room 
Moderators: Ursula Bauer and Tala Fakhouri 
10:50 	 Cardiovascular Disease Risk Factors by Level of Active Transportation Among U.S. Adults, 2011–2014  
Marissa L. Zwald 
11:10 	 Comparison of Inactivity Among Adults with Disabilities by Using Two Disability Measures — National 
Health Interview Survey, 2011–2015. Dana Olzenak McGuire 
11:30 	 Racial Differences in Survival of Pediatric Patients with Brain and Central Nervous System Cancer —  
United States, 2001–2012. David A. Siegel 
Awards presented during session.
 











11:50 	 Trends in Hospitalization Rates for Patients with Myocardial Infarction by Race/Ethnicity Among Kaiser 
Permanente Southern California Members — Southern California, 2000–2014. Gloria Chi 
12:15–1:30 	LUNCH 
1:45–3:30 	 SESSION C: J. Virgil Peavy Memorial Award Finalists  ....................................................................... Frieden Plenary 
Moderators: Jennifer Parker and Byron Robinson 
1:50 	 A Novel Approach to Analysis of Cryptosporidiosis and Giardiasis Surveillance in the United States,  
2005–2015. Katharine Benedict 
2:10 	 Power Law Analysis of Foodborne Outbreaks — United States, 1998–2015. Julie Lynn Self
2:30 	 HIV, Serostatus Knowledge, and Viral Load Suppression Among Female Sex Workers in Kampala, Uganda, 
2012 — A Respondent-Driven Sampling Survey. Reena H. Doshi 
2:50 	 Impact of HIV Sequence Reporting Completeness on Detection of Growing HIV Transmission Clusters — 
Michigan, 2012–2014. Sharoda Dasgupta 
3:10 	 Spatial Clustering of Suicide and Area-Level Characteristics at Census Block Group Level — Idaho 
2010–2014. Ahmed Magdy Kassem 
3:30–4:30 	 EIS RECRUITMENT INFORMATION SESSION  ..................................................................... 3rd Floor R oom 203E
 
3:45–5:10	 CONCURRENT SESSION D1: Zoonotic Diseases  ............................................................................. Frieden Plenary 
Moderators: Casey Barton Behravesh and Brett Petersen
3:50 	 No Kidding: Large Outbreak of Human Escherichia coli O157 Infections Linked to a Goat Dairy Farm — 
Connecticut, 2016. Kelly Gambino-Shirley 
4:10 	 A Comparison of Three Statistical Thresholds to Trigger a Public Health Response to Monkeypox — 
Democratic Republic of the Congo, 2011–2013. Sarah Guagliardo 
4:30 	 Q Fever Endocarditis — United States, 1999–2015. Anne Straily 
4:50 	 Northern Trajectory of Human Tularemia — United States, 1965–2013. Natalie Anne Kwit 
3:45–5:10	 CONCURRENT SESSION D2: Reproductive Health  .........................................................Concurrent Session Room 
Moderators: Wanda Barfield and Cheryl Broussard
3:50 	 Intracytoplasmic Sperm Injection (ICSI) Use Among States With and Without Insurance Coverage for 
Infertility Treatment — United States, 2000–2014. Ada Dieke 
4:10 	 Antiviral Treatment Among Hepatitis B Virus–Infected Pregnant Women — New York City and Michigan, 
2013–2015. Ruth Link-Gelles 
4:30 	 Distribution of Severe Maternal Morbidity by Comorbidity Status Among Delivery Hospitalizations — 
Massachusetts, 1998–2013. Nicholas Somerville 
4:50 	 Attention-Deficit Hyperactivity Disorder Medication Use During Pregnancy and Risk for Birth Defects — 
United States, 1997–2011. Kayla Anderson 
3:45–5:10	 CONCURRENT SESSION D3: Global Health: Treatment and Safety ................................... 3rd Floor Room 203 AB 
Moderators: Rebecca Martin and Wences Arvelo
3:50 	 Efficacy of Artemether-Lumefantrine for Treatment of Uncomplicated Plasmodium falciparum Malaria — 
Cruzeiro do Sul, Brazil, 2016. Megumi Itoh 
4:10 	 Effect of Mass Drug Administration Regimen on Schistosoma mansoni Morbidity Among School-Aged 
Children Over a 5-Year Period — Kenya, 2010–2015. Anita Devi Sircar 




4:30 Improving Injection Safety in Cambodia: A Public Health Response to the 2014–2015 HIV Outbreak in Roka 

Commune. Ugonna C. Ijeoma 
4:50 Misuse of Antibiotics for Childhood Diarrhea Case Management — Western Kenya, 2009–2016.  
Chulwoo Rhee 
5:15–7:00 EIS ALUMNI ASSOCIATION MEETING .............................................................................. 3rd Floor Room 203 AB
 
Tuesday, April 25, 2017 
8:30–9:55 	 CONCURRENT SESSION E1: STDs and HIV ................................................................................. ... Frieden Plenary 
Moderators: Gail Bolan and Bob Kirkcaldy 
8:35 	 Syphilis Screening Among Pregnant Women — Guam, 2014. Susan Cha 
8:55 	 Prevention of Mother-to-Child Transmission of HIV Service Utilization Among Adolescents and Young 
Women — Zimbabwe, 2013. Amanda Burrage 
9:15 	 Infant HIV Diagnosis and Testing Turnaround Time — Malawi, 2012–2015. Hammad Ali 
9:35 	 Factors Associated with Condomless Anal Sex Among Black Men Who Have Sex with Men — New York City, 
2012. Erica Dawson 
8:30–9:55 	 CONCURRENT SESSION E2: Occupational Safety and Health  ....................................... Concurrent Session Roo m 
Moderators: John Gibbins and Candice Johnson 
8:35 	 Respiratory and Ocular Symptoms Among Employees at an Indoor Waterpark Resort — Ohio, 2016.  
Sophia Chiu 
8:55 	 Respiratory Morbidity Among U.S. Coal Miners — States Outside of Central Appalachia, 2005–2015.  
Laura Reynolds 
9:15 	 Occupational and Take-Home Lead Exposure Associated with a Lead Oxide Manufacturing Plant —  
North Carolina, 2016. Jessica Lynn Rinsky 
9:35 	 Occupational Distribution of Campylobacteriosis and Salmonellosis Cases — Maryland, Ohio, and Virginia, 
2014. Chia-Ping Su 
10:15–12:00 	 SESSION F: Donald C. Mackel Memorial Award Finalists  ............................................................. .... Frieden Plenary 
Moderators: Gregory Armstrong and Reynolds Salerno 
10:20 	 Acute Zika Virus Infection as a Risk Factor for Guillain-Barré Syndrome — Puerto Rico, April–December 
2016. Emilio Dirlikov 
10:40 	 Unusual Source of Gram-Negative Bloodstream Infections in Hemodialysis Patients — Illinois and Missouri, 
2015–2016. Shannon A. Novosad 
11:00 	 Integrating Epidemiologic and Molecular Data During an Outbreak of a Rare Strain of Shigella Among Men 
Who Have Sex with Men — Southern California, 2016. Megan C. Dillavou Jarashow 
11:20 	 Hospital-Associated Outbreaks of Multidrug-Resistant Candida auris — Multiple Cities, Colombia, 2016. 
Paige Armstrong 
11:40 	 Unusual Pathogen Associated with Nonbiting Flies in a Person with Bacteremia — Washington State, 2016. 
Jesse Bonwitt 
12:05–1:20 	LUNCH 
SPECIAL SESSION 1: Epidemiologic Investigations of Environmental Exposures  ............. 3rd Floor Room 203 AB
 






POSTER SYMPOSIUM I ..................................................................................................... Concurrent Session Room 
Moderators: Douglas Hamilton and Michael King 
During the first 30 minutes of the poster symposium, the following authors will each give a 2-minute oral presentation
at the podium in front of a seated audience in the Concurrent room. Afterward, the authors will stand with their 
posters for the remaining session time in the poster area. The audience is encouraged to view the individual posters 
and engage in direct discussion with the author. 
P1.1 	 Mental Health and HIV-Related Sexual Risk Behaviors Among Adolescent Sexual-Minority Males — 
Chicago, New York City, and Philadelphia, 2015. Christine B. Agnew-Brune
P1.2 	 Characteristics and Predictors of Inflammation Among Infants Aged 6–23 Months — Nepal, 2012.  
Victor Akelo 
P1.3 U.S. Zika Pregnancy Registry Evaluation — United States, 2016. Meng-Yu Chen 
P1.4 Correlates of Blood Lead Testing and Test Results in Young Children — Southern California, 2008–2015.  
Gloria C. Chi 
P1.5 	 Prevalence and Factors Associated with Local Herb Use by Pregnant Women — Kigoma, Tanzania, 2014.  
Rena Fukunaga 
P1.6 Epidemiology of Railway Suicide Deaths: National Violent Death Reporting System, 18 States — United 
States, 2003–2014. Amanda Garcia-Williams 
P1.7 Novel Data Source for the Northwest Tribal Registry Project — Washington, 2016. Sarah M. Hatcher 
P1.8 Comparison of Vaccination Coverage Among U.S.-Born and Foreign-Born Adolescents Aged 13–17 Years — 
United States, 2012–2014. Jessica M. Healy 
P1.9 Assessment of Property and Health Effects of a Drought Emergency — Mariposa County, California, 2016. 
Rebecca L. Laws 
P1.10 Seoul Searching: Outbreak of Seoul Virus among Ratteries and Pet Owners — Illinois, 2017. Janna Kerins 
P1.11 Suspected Illicitly Manufactured Fentanyl-Related Overdose Death Characteristics — Massachusetts,  
2014–2015. Julie K. O’Donnell 
P1.12 Under-Five Mortality Reporting Following the Ebola Virus Disease Epidemic — Sierra Leone, 2015–2016. 
Amanda Wilkinson 
SESSION G: Laboratory Leadership Service Presentations  .................................................. 3rd Floor Room 203 AB 
Moderators: Conrad Quinn and Xin Liu 
1:35 	 Legionella Prevalence and Diversity in Cooling Towers — United States, Summer 2016.  Anna C. Llewellyn 
1:55 	 Emergence of 23S Mutations Associated with Macrolide Resistance in Group B Streptococcus — Georgia, 
2015. Jessica N. Ricaldi 
2:15 	 Comparative Risk Assessment of Laboratory Response Network (LRN) Methods to Process Potable Water 
Samples for Detection of Bioterrorism Threat Agents. Diana Riner 
2:35 	 Understanding Antimicrobial Resistance in Neisseria gonorrhoeae: An Epigenetic Approach. 
Brunilís White 
CONCURRENT SESSION H1: Global Health: Epidemiology and Disease Prevention .................... Frieden Plenary 
Moderators: Kimberley Fox and Susan Chu 
3:05 	 Ascertaining Infant Measles Mortality and Risk Factors During a Prolonged Nationwide Measles Outbreak — 
Mongolia, 2015–2016. Christopher Lee 
3:25 	 Epidemic Cholera and Micronutrient Deficiency — Grande Saline, Haiti, 2011. Sae-Rom Chae 
3:45 	 Measles-Rubella Vaccination Campaign Coverage and Use of Campaign-Related Mobile Phone Message 
Reminders — Kenya, 2016. Saleena Subaiya 
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4:05 	 Sustained Use of Portable Handwashing and Drinking Water Stations in Health Care Facilities — Siaya 
County, Kenya, 2016. William Davis 
4:25 	 Immunogenicity of Type 2 Monovalent Oral and Inactivated Poliovirus Vaccines — Bangladesh, 2016.  
Michelle Morales 
CONCURRENT SESSION H2: Notes from the Field ......................................................... Concurrent Session Room 
Moderators: Joseph McLaughlin and Kris Bisgard 
3:05 	 Burden of Extrapulmonary Nontuberculous Mycobacterial Disease and Utility of Statewide Surveillance — 
Oregon, 2014–2016. David Shih 
3:25 	 Shiga Toxin-Producing Escherichia coli. Convalescent Testing by Using Multiplex Polymerase Chain Reaction
Panel and Culture Methods — Kansas, 2016. Jessica Nadeau Tomov 
3:45 	 Zika-Related Birth Defects Surveillance — Texas, 2016. Noemi Hall 
4:05 	 Evidence of Health Care Transmission of Candida auris: An Investigation of 2 Cases — Chicago, Illinois, 
2016. Janna Kerins 
4:25 	 Food-Related Anaphylactic Deaths — New York City, 2000–2014. Eugenie A. Poirot 
Prediction Run ......................................................................................................................................  Piedmont Park 
Sponsored by the EIS Alumni Association  
Self transport to venue; carpooling is encouraged 
SESSION I: FETP International Night — Poster Presentations ......................................... Concurrent Session Room
 
Wednesday, April 26, 2017 
CONCURRENT SESSION J1: Emerging Infections  ........................................................................... Frieden Plenary 
Moderators: Christopher Braden and Michael Gronostaj 
8:35 	 Zika Virus Infection in a Patient with No Known Risk Factors — Utah, 2016. Elisabeth Raquel Krow-Lucal
8:55 	 Prediction of the Zika Virus Infection Burden in Puerto Rico Using Bayesian Methods, November  
2015–October 2016. Jessica M. Healy 
9:15 	 Care of Ebola Survivors at ELWA Clinic in Monrovia, Liberia. Annabelle de St. Maurice 
9:35 	 It’s Not Polio! Acute Flaccid Myelitis — United States, August 2014–October 2016. Tracy Ayers 
9:55 	 The First Eight Reported Cases of Candida auris, an Emerging, Multidrug-Resistant Yeast — New York, 
2013–2016. Sharon Tsay 
CONCURRENT SESSION J2: Injury .................................................................................. Concurrent Session Room 
Moderators: Debra Houry and Katie Fowler 
8:35 	 Mental Health Related Emergency Department Visits After a Noncasualty Terrorist Event — New Jersey, 
September 2016. Faye Rozwadowski 
8:55 	 Risk and Protective Factors for Driving After Five or More Alcoholic Drinks Among College Students — Fall 
National College Health Assessment, United States, 2011–2014. Alexis Peterson 
9:15 	 Fatal Injuries in the Alaska Logging Industry, 1991–2014. Yuri Paris Springer 
9:35 	 Investigation of Fatal and Nonfatal Suicidal Behavior, Ages 10–24 — Santa Clara County, California, 2016. 
Amanda Garcia-Williams 
9:55 	 Adherence of Media Reporting of Suicides to Suicide Reporting Guidelines — Santa Clara County, California, 






10:30–11:45 	 POSTER SYMPOSIUM II  .............................................................................................. ..... Concurrent Session Room 
Moderators: Tim Jones and Dianna Carroll 
During the first 30 minutes of the poster symposium, the following authors will each give a 2-minute oral presentation
at the podium in front of a seated audience in the Concurrent room. Afterward, the authors will stand with their 
posters for the remaining session time in the poster area. The audience is encouraged to view the individual posters 
and engage in direct discussion with the author. 
P2.1 Multistate Epidemiologic Description of Histoplasmosis in the United States, 2011–2014.  
Paige Alexandria Armstrong 
P2.2 	 Adaptation of the County-Level Vulnerability Assessment for Rapid Dissemination of HIV or Hepatitis C 
Virus Infections Among Persons Who Inject Drugs — Colorado, 2011–2015. Alexis Burakoff 
P2.3 	 Risk Factors for Zika Virus Infection Identified Through Household Cluster Investigations — Puerto Rico, 
2016. Rachel Burke 
P2.4 	 Characteristics of Persons with Repeat Syphilis Infection — Idaho, 2011–2015. Ahmed Magdy Kassem 
P2.5 	 Streptococcus equi Subspecies zooepidemicus Fatal Infection Associated with Equine Exposure — King
County, Washington State, 2016. Vance Morio Kawakami 
P2.6 	 Antimicrobial Resistance Among Pediatric Central Line–Associated Bloodstream Infections Reported to the 
National Healthcare Safety Network, 2011–2014. Jason Lake
P2.7 	 Gastrointestinal Illness Surveillance in Peace Corps Volunteers: An Evolving Epidemiologic Surveillance 
System, 2013–2016. Jarred McAteer 
P2.8 	 Assessment of the Sensitivity of Group A Streptococcal Necrotizing Fasciitis Surveillance from Alaska’s
Laboratory-Based Surveillance System, 2015–2016. Emily Mosites 
P2.9 	 Evaluating Interest in an H5N1 Vaccine Among Highly Pathogenic Avian Influenza Laboratory Workers in 
the United States. Kate Russell 
P2.10 	 High Rates of Active Tuberculosis Among Immigrants from the Philippines — Hawaii, 2010–2014.  
Kristine Marie Schmit 
P2.11 Healthcare-Associated Legionnaires’ Disease — United States, 2014. Elizabeth Soda 
P2.12 Evaluation of the Case Definition for Suspected Yellow Fever Deaths in an Outbreak Setting — Angola, 2016. 
Anna Yaffee 
11:50–1:05 	LUNCH 
11:50–1:05 	 SPECIAL SESSION 2: Zika Virus Infection  ...........................................................................  3rd Floor Room 203 AB 
Moderators: Steve Monroe and Robert Tauxe 
1:15–3:00 	 CONCURRENT SESSION K1: Healthcare-Associated Outbreaks  .................................................... Frieden Plenar y 
Moderators: Mike Bell and Isaac See 
1:20 	 Careful of the Wound: Group A Streptococcus Outbreak in a Skilled Nursing Facility — Chicago, 2015–2016. 
Sana Shireen Ahmed 
1:40 	 Fungal Bloodstream Infections Associated with Substandard Compounding Practices at an Outpatient 
Oncology Practice — New York City, 2016. Amber Marie Vasquez 
2:00 	 Nontuberculous Mycobacteria Infections Among Breast Plastic Surgery Patients — Hospital A,  
South Carolina, 2014–2016. Kimberly Skrobarcek 
2:20 	 Cluster of Pseudomonas Infections Among Neonatal Intensive Care Unit Patients — Maryland, 2016.  
Mark Weng 
2:40 	 Burkholderia cepacia Bloodstream Infections Among Skilled Nursing Facility Residents — United States, 
2016. Richard Benjamin Brooks 
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1:15–3:00 	 CONCURRENT SESSION K2: Environmental Health .......................................................Concurrent Session Room 
Moderators: Patrick Breysse and Suzanne Beavers 
1:20 	 My Old Kentucky Home: Arsenic Contaminated Soil in a Kentucky Neighborhood and Response, 2016.  
Anna Yaffee 
1:40 	 Project Coyote Water: Assessment of Unregulated Drinking Water on Tribal Lands Within the  
United States — January 2015–March 2016. Gamola Z. Fortenberry 
2:00 	 Secondhand Exposure to E-Cigarette Aerosol in Public Places: Findings from the 2015 National Youth 
Tobacco Survey. Teresa Wei Wang 
2:20 	 The Burden of Asthma: Healthcare Utilization Patterns and Asthma Triggers — Puerto Rico, 2013.  
Lillianne M. Lewis 
2:40 	 Community Assessment for Public Health Emergency Response (CASPER) After the Flint Water Crisis — 
Flint, Michigan, 2016. Alice Wang 
3:15-4:45 SESSION L: Alexander D. Langmuir Lecture ...................................................................................... Frieden Plenary 
Presentation of Alexander D. Langmuir Award and Distinguished Friend of EIS Award  
Moving from Epidemiology to Quantitative Population Health Science 
Moderator: Patricia Simone 
Speaker: Sandro Galea, MD, MPH, DrPH 
5:15–7:00 	 EIS CAREER NETWORKING NIGHT  ...................................  3rd Floor Prefunction Space and Room 203 D and  F
 
6:30–9:00 	 SESSION M: FETP International Night — Oral Presentations  ......................................... Concurrent Session Room
 
Thursday, April 27, 2017 
8:30–9:55 	 CONCURRENT SESSION N1: Respiratory Diseases  ........................................................................ . Frieden Plenary 
Moderators: Mark Pallansch and Lindsay Kim 
8:35 	 Neighborhood-Level Poverty, Poverty-Associated Factors, and Severe Outcomes Among Adults Hospitalized 
with Influenza — United States, 2012–2015. Rebekah Stewart Schicker 
8:55 	 Influenza-Associated Pediatric Deaths in the United States, 2010–2016. Mei Shang 
9:15 	 Epidemic Keratoconjunctivitis Outbreak Due to Human Adenovirus Type 8 — U.S. Virgin Islands, 2016.  
Marie Killerby 
9:35 	 Differences in Pneumococcal Carriage and Serotype Distribution Between Children With and Without 
Pneumonia — Maputo, Mozambique, 2014–2016. Tolulope Adebanjo 
8:30–9:55 	 CONCURRENT SESSION N2: Hepatitis and Tuberculosis  .............................................. Concurrent Session Room 
Moderators: Carla Winston and Larry Cohen 
8:35 	 Hepatitis A Outbreak from Imported Frozen Strawberries — 9 States, 2016. Megan Hofmeister 
8:55 	 Increased Incidence of Acute Hepatitis B in a Rural County — Alabama, 2012–2015. Charlene Siza 
9:15 	 Hepatitis C-Associated Mortality Rates Among American Indian/Alaska Natives — Washington, 2009–2014. 
Sarah Hatcher 
9:35 	 Demographic and Clinical Characteristics Associated with Tuberculosis/HIV Comorbidity — United States, 
2011–2015. Kristine Marie Schmit 
10:15–12:00 	 CONCURRENT SESSION O1: Foodborne Outbreaks  .......................................................................  Frieden Plenary 
Moderators: Robert Tauxe and Michael Jhung 
10:20 	 Botulism Outbreak at a Federal Correctional Facility — Mississippi, 2016. Lindsey Sarah McCrickard 
Awards presented during session.
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 10:40 	 Undetermined Source of Salmonella Infantis Infections Among Detention Center Inmates — South Carolina, 
2016. Sarah Luna 
11:00 	 Fluoroquinolone-Resistant Campylobacter jejuni Infections Associated with Unpasteurized Milk from a Dairy 
Cow Herdshare — Colorado, 2016. Alexis Burakoff 
11:20 	 Salmonella Javiana Infections Linked to a Restaurant in Maricopa County — Arizona, 2016. Heather Venkat 
11:40 	 Salmonella Typhimurium Outbreak Associated with Cheese from a Local Creamery — North Carolina, 2016. 
Jessica Lynn Rinsky 
10:15–12:00 	 CONCURRENT SESSION O2: Child Health  ..................................................................... Concurre nt Session Room 
Moderators: Georgina Peacock and Andrea Sharma 
10:20 	 Acute Flaccid Myelitis in Pediatric Patients — Maricopa County, Arizona, 2016. Sally Iverson 
10:40 	 Worsening Childhood Health in Conflict-Affected Areas of Borno State — Northeastern Nigeria,  
October–November 2016. Erin Tromble 
11:00 	 How Infants Die in Ohio: Comparison of Two Methods to Ascertain Cause of Death, 2009–2013.  
Martha Montgomery 
11:20 	 Breastfeeding and Autism Spectrum Disorder in Preschool Children Enrolled in the Study to Explore Early 
Development — United States, 2008–2011. Gnakub Norbert Soke 
11:40 	 Epidemiology and Trends of Pertussis Among Infants — United States, 2000–2015. Catherine Bozio 
12:05–1:30 	LUNCH 
1:35–3:20 	 CONCURRENT SESSION P1: Drug-Related Illness  .......................................................................... Fr ieden Plenary 
Moderators: Debbie Dowell and Andrea Winquist 
1:40 	 Qualitative Description of Suspected Illicitly Manufactured Fentanyl-Related Overdose — Massachusetts, 
2016. Nicholas Jacob Somerville 
2:00 	 Fentanyl Overdose Deaths in New Mexico During 2015–2016. Nicole Anna Middaugh 
2:20 	 Deaths Associated with Opioid Use and Possible Infectious Disease Etiologies Among Persons in the 
Unexplained Death (UNEX) Surveillance System — Minnesota, 2006–2015. Victoria Hall 
2:40 	 Electronic Surveillance System for the Early Notification (ESSENCE) for Marijuana-Associated Visits to One 
Hospital Emergency Department — Denver, Colorado, 2016. Grace E. Marx 
3:00 	 Marijuana Use Among Persons with Select Health Conditions — United States, 2011–2014. Amy Seitz 
1:35–3:20 	 CONCURRENT SESSION P2: Water-Related Illness  ........................................................ Concurrent Session Room 
Moderators: Michael Beach and Stacey Bosch 
1:40 	 Shigella sonnei Outbreak Investigation in the Setting of a Municipal Water Crisis — Genesee and Saginaw 
Counties, Michigan, 2016. Robert Paul McClung 
2:00 	 Shigella sonnei Outbreak Among Homeless Persons After Substantial Rainfall — Oregon, 2015–2016.  
Jonas Hines 
2:20 	 Postflooding Leptospirosis — Louisiana, 2016. Alean Frawley 
2:40 	 Access to Safe Water in Haiti: Have We Made Progress? Alaine Kathryn Knipes 
3:00 	 Cryptosporidiosis Associated with Recreational Water — Maricopa County, Arizona, 2016. Sally Iverson 







3:35–5:15 Awards and Late-Breaking Reports 
3:35 	Presentation of Awards  ........................................................................................................................ Frieden Plenary 
Moderator: Tracie Gardner 
• Outstanding Poster Presentation Award 
• Donald C. Mackel Memorial Award 
• J. Virgil Peavy Memorial Award 
• Paul C. Schnitker International Health Award 
• Iain C. Hardy Award 
• James H. Steele Veterinary Public Health Award 
• Mitch Singal Excellence in Occupational and Environmental Health Award 
3:50 	 SESSION Q: Late-Breaking Reports 
Moderators: Stephen Redd and Tracie Gardner 
3:55 	 Evaluating the Utility of rRT-PCR Testing in Whole Blood Compared to Other Specimens and IgM Testing 
to Optimize the Diagnosis of Zika Virus Infection among Asymptomatic Pregnant Women — Puerto Rico, 
2016. Asher Yoel Rosinger 
4:05 	 Identification of Cat-to-Human Transmission During an Outbreak of Influenza A (H7N2) Among Cats in an
Animal Shelter — New York City, 2016. Christopher T. Lee 
4:15 	 Investigation of Salmonella Enteritidis Harboring the mcr-1 Resistance Gene — Connecticut, 2017.   
Vivian H. Leung 
4:25 	 Investigation of a Nationally Distributed Contaminated Organ Transplant Preservation Solution —  
United States, 2016–2017. Matthew J. Stuckey 
4:35 	 Mumps Outbreak — Colorado, 2017. Grace E. Marx 
4:45 	 Shiga Toxin-Producing Escherichia coli O157:H7 Infections After Attendance at a Cider Festival — Kansas, 
2016. Jessica Nadeau Tomov 
4:55 	 Immune Response Following Reactive Vaccination Campaign Using Fractional Dose Yellow Fever Vaccine — 
Kinshasa, Democratic Republic of Congo, 2016. Rebecca M. Casey 
5:05 	 Determining the End Date of Routine Screening of Asymptomatic Pregnant Women for Zika Virus  
Infection — American Samoa, 2016–2017. Ruth Link-Gelles 
5:15–5:25 	 CLOSING REMARKS AND ADJOURNMENT  .................................................................................. F rieden Plenary 
Patricia Simone 
POSTCONFERENCE ACTIVITY 
7:30 	 EIS Satirical Review ............................................................................................................................. Frieden Plenary 
Presentation of Philip S. Brachman Award 
Awards presented during session.
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Awards Descriptions and Committee Members
 
Alexander D. Langmuir Prize 
Manuscript Award 
The Alexander D. Langmuir Prize, established in 1966 by the 
EIS Alumni Association, recognizes a current EIS officer or
recent alumnus (1 year) for excellence in a written report or an
epidemiologic investigation or study. 
2017 Committee Members: Steve Waterman (Chair),  
Neil Gupta, Douglas Hamilton, Art Liang, Laurene Mascola, 
Christina Mikosz, Christina Tan 
Philip S. Brachman Award 
The Philip S. Brachman Award, sponsored by the graduating
class of EIS officers, recognizes excellence in teaching 
epidemiology to EIS officers. 
2017 Committee Members: 2015 EIS Class 
Distinguished Friend of EIS Award 
The Distinguished Friend of EIS Award, sponsored by the EIS 
Alumni Association, recognizes an individual for contributions 
to the health, welfare, and happiness of EIS officers and the  
EIS Program. 
2017 Committee Members: Douglas Hamilton (Chair), 
Tegan Boehmer, Danice Eaton, Art Liang, Christina Mikosz,
Kimberly Porter. 
Iain C. Hardy Award 
The Iain C. Hardy Award, sponsored by the National Center
 
for Immunization and Respiratory Diseases, recognizes a
 
current EIS officer or alumnus (within 5 years) who has
 




2017 Committee Members: Sam Posner (Chair), Eric Mast, 





J. Virgil Peavy Memorial Award 
The J. Virgil Peavy Memorial Award, established in 2003 by
the EIS Alumni Association, recognizes a current EIS officer 
for the oral presentation that best exemplifies the effective and 
innovative application of statistics and epidemiologic methods 
in an investigation or study. 
2017 Committee Members: Katie Fowler (Chair),  
Tala Fakhouri, Andrea Sharma, Glen Satten, Anindye De 
Donald C. Mackel Memorial Award 
The Donald C. Mackel Memorial Award, sponsored by the EIS 
Alumni Association, recognizes a current EIS officer for the 
oral presentation that best exemplifies the effective application 
of a combined epidemiology and laboratory approach to an
investigation or study. 
2017 Committee Members: Jennifer Wright (Chair),  
Suzanne Beavers, Serena A. Carroll, Robert D. Kirkcaldy,
Brandi Limbago 
Outstanding Poster Presentation Award 
The Outstanding Poster Presentation Award is presented by
the EIS Scientific Program Committee to a current EIS officer 
for the poster that best exemplifies scientific content, including 
originality, study design and analysis; public health impact; and 
presentation effectiveness. 
2017 Committee Members: Brett Petersen (Chair),  
Candice Johnson, Sue Chu, Kimberley Folkman, Isaac Evans 
Paul C. Schnitker International Health 
Award 
Paul C. Schnitker, MD, passed away in a plane crash in Nigeria 
in 1969. He was en route to serve as a public health officer in the 
response to famine and other public health problems resulting 
from the Biafra Civil War in Nigeria. He is the only person who 
has died while serving as an EIS officer. The Paul C. Schnitker 
International Health Award, sponsored by the Schnitker family, 
recognizes a current EIS officer or alumnus (1 year) who has 
made a significant contribution to international public health. 
2017 Committee Members: Ezra Barzilay (Chair),
Roodly Archer, Tom Handzel, Nancy Messonnier, Diana Morof,
Kevin Clarke 







James H. Steele Veterinary Public 
Health Award 
The James H. Steele Veterinary Public Health Award,
sponsored by CDC veterinarians, recognizes a current EIS 
officer or alumnus (within 5 years) who has made outstanding 
contributions in the field of veterinary public health through 
outstanding contributions in the investigation, control, or
prevention of zoonotic diseases or other animal-related human 
health problems. 
2017 Committee Members: Casey Barton Behravesh (Chair),
Fred Angulo, Barbara Knust, Kirk Smith, Kendra Stauffer 
Mitch Singal Excellence in Occupational 
and Environmental Health Award 
The Mitch Singal Excellence in Occupational and 

Environmental Health Award, co-sponsored by the National 

Institute for Occupational Safety and Health and the National 

Center for Environmental Health/Agency for Toxic Substances 

and Disease Registry, was established in 2010. The Mitch Singal 

Award recognizes a current EIS officer for excellence in an oral 

presentation that best exemplifies the effective application of
 
public health epidemiology to an investigation in the area of
 
occupational or environmental health.
 
2017 Committee Members: Kanta Sircar (Chair),  

Candice Johnson (Co-Chair), Cammie Chaumont Menendez, 

Timothy Dignam, Tim Jones, Michael King,  

Alexandre Macedo de Oliveira
 
Stephen B. Thacker EIS Champion Award 
The Stephen B. Thacker EIS Champion Award, established in 
2013 by the EIS Alumni Association, recognizes an individual 
who inspires the EIS community through deep and unwavering
commitment to the EIS Program, officers, and alumni.   
2017 Committee Members: Art Liang (Chair), 
Rachel Avchen, Larry Cohen, Jonetta Mpofu, Maria Thacker 
Awards Presented at the 2016 EIS 
Conference 
Alexander D. Langmuir Prize Manuscript Award 
Tushar Singhr 
Philip S. Brachman Award 
Diana Bensyl 
Distinguished Friend of the EIS Award 
Sally Brown 
Iain C. Hardy Award 
Eugene Lam 
J. Virgil Peavy Memorial Award 
Christopher Lee 
Donald C. Mackel Memorial Award 
Isaac Benowitz 
Outstanding Poster Presentation Award 
Charnetta Williams 
Paul C. Schnitker International Health Award 
José E. Hagan 
James H. Steele Veterinary Public Health Award 
Colin Basler and Neil Vora 
Mitch Singal Excellence in Occupational and Environmental 
Health Award 
Megan Casey 
Stephen B. Thacker EIS Champion Award 
Polly A. Marchbanks 

















Alexander D. Langmuir Lectures, 
1972–2016 
The Langmuir Lecture is the preeminent public health lecture in 
the United States. The first lecture was given in 1972, and it has 
been a highlight of the annual EIS Conference each year since 
then. The lecture is named for Alexander D. Langmuir, MD, 
MPH (1910–1993), a public health visionary and leader who 
established the Epidemiology Program at what was then called 
the Communicable Disease Center in 1949; he remained as 
CDC’s chief epidemiologist until his retirement in 1970. 
Notably, Dr. Langmuir founded EIS, established national disease 
surveillance for the United States, and brought the Morbidity
and Mortality Weekly Report to CDC. Langmuir Lecture 
speakers have included Abraham Lilienfeld, Sir Richard Doll, 
Geoffrey Rose, Jonas Salk, and many other prominent public 
health thinkers and researchers. 
1972 	Prevention of Rheumatic Heart Disease — Fact or Fancy. 
Charles H. Rammelkamp 
1973 	Cytomegaloviral Disease in Man: An Ever Developing 
Problem. 
Thomas H. Weller 
1974 	Hepatitis B Revisited (By the Non-Parenteral Route). 
Robert W. McCollum 
1975 	Origin, Spread, and Disappearance of Kuru: Implications 
of the Epidemic Behavior of a Disease in New Guineans
for the Epidemiologic Study of Transmissible Virus 
Dementias. 
D. Carleton Gajdusek 
1976 	The Future of Epidemiology in the Hospital. 
Paul F. Wehrle 
1977 	The Historical Evolution of Epidemiology. 
Abraham Lilienfeld 
1978 	The Biology of Cancer: An Epidemiological Perspective. 
Sir Richard Doll 
1979 	The Epidemiology of Antibiotic Resistance. 
Theodore C. Eickoff 
1980 	Health and Population Growth. 
Thomas McKeown 
1981 	The Pathogenesis of Dengue: Molecular Epidemiology 
in Infectious Disease.
Scott B. Halstead 
1982 	The Epidemiology of Coronary Heart Disease: Public 
Health Implications. 
Henry W. Blackburn, Jr. 
1983 	Sexually Transmitted Diseases — Past, Present, and 
Future.
King K. Holmes 
1984 	Poliomyelitis Immunization — Past and Future. 
Jonas E. Salk 
1985 	An Epidemiologist’s View of Postmenopausal Estrogen 
Use, or What to Tell Your Mother. 
Elizabeth Barrett-Connor 
1986 	Hepatitis B Virus and Hepatocellular Carcinoma: 
Epidemiologic Considerations. 
Robert Palmer Beasley 
1987 	Environmental Hazards and the Public Health. 
Geoffrey Rose 
1988 	Lymphotropic Retroviruses in Immunosuppression. 
Myron E. (Max) Essex 
1989 	Aspirin in the Secondary and Primary Prevention 
of Cardiovascular Disease.
Charles H. Hennekens 
1990 	Epidemiology and Global Health. 
William H. Foege 
1991 	Public Health Action in a New Domain: The 
Epidemiology and Prevention of Violence. 
Garen J. Wintemute 
1992 	 Helicobacter pylori, Gastritis, Peptic Ulcer Disease,
and Gastric Cancer. 
Martin J. Blasér 
1993 	Diet and Health: How Firm Is Our Footing? 
Walter C. Willett 
1994 	Alexander D. Langmuir: A Tribute to the Man. 
Philip S. Brachman and William H. Foege 
1995 	Epidemiology and the Elucidation of Lyme Disease. 
Allen C. Steere 
1996 	50 Years of Epidemiology at CDC. 
Jeffrey P. Koplan 
1997 	Public Health, Population-Based Medicine, and Managed 
Care.
Diana B. Petitti 
1998 	Pandemic Influenza: Again? 
Robert Couch 
1999 	The Evolution of Chemical Epidemiology. 
Philip J. Landrigan 
2000 Does Chlamydia pneumoniae Cause Atherosclerotic 
Cardiovascular Disease? Evaluating the Role of Infectious 
Agents in Chronic Diseases. 
Walter E. Stamm 














2001 	Halfway Through a Century of Excellence. 
J. Donald Millar 
2002 	Public Health Response to Terrorism: Rising to the 
Challenge.
Marcelle Layton 
2003 	Alex Langmuir’s Somewhat Quiet Legacy: Epidemiology, 
Sexual Health, and Personal Choices. 
Willard (Ward) Cates, Jr. 
2004 	HIV, Epidemiology, and the CDC. 
James W. Curran 
2005 	Killin’ Time: Alcohol and Injury. 
Alexander C. Wagenaar 
2006 Measuring Malaria. 
Brian Greenwood 
2007 	Implications of Tuberculosis Control on Evidence-Based 
Public Health Practice. 
Thomas R. Frieden 
2008 	Physical Activity and Public Health: Does the 
Environment Matter? 
Ross C. Brownson 
2009 	Epidemiology, Public Health, and Public Policy. 
Jim Marks 
2010 Community Health Rankings—Epidemiology in Action.
Pat Remington 
2011 	Skirmishes, Battles, and Wars: Tracking Infection Control 
Success in the Age of Social Networks. 
Robert A. Weinstein 
2012 	Prevention of Teen Pregnancy: What Do We Know? 
Where Do We Go? 
Robert Blum 
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8:35 Prevalence of Human Papillomavirus Before and After Vaccine Introduction —  
National Health and Nutrition Examination Surveys, United States, 2003–2014 
Authors: Sara E. Oliver, E.R. Unger, R. Lewis, D. McDaniel,
J. Gargano, M. Steinau, L.E. Markowitz 
Background: Human papillomavirus (HPV) vaccine was 
recommended in mid-2006 for routine vaccination of females 
aged 11–12 years, through age 26 years, for the prevention
of cervical and other HPV-associated cancers. Most vaccine 
used through 2014 was quadrivalent vaccine (4vHPV), which 
prevents HPV-6, -11, -16, and -18 infection. Vaccine impact
on cancers will not be observed for decades, but vaccine-type 
infection can be monitored to assess early impact. We evaluated 
HPV prevalence among females using cross-sectional National 
Health and Nutrition Examination Surveys (NHANES) data. 
Methods: We analyzed NHANES demographic and self-
reported vaccination data, and HPV DNA from self-collected 
cervicovaginal specimens from females aged 18–24, 25–29 and 
30–34 years. We estimated 4vHPV-type prevalence in pre­
vaccine (2003–2006), early vaccine (2007–2010) and recent 
vaccine (2011–2014) eras. Using weighted logistic regression 
models adjusted for race and poverty, we estimated adjusted 
prevalence ratios (aPRs) comparing recent vaccine to
pre-vaccine eras, overall and by vaccination status (≥1  
vaccine dose). 
Results: Among 18–24 year olds in 2011–2014, ≥1 dose 
coverage was 45%. 4vHPV-type prevalence was 18.8% in the 
pre-vaccine and 16.9% in the early vaccine era, declining to
7.1% in the recent vaccine era (aPR: 0.35; 95% confidence 
interval [CI]: 0.23–0.52). In the recent vaccine era, 4vHPV-type 
prevalence was 1.9% in vaccinated females (aPR: 0.09; 95% CI: 
0.04–0.21) and 11.8% in unvaccinated females (aPR: 0.60; 95% 
CI: 0.38–0.97). No significant decreases were observed among 
older age groups. 
Conclusions: HPV vaccine-type prevalence decreased 65% 
among 18–24 year-olds overall, with a 91% decrease among 
vaccinated females through 2014. Herd protection may explain 
the 40% decrease among unvaccinated females, despite <50% 
vaccination coverage. 
Awards presented during session.
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8:55 Raw Deal: Multistate Outbreak of Salmonella Virchow Infections Linked to a Powdered 








Authors: Kelly J. Gambino-Shirley, C. Schwensohn, A. Tesfai,
B. Tolar, C. Burnett, D. Eikmeier, J. Stone, J. Hines, S. Viazis,  
M. Wise, K. Nei 
Background: Salmonella causes an estimated 1 million 
foodborne illnesses and 400 deaths in the United States annually. 
In January 2016, PulseNet, the national laboratory network for 
foodborne disease surveillance, detected a multistate outbreak by
a novel strain of Salmonella Virchow. We investigated to identify
the source and prevent additional illnesses. 
Methods: : A case was defined as infection with the pulsed-
field gel electrophoresis outbreak pattern of Salmonella Virchow
occurring between 12/5/2015 and 4/12/2016. Patients were
interviewed to identify common exposures, and results were
compared with healthy people in the 2006–2007 FoodNet
Population Survey. We investigated product and supplier 
information to identify a common source of ingredients and 
inspected production facilities. Samples of the suspected 
product and its ingredients were cultured for Salmonella. 
Results: Thirty-five cases from 24 states were identified; 6
hospitalizations and no deaths were reported. Thirty-one (94%)
of 33 patients reported consuming powdered supplements in
the week before becoming ill, which is significantly higher
than the 4% of healthy people in the FoodNet Survey (P<.001);
30 of 31 patients reported consuming Brand A, a raw organic
powdered shake product consumed as a meal replacement.
Laboratory testing identified the Salmonella Virchow outbreak
strain from leftover Brand A products collected from two
patients’ homes and from moringa leaf, an ingredient in Brand
A imported from South Africa. 
Conclusions: This is the first reported salmonellosis outbreak 
linked to a raw meal replacement powder. Company A issued 
a voluntary recall and reformulated the product to exclude 
moringa leaf. As this product has a long shelf-life, the recall likely
prevented additional illnesses. This investigation identified a 
novel outbreak-related food and highlighted a potential risk with
similar ready-to-eat products. 
9:15 Sexual Orientation Discordance and Suicidal Ideation and Suicide Attempt Among U.S. 
High School Students — United States, 2015 
Authors: Francis B. Annor, S. Irving, L. Gilbert 
Background: Suicide is the second leading cause of death among 
U.S. youth aged 10-24 years. Adolescents experiencing sexual 
orientation discordance (i.e., their sexual identity is discordant
with their sexual contacts), may be at increased risk of negative
health outcomes such as stress, depression, and substance use.
Because these factors are associated with suicidal ideation and 
attempts, this study examined the relationship between sexual 
orientation discordance and suicidal ideation and attempts 
among high school students. 
Methods: Data are drawn from the 2015 Youth Risk Behavior
Survey. The sexual identity and sex of sexual contacts items 
were used to create a two-level sexual discordance variable;
concordant and discordant. A three-level suicidal risk variable 
was also created using items on suicidal ideation and suicide 
attempt: low (no ideation/attempt), medium (ideation, no
attempt) and high (ideation and attempt). The association 
between suicide risk and sexual orientation discordance 
was assessed using ordinal logistic regression, adjusting for 
demographic variables and other covariates.
Results: The analytic sample size was 5,551. Approximately 4.0% 
of participants reported sexual orientation discordance. After 
adjusting for known risk factors of suicidal ideation and attempt, 
sexual orientation discordant youth had significantly higher 
prevalence odds of medium (adjusted odds ratio (AOR) =3.1; 
95% CI:1.9-5.2) and high (AOR=2.6; 95% CI:1.7-4.0) suicide risk 
compared to those reporting sexual orientation concordance. 
Conference of Governmental Industrial Hygienists’ Threshold 
Limit Value in three employees working in material handling, 
automated polishing, and laminating. 
Conclusions: Sexual orientation discordance was associated 
with suicidal ideation and attempt among U.S. high school
students. The finding highlights the complex relationship
between sexual identity-related characteristics and suicidal 
ideation and attempts. Adolescents reporting discordant sexual 
orientation may have different challenges and risk factors that
should be considered when developing and implementing suicide 
interventions for them. 
















9:35 Knowledge, Attitudes, and Practices Rapid Assessment To Improve Yellow Fever Vaccine 
Uptake Among Men During an Outbreak — Luanda, Angola, 2016 
Authors: Mariel A. Marlow, M. Pambasange, R. Hall, M. Ghiselli, 
C. Francisco, M. Soares, S. Silva, C. Navarro-Colorado,  
E. Zielinski-Gutierrez 
Background: In January 2016, the Angola Ministry of Health 
reported a yellow fever (YF) outbreak and initiated mass 
vaccination campaigns. In April, field teams reported low 
numbers of men attending vaccination sites; about 70% of
confirmed case-patients were male. We developed a rapid 
assessment to identify and address barriers to vaccination
among men. 
Methods: From April 23–25, 2016, a knowledge, attitudes, 
and practices (KAP) rapid assessment was administered to
men at public sites across four municipalities in Luanda. 
Based on results, targeted messaging was distributed in all 
municipalities; off-hours campaigns and new vaccination sites 
were implemented in Kilamba Kiaxi. We conducted a second 
KAP from July 30–31, 2016. 
Results: In April, we observed lowest coverage in Kilamba Kiaxi 
(52%, 48/92). Coverage in other municipalities was 68% (41/60) 
in Cacuaco, 78% (46/59) in Cazenga, and 70% (64/91) in Viana. 
The most common reasons reported for non-vaccination were
lack of time or vaccination conflicting with working hours (25%, 
26/199), thinking the vaccine was dangerous (21%, 22/199), and 
not wanting to wait in line (20%, 21/199). Following modified 
vaccination activities, we observed 22% higher coverage in 
Kilamba Kiaxi (74%, 57/77) in July. Coverage was lower in 
Cacuaco (62%, 57/92) and Cazenga (75%, 67/89) and higher in 
Viana (74%, 68/92). Kilamba Kiaxi was the only municipality to
have fewer men reporting fear of the vaccine, decreasing from
36% in April to 5% in July. 
Conclusions: The KAP rapid assessment was a useful tool for 
informing vaccination efforts during the response. The YF 
campaign was not well adapted to men’s time and information
needs. Targeted interventions taken from KAP recommendations 








9:55 Special Education Outcomes Among Children Born with Neonatal Abstinence  
Syndrome — Tennessee, 2008–2011 
Authors: Mary-Margaret A. Fill, A. Miller, R. Wilkinson, M. 
Warren, S. Patrick, J. Dunn, W. Schaffner, T. Jones 
Background: Neonatal abstinence syndrome (NAS) is a 
postnatal drug withdrawal syndrome that commonly occurs
after intrauterine opioid exposure. Tennessee experienced a 
15-fold increase in NAS incidence during 2002–2012. Adverse 
neurobehavioral outcomes are documented in infants born
with NAS; however, educational outcomes have not been 
examined. We analyzed Tennessee data to more fully understand 
educational outcomes of infants born with NAS. 
Methods: Using Tennessee Medicaid data, infants born in 
Tennessee during 2008–2011 with a history of NAS were
matched (1:3) to infants born during 2008–2011 without a 
history of NAS. The groups were matched on sex, race, ethnicity, 
kindergarten cohort, and public health region of residence at
birth. These data were linked to a Tennessee Department of
Education database (1/2004–11/2016) to assess select special 
education outcomes during early childhood (age ≥3 years). 
Results: A total of 1,815 children with and 5,441 children 
without a history of NAS were included in the study. Children 
with a history of NAS were significantly more likely to be
referred for disability evaluation (351/1,815 [19.3%] versus 
745/5,441 [13.7%]; P <0.0001) and meet criteria for a disability 
(284/1,815 [15.6%] versus 634/5,441 [11.7%]; P <0.0001). A 
significantly higher proportion of children with a history of NAS 
had special education exceptionalities of developmental delay 
(84/1,815 [4.6%] versus 170/5,441 [3.1%]; P = 0.002) and speech 
or language impairment (181/1,815 [10.0%] versus 434/5,441 
[8.0%]; P = 0.008). 
Conclusions: In this novel analysis linking health and education 
datasets, children with NAS were significantly more likely to
have certain disabilities than children without NAS. Thus, 
efforts to reduce intrauterine opioid exposure and NAS might
also reduce the risk of developmental disabilities in these 
children. 





















CONCURRENT SESSION B1: Vaccine-Preventable Diseases 
10:45 AM–12:10 PM 
Frieden Plenary 
Moderators: Nancy Messonnier and Sam Posner 
10:50 	 Epidemiology of a Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting 
and Use of a Third Dose of Measles-Mumps-Rubella Vaccine (MMR) for Outbreak  
Control — Iowa, July 2015–May 2016 
Authors: Minesh Shah, P. Quinlisk, A. Weigel, J. Riley, L. James,  
J. Patterson, C. Hickman, P. Rota, R. Schicker, N. Clemmons,  
N. Kalas, C. Cardemil 
Background: In response to a mumps outbreak at the University 
of Iowa, a setting with 22,000 undergraduates and mandatory 
2-dose measles-mumps-rubella vaccination (MMR) policy,
a 3rd MMR dose campaign targeting students <25 years was 
held.  Over 4,500 doses were administered.  We characterize the 
outbreak before and after the vaccination campaign. 
Methods: Students meeting the Council of State and Territorial
Epidemiologists mumps case definition were interviewed and
had medical charts abstracted to determine demographics,
clinical symptoms and complications. Vaccination status was
verified with university and state immunization records. Case
count was examined pre-campaign (start of outbreak on July
13, 2015 through one mumps incubation period after the final
3rd dose clinic on December 10, 2015) versus post-campaign
(December 11, 2015-May 13, 2016).  Cases among persons <25
vs. ≥25 years old were compared pre- and post-campaign using
Fisher’s exact test. 
Results: Of 301 mumps cases in students from July 13 2015 
through May 13 2016, 190 (63%) were lab-confirmed.  Cases 
were primarily undergraduates (91%) and highly vaccinated 
(98% had ≥2 MMR doses).  Cases were ill for a median of 8 
(inter-quartile range [IQR] 6-10) days and self-isolated for a 
median of 6 (IQR 5-7) days.  Complications included meningitis 
(n=1), hearing loss (n=3), orchitis (n=14) and mastitis (n=2).  
Fewer cases occurred post-campaign (75, 25%) compared to
pre-campaign (226, 75%), and cases in the targeted age group 
declined from 98% to 91% (p=0.01). 
Conclusions: Despite high 2-dose MMR coverage, a large
mumps outbreak occurred at the University of Iowa. After a 3rd 
MMR dose campaign, fewer cases occurred overall and in the 
target population. Further studies are needed to determine if this 
decline is due to the campaign. 























11:10 Measles Outbreak at a United States Immigration and Customs Enforcement Facility— 
Arizona, May–June 2016 
Authors: Heather Venkat, A. Kassem, C. Su, S. Mercader,  
S. Bae Sowers, G. Briggs, C. Hill, E. Timme, K. Komatsu,
R. Sunenshine,  M. Patel, D. Elson, C. Hickman, P. Gastañaduy,  
S. Brady 
Background: The first documented measles outbreak in an
Immigration and Customs Enforcement facility in the United 
States was identified in Arizona in May 2016. We sought to
describe cases, implement outbreak control measures, and study 
attack rates to assess transmission patterns. 
Methods: Cases were defined as having laboratory-
confirmed measles infection, or an acute febrile rash illness 
and epidemiological link to a laboratory-confirmed case. 
Measles-specific immunoglobulin G (IgG) was measured to
assess immunity levels, and IgG-avidity testing was performed 
to distinguish between primary and secondary antibody
responses. We compared attack rates among detainees and staff, 
seronegative and seropositive detainees, and by detainee housing 
unit and sex. 
Results: We identified 29 measles cases (20 detainees, 9 staff); 
rash onsets were during May 6–June 26. Sera from 205 detainees 
revealed that 186 (91%) had detectable IgG. Five (83%) of 6 
confirmed cases had high avidity antibody titers, indicating 
a secondary immune response to measles. Attack rates were
not significantly different among detainees and staff (1.40% 
versus 1.77%, P=0.56), or among seronegative and seropositive
detainees (10.53% versus 3.37%, P=0.21), but were significantly 
higher among unit A detainees, compared with the aggregate
for units B–F (6.61% versus 0.42%; P<0.001), and among male, 
compared with female detainees (2.11% versus 0.19%; P<0.01).  
Control measures included measles vaccination for 1,424 of
1,425 detainees, verification of immunity or vaccination for 445 
(87%) of 510 staff, case isolation, and quarantining of affected 
housing units. 
Conclusions: Although attack rates were low, measles outbreaks 
can occur in intense exposure settings despite high immunity 
levels. We highlight the importance of preemptive high 
immunization coverage and containment in limiting measles 








11:30 Impact of Sociodemographic Factors on Implementation of the Standards for Adult 
Immunization Practice — United States, 2016 
Authors: Neil C. Murthy, A. O’Halloran, R. Fink, W.W. Williams, 
C. Bridges, D. Kim, A.P. Fiebelkorn 
Background: Vaccine-preventable diseases cause substantial
morbidity and mortality among adults. However, U.S.
adult vaccination rates are low.  The Standards for Adult
Immunization Practice (the “Standards”), recommend
healthcare providers (HCPs) conduct vaccination assessments,
recommendations, offers, and/or referrals for needed vaccines
at every clinical encounter.  We surveyed U.S. adults to assess
differences in reported implementation of the Standards by
sociodemographic factors. 
Methods: We conducted an internet panel survey using a 
nationally representative sample of U.S. adults. We calculated 
weighted proportions of respondents who reported receiving
vaccine needs assessment, recommendation, offer and referral 
from their HCPs during their most recent visit in the past year
by sociodemographic factors. T-tests and chi square tests were
used to test the significance of comparisons (p<0.05). 
Results: Vaccine needs assessments were reported more
frequently among adults aged ≥65 (56.1%) and 50-64 years 
(47.5%) versus 19-49 years (37.7%), and adults with at least some 
college education (48.5%) versus high school or less (39.0%).  
Vaccine recommendations were reported more frequently among 
adults aged ≥65 (28.1%) and 50-64 years (27%) versus 19-49 
years (18.1%), and among employed (22.4%) versus unemployed 
(9.3%). Vaccine offers were reported more frequently among 
adults aged ≥65 years (24.2%) versus 19-49 years (13.3%), and 
among employed (17.2%) versus unemployed (5.9%).  Among 
adults aged ≥65 years, 50-64, and 19-49, those who reported 
receipt of at least one vaccine was 14.4%, 9.8%, and 4.2%, 
respectively. 
Conclusions: Large gaps in implementation of the Standards 
were found among persons of all ages, but differed by age group,
education status, and employment status. These findings can 
help HCP and healthcare systems prioritize changes to improve 
standards implementation and avoid missed opportunities for 
vaccination. 












11:50 Risk Factors for Meningococcal Disease Among Adults Experiencing Homelessness in 








Authors: John O. Otshudiema, M. Patton, N. Westercamp,  
N. Aliabadi, A. DeMaria, L. Madoff, M. Burns, S. Lett,  
D. De Las Nueces, C. Léon, P. Bhalla, A. Barry, J. Gunn,  
S. Martin, J. MacNeil, A. Acosta 
Background: Between January and March 2016, five cases of
meningococcal disease were reported among adults experiencing 
homelessness in Boston. Reports of meningococcal disease 
in this population are rare. We aimed to evaluate factors
contributing to increased risk for meningococcal disease among 
adults experiencing homelessness in Boston. 
Methods: We conducted a matched case-control evaluation. 
A case was defined as laboratory-confirmed Neisseria
meningitidis with illness onset on or after May 1, 2015, in an
adult experiencing homelessness in the Boston-metro area. Five
controls were matched to each case by sex, age-group, and use of
the same emergency shelter facility during the case’s infectious 
period. Participants were interviewed and their medical records 
reviewed to identify risk factors. Univariate conditional logistic 
regression was used to calculate exact matched odds ratios 
(eMOR) and 95% confidence intervals (CI).   
Results: Five cases and 25 controls were enrolled. Compared 
to controls, a higher proportion of cases were black (80% vs. 
44%) or experienced homelessness for less than one year (60% 
vs. 32%). During the infectious period, a higher proportion
of cases had >1 kissing partner (60% vs. 32%) or slept in an
emergency shelter room with ≥50 people (40% vs. 20%). None 
of these differences were statistically significant. The only
factor significantly associated with disease was history of any 
immunosuppressive condition (HIV, lupus, or diabetes) (eMOR: 
10.57; 95% CI: 1.79–∞; p = 0.02). 
Conclusions: While history of immunosuppressive condition 
was significantly associated with meningococcal disease among 
adults experiencing homelessness, other typical risk factors such
as crowding and kissing multiple partners were not. Sample 
size limited this analysis; enhancing meningococcal disease 
surveillance by collecting homeless status will allow for more
robust evaluation. 









CONCURRENT SESSION B2: Chronic Disease Prevention and Health Disparities 
10:45 AM–12:10 PM 
Concurrent Session Room 
Moderators: Ursula Bauer and Tala Fakhouri 
10:50 Cardiovascular Disease Risk Factors by Level of Active Transportation Among U.S. Adults, 
2011–2014
 
Authors: Marissa L. Zwald, L. Akinbami, T. Fakhouri,  
G. Whitfield, C. Fryart 
Background: Regular physical activity (PA) decreases the risk of
cardiovascular disease (CVD), the leading cause of death in the 
U.S. Morbidity and mortality from CVD continue to impose a 
health and economic burden to Americans. Active transportation
(walking or bicycling) represents one way individuals can 
alter their lifestyle to incorporate recommended PA levels. 
We examined associations between active transportation and 
selected CVD risk factors, including hypertension, high total and 
low high-density (HDL) cholesterol, diabetes, and obesity. 
Methods: Analysis included a representative sample of
8605 U.S. adults aged 20 years and over from the 2011-2014 
National Health and Nutrition Examination Survey. Using 
the WHO Global PA Questionnaire, participants reported PA
as part of travel to and from destinations in a typical week. 
Active transportation was categorized as none (0-9 minutes/ 
week); low (10-149 minutes/week); or high (≥150 minutes/ 
week). Multivariable logistic regression was used to examine 
associations for each CVD risk factor, controlling for age, sex, 
race, education, poverty, smoking, and PA for work and leisure. 
SUDAAN was used to account for complex survey design. 
Results: Most adults (71%) reported no active transportation. 
Compared to no active transportation, high levels of active
transportation were associated with lower odds of high 
total cholesterol (aOR=0.74; 95% CI=0.55-0.99), low HDL 
cholesterol (aOR=0.69; 95% CI=0.55-0.87), diabetes (aOR=0.73; 
95% CI=0.57-0.95), and obesity (aOR=0.65; 95% CI=0.54­
0.78). Similar findings were observed comparing no active
transportation to low levels, but not all differences  
were significant. 
Conclusions: TActive transportation is beneficially associated 
with CVD risk factors. These findings may inform the 
development and implementation of PA interventions, including 
those outlined in CDC’s Guide to Community Preventive























11:10 Comparison of Inactivity Among Adults with Disabilities by Using Two Disability  








Authors: Dana Olzenak McGuire, K. Watson, D. Carroll,
E. Courtney-Long, S. Carlson 
Background: Measuring disability is key to understanding 
the health risks and disparities experienced by people with
disabilities, as well as to identifying areas that need improvement 
through program efforts. However, different measures ascertain 
different people, yielding varying disability prevalence estimates. 
Little is known about how prevalence of health behaviors varies 
by disability measure. Our study compares prevalence and 
patterns of physical inactivity by using two different disability 
measures. 
Methods: Data from the 2011–2015 National Health Interview 
Survey were analyzed for adults aged 18 years or older.  
Disability prevalence was examined for two measures: (a) Basic 
Actions Difficulty (BAD) questions (5 domains measuring 
vision, hearing, cognition, movement, and emotion); and 
(b) American Community Survey (ACS) standard disability 
questions (6 questions assessing vision, hearing, cognition, 
mobility, self-care, and independent living). Physical inactivity 
meant reporting no leisure time physical activity during the 
past week. Demographic differences and trends in inactivity 
prevalence were assessed by using pairwise t-tests and 
orthogonal polynomial contrasts. 
Results: Disability prevalence was 31.1% (BAD) and 17.5%
(ACS). For both measures, inactivity prevalence was higher
among adults with disability (BAD: 42.9%, ACS: 52.5%) than
those without (BAD: 24.3%, ACS: 26.2%). Inactivity patterns
among adults with disability were consistent for both measures:
increased with age; decreased with higher education level; and
highest among non-Hispanic black and Hispanic adults. 
Conclusions: Although inactivity patterns were consistent for 
demographic characteristics, inactivity prevalence was higher 
among adults with disability, as defined by using ACS than BAD.
Understanding who is ascertained by different measures could 
lead to improved public health strategies for better health of
adults with disabilities. 
11:30 Racial Differences in Survival of Pediatric Patients with Brain and Central Nervous System 
Cancer — United States, 2001–2012 
Authors: David A. Siegel, J. Li, S. Singh 
Background: Brain and central nervous system (CNS) cancer is 
the second most common childhood cancer and is the leading 
cause of cancer death among children and adolescents. Despite 
improvements in survival during the past 40 years, some data
suggest a racial disparity for survival. Our study describes 
survival by race by using national data to better understand the 
effects of demographic and clinical factors. 
Methods: Data from the National Program of Cancer Registries 
were used to evaluate relative survival (RS) (cancer survival 
in the absence of other causes of death) among children and 
adolescents aged 0-19 years diagnosed with brain and CNS 
cancer during 2001-2012. Data were from 29 states and covered 
66% of the U.S. population. Overall and specific to black and
white races, RS was stratified by sex, age, cancer stage, anatomic 
site, histology, U.S. Census region, and county economic status. 
Results: We identified 16,675 primary brain and CNS cancer 
cases during 2001-2012, with a 5-year RS of 75.5% (95% 
confidence interval [CI]: 75.0-76.5). White patients had a 
significantly higher 5-year RS (76.5%; 95% CI: 75.7-77.3) than
black patients (70.8%; 95% CI: 68.6-72.9). The racial difference 
remained significant at 1 and 3-year RS, for both sexes, among 
children and adolescents, and in the South Census region. 
Cancer stage, primary anatomic site, histology, and economic 
status also affected racial differences for survival. 
Conclusions: This study highlights brain and CNS cancer 
survival differences between black and white pediatric patients 
and identifies potential contributing sociodemographic 
and clinical factors. Future investigation of access to care, 
socioeconomic status, and host genetic factors may explain  
why race is a marker for survival and could help guide public 
health planning. 






11:50 	 Trends in Hospitalization Rates for Patients with Myocardial Infarction by Race/Ethnicity 
Among Kaiser Permanente Southern California Members — Southern California, 
2000–2014 
Authors: Gloria C. Chi, K. Reynolds, B. Li, L. Qian, T. Harrison, 
S. Jacobsen, R. Scott, M. Kanter 
Background: Acute myocardial infarction (AMI) is a common
presentation of heart disease, the leading cause of mortality in 
the United States. AMI rates differ by race/ethnicity, and studies 
examining changes to AMI incidence among diverse adult 
populations are needed. We examined trends in hospitalized
AMI by race/ethnicity during 2000–2014 among Kaiser 
Permanente Southern California members aged ≥35 years. 
Methods: Hospitalization for AMI each year was identified 
by using diagnosis codes from hospital discharge records and 
billing claims. We calculated age- and sex-standardized annual 
incidence rates by race/ethnicity (Hispanic, non-Hispanic  
Asian or Pacific Islander, non-Hispanic black [NHB], and  
non-Hispanic white [NHW]). We estimated incidence rate ratios 
(IRRs) among race/ethnicity groups by using Poisson regression 
adjusting for age and sex. We compared trends among race/ 
ethnicity groups by including interaction terms between year
(continuous) and race/ethnicity in regression models. 
Results: We identified 45,331 AMI hospitalizations during
2000–2014. AMI incidence decreased in each race/ethnicity 
group (all P <0.001). NHBs, but not other groups, experienced a 
significantly smaller decline in AMI incidence than NHWs (P = 
0.04). During 2000–2014, standardized AMI incidence (per 1,000 
person-years) declined from 3.82 (95% confidence interval [CI]: 
3.65–3.99) to 1.92 (95% CI: 1.82–2.02) for NHWs and from 3.54 
(95% CI: 3.17–3.91) to 2.03 (95% CI: 1.81–2.25) for NHBs. In
2000, NHBs had a lower AMI incidence than NHWs (IRR: 0.90; 
95% CI: 0.85–0.96), but 2014 rates were similar (IRR: 1.00; 95% 
CI: 0.95–1.06). 
Conclusions: AMI hospitalization incidence declined 
substantially during 2000–2014 for all race/ethnicity groups. 
Convergence of NHB and NHW AMI incidence rates suggests 























SESSION C: J. Virgil Peavy Memorial Award Finalists 
1:45–3:30PM 
Frieden Plenary 
Moderators: Jennifer Parker and Byron Robinson 
1:50 A Novel Approach to Analysis of Cryptosporidiosis and Giardiasis Surveillance in the 
United States, 2005–2015
 
Authors: Katharine M. Benedict, S. Collier, E. Marder,  
M. Hlavsa, K. Fullerton, J. Yoder 
Background: Traditionally, population-based case-
control studies have been used to identify risk factors for 
cryptosporidiosis and giardiasis. However, these studies are 
expensive and include controls with characteristics that likely
differ from reported cases since they are selected from the 
general population while only a relatively small proportion of
cases of cryptosporidiosis and giardiasis are reported to public 
health authorities. In this analysis, we use a variation of the case-
control analysis wherein reported cases of a different disease are 
used as a comparison group to identify potential risk factors for 
cryptosporidiosis and giardiasis. 
Methods: Surveillance data from the National Notifiable Disease 
Surveillance System (NNDSS) were accessed through the 
NNDSS Data Availability Project (NDAP). Exposures reported 
for cryptosporidiosis and giardiasis case-patients were compared 
to exposures of salmonellosis case-patients reported by 16 states 
(2005–2015). Odds ratios adjusted for age and reporting state 
(aOR) and 95% confidence intervals (95% CI) for exposures were
calculated using SAS 9.3. 
Results: A total of 14,996 cryptosporidiosis, 22,595 giardiasis, 
and 123,180 salmonellosis cases were reported. When compared 
to cases of salmonellosis, exposure to treated recreational water 
(aOR: 5.3; 95% CI: 5.0-5.6) and livestock (aOR: 2.8; 95% CI: 
2.5-3.1) were risk factors for cryptosporidiosis, and exposure to
untreated drinking (aOR: 5.8; 95% CI: 5.3-6.4) or recreational 
water (aOR: 3.4; 95% CI: 3.2-3.7) and prior travel (aOR: 2.5; 95% 
CI: 2.4-2.7) were risk factors for giardiasis. 
Conclusions: Risk factors for cryptosporidiosis and giardiasis 
identified through national surveillance data were comparable to
those identified in outbreak investigations or population based 
case-control studies. Case-case analyses can be used to better 
understand disease epidemiology and more efficiently identify
risk factors to guide the development of prevention and  
control measures. 



















2:10 Power Law Analysis of Foodborne Outbreaks — United States, 1998–2015
 
Authors: Julie L. Self, M. Hoekstra, K. Wong, C. Pilewski,  
R. Tauxe, B. Bruce 
Background: Large foodborne outbreaks are rarer than
small outbreaks, but the mathematical relationship between
outbreak size and frequency is unknown. If size and
frequency have an inverse linear relationship on a log-
log plot then they follow a power law, and we can better
understand how often we expect to observe outbreaks of
different sizes. We assessed whether outbreak data follow a
power law and how certain outbreaks may deviate from it. 
Methods: Using foodborne outbreaks reported to the  
Foodborne Disease Outbreak Surveillance System during
1998–2015, we used bootstrapping (3,000 samples) to assess 
whether outbreaks fit a power law using the Kolmogorov-
Smirnov statistic and determined the slope of outbreak size 
versus frequency on a log-log scale. We also compared multistate
and single-state outbreaks. 
Results: We identified 8,037 outbreaks (296 multistate; 7,741 
single-state). Their size-frequency relationship was consistent
with a power law (slope: 2.21; 90% credible interval [CI]: 
2.17–2.26) although outbreaks with <5 or ≥200 cases were rarer 
than expected. The slope for single-state outbreaks (2.13, 90% CI: 
1.95–2.37) was significantly smaller than for multistate outbreaks 
(2.47, 90% CI: 2.39–2.57), indicating that larger single-state
outbreaks were rarer than larger multistate outbreaks. 
Conclusions: Foodborne outbreak data show that intermediate-
sized outbreaks follow a power law that predicts how often they
should be observed. Small outbreaks are rarer than expected,
suggesting relative under-detection; large outbreaks are also
rarer than expected, which may reflect successful public health
interventions. This method, which can be customized to single-
state or multistate outbreaks, can be a useful tool to estimate how 
many small outbreaks are missed and to evaluate the impact of








2:30 HIV, Serostatus Knowledge, and Viral Load Suppression Among Female Sex Workers In 
Kampala, Uganda, 2012 — A Respondent-Driven Sampling Survey 
Authors: Reena H. Doshi, E. Sande, M. Ogwal, H. Kiyingi,  
J. Kusiima, A. McIntyre, W. Hladik 
Background: The Joint United Nations Programme on HIV 
and AIDS (UNAIDS) set global targets for 2020, aiming for 90% 
of people living with HIV to know their serostatus and for 73% 
to have viral load suppression (VLS). We investigated progress 
towards these targets among female sex workers (FSW) in 
Kampala, Uganda, who bear a disproportionate burden of HIV. 
Methods: Between April and December 2012, FSW, defined as 
women, 15-49 years, residing in greater Kampala, and selling  
sex for money in the last 6 months, were recruited using 
respondent-driven sampling (RDS). Venous blood was collected 
for HIV testing according to Uganda’s national serial rapid test 
algorithm and for VL testing (VLS defined as <50 copies/mL). 
We collected data using audio computer-assisted self-interviews. 
Weighted population estimates were calculated using RDS 
Analyst software. 
Results: Sampling was initiated with 4 respondents; 1,487 FSW 
were enrolled over 25 recruitment waves; median age was 27 
years (interquartile range: 23 to 32). HIV seroprevalence was 
31.4% (95% confidence interval [CI]: 28.7-34.0%). Among 
HIV-positive FSW, serostatus knowledge was 26.5% (95% CI: 
21.7-31.4%) and VLS was 21.6% (95% CI: 16.2-27.0%). Assuming 
that all FSW with VLS know their serostatus yielded a corrected 
serostatus knowledge estimate of 37.5% (95% CI: 32.4-42.6%). 
Conclusions: HIV prevalence among Kampala FSW is high, 
whereas serostatus knowledge and VLS are far below UNAIDS 
population-level targets. The high population prevalence of
unsuppressed VL suggests substantial risk of transmission to
partners and clients. FSW in Kampala are in need of intensified 
and targeted control efforts, including pre-exposure  
prophylaxis, frequent HIV screening, and improved linkage
to treatment services. 



















2:50 Impact of HIV Sequence Reporting Completeness on Detection of Growing HIV 








Authors: Sharoda Dasgupta, A. France, M. Brandt, M. Ocfemia, 
T. Zhang, N. Pannee, A. Hernandez, A. Oster 
Background: HIV nucleotide sequence data, collected through 
surveillance, can help identify clusters of persons infected with
genetically similar strains suggesting transmission that warrants 
public health investigation. Because the percentage of HIV 
diagnoses with a reported genetic sequence (completeness) varies 
by jurisdiction, we assessed the association of completeness with
ability to detect growing HIV transmission clusters. 
Methods: Using HIV surveillance data for Michigan, whose 
69% completeness was highest among states in 2012–2014, we
calculated genetic distance between all possible sequence pairs to
determine clusters of highly similar HIV strains. We identified 
the total number of growing transmission clusters, each with
highly similar HIV strains with ≥3 cases diagnosed in 2014. 
We simulated variation in completeness by taking 100 random
samples of the full data set with replacement with a range of
5%–65%, in increments of 5%. We reported the median number 
of growing clusters and 5% and 95% quantiles, and calculated the 
sensitivity for each completeness level by comparing the number 
of growing clusters in each sample with the full data set. 
Results: Among 1614 cases with a sequence reported during
2012–2014, 15 growing clusters were identified. As completeness 
declined, the number of growing clusters decreased from 15 to a 
median of 8 (5%–95%: 4–12) at 50% completeness and to 1 (5%– 
95%: 0–4) at 25% completeness. Sensitivity decreased from 100% 
to 37% at 50% completeness and to 7% at 25% completeness. 
Conclusions: Reduced HIV sequence data completeness lowers
the sensitivity for detecting growing transmission clusters, 
resulting in missed opportunities for public health intervention. 
To ensure detection of growing clusters, jurisdictions should 
expand efforts to maximize sequence completeness. 
3:10 Spatial Clustering of Suicide and Area-Level Characteristics at Census Block Group 
Level — Idaho, 2010–2014 
Authors: Ahmed M. Kassem, K. Carter, C. Johnson, P. Harder,  
C. Hahn 
Background: In 2014, suicide was the eighth leading cause of
death in Idaho and tenth nationwide. Limited data are available 
about characteristics of areas with high suicide rates. We sought
to identify and characterize spatial clusters of Idaho suicides. 
Methods: We analyzed Idaho Division of Public Health`s death 
certificate data on deaths occurring among Idaho residents 
during 2010–2014 and used International Classification of
Diseases, Tenth Revision codes X60.0–X84.9, Y87.0, U03.0, and 
U03.9 to identify suicides; we geocoded residential addresses 
to census block groups (CBGs). We obtained population data
from the 2010 Census and the 2010–2014 American Community 
Survey. We used a discrete Poisson model in SaTScan™, with
P <0.10 cutoff for programmatic considerations, to identify
nonoverlapping, high-rate spatial clusters of suicide. Logistic 
regression was used to examine associations between suicide 
clustering and CBG-level population characteristics (comparing 
highest quartile with lowest 3 quartiles); P <0.05 cutoff for 
inclusion in multivariable modeling. 
Results: During 2010–2014, deaths by suicide occurred in 1,501 
Idaho residents. We identified 2 clusters of suicide in distinct
regions as follows: a 25-CBGs cluster (age- and sex-adjusted 
relative risk [aRR] = 1.94) and a 6-CBGs cluster (aRR = 3.61). 
CBGs within the identified clusters were positively associated 
with the following CBG-level population characteristics: median
age ≤31.1 years (multivariable-adjusted odds ratio [aOR] = 2.41; 
P = 0.041), >53% female (aOR = 2.69; P = 0.011), >1% American
Indian or Alaska Native (aOR = 2.92; P = 0.006), and >30% 
never married (aOR = 3.43; P = 0.004). 
Conclusions: We identified suicide clustering in Idaho and 
associations with CBG-level characteristics. Idaho suicide 
prevention programs should consider using results to target 
prevention efforts. 













CONCURRENT SESSION D1: Zoonotic Diseases 
3:45–5:10PM 
Frieden Plenary 
Moderators: Casey Barton Behravesh and Brett Petersen 
3:50 No Kidding: Large Outbreak of Human Escherichia coli O157 Infections Linked to a Goat 
Dairy Farm — Connecticut, 2016
 
Authors: Kelly J. Gambino-Shirley, M. Laughlin, P. Gacek,  
Q. Phan, L. Stevenson, A. Mercante, J. Razeq, M. Cartter,
M. Nichols 
Background: Zoonotic transmission of shiga-toxin producing 
Escherichia coli (STEC) causes an estimated 5,960 annual  
U.S. infections. Young children with STEC infections can  
develop hemolytic uremic syndrome (HUS), a potentially  
life-threatening complication. In March 2016, 7 people with
STEC infections were reported to Connecticut Department
of Public Health (CTDPH); of these, 6 visited the same goat
dairy farm (Farm X) before illness onset. We investigated to
determine sources of STEC infection at Farm X and develop 
public health recommendations. 
Methods: A case-control study was conducted; cases and 
controls were recruited via a press release encouraging Farm X 
visitors to report to CTDPH. Cases were defined as laboratory-
confirmed infection with outbreak strains of STEC O157 or
physician-diagnosed HUS, with illness onset during March– 
April 2016. Controls were without gastrointestinal symptoms
after visiting Farm X in March 2016. Environmental and 
animal samples collected from Farm X were cultured; isolates 
were compared with patient isolates using pulsed-field gel 
electrophoresis. 
Results: Thirty-eight cases and 73 controls were identified. Three 
(9%) case-patients developed HUS; 23 (61%) were aged <5 years. 
Case-patients were significantly more likely than controls to
use hand sanitizer after leaving a barn at Farm X (odds ratio: 2.4; 
95% confidence interval: 1.0–5.5). No handwashing stations
were noted. Of 44 environmental samples and 17 goat fecal 
samples, 28 (64%) and 16 (94%), respectively, yielded STEC 
outbreak strains. 
Conclusions: Environmental contamination and excreting of
STEC by goats at Farm X was extensive, and exclusive use of
hand sanitizer was ineffective in preventing this outbreak. Farms 
open to the public should provide handwashing stations with
soap and running water, education, and consider limiting access 
































4:10 A Comparison of Three Statistical Thresholds to Trigger a Public Health Response to 








Authors: Sarah Anne J. Guagliardo, M. Reynolds, R. Lushima,  
O. Wemakoy, A. McCollum 
Background: Endemic to the Democratic Republic of the 
Congo (DRC), monkeypox is a zoonotic disease that causes 
smallpox-like illness in humans. Observed fluctuations in the 
number of reported cases over time raises questions about when 
it is appropriate to mount a public health response, and what
specific actions should be taken. Here, we evaluate three different
thresholds to differentiate between baseline and heightened 
incidence of disease, and propose a tiered approach to public 
health action. 
Methods: Confirmed monkeypox cases occurring in Tshuapa 
Province from 2011-13 were used to calculate three different
statistical thresholds (Cullen, C-sum, and a World Health
Organization method) based on monthly incidence. When the 
observed cases exceeded the threshold for a given month, that
month was considered to be an ‘aberrant’ month. The number of
aberrant months detected was summed by year for  
each approach. 
Results: There was notable variation in the number of aberrant
months for each method. The Cullen approach, based on the 
mean incidence + 2*standard deviation, did not detect any 
aberrant signals over the period of consideration (0/36 months). 
The C-sum method, calculated as the ratio of past to present 
cases, was the most sensitive, resulting in 18/36 aberrant months. 
The WHO method, involving the upper 3rd quartile of data from
past cases, resulted in 11/36 aberrant months. 
Conclusions: A single threshold for triggering public health
action may be insufficient for monkeypox and other diseases 
that are endemic yet relatively rare. We propose instead that
multiple thresholds be considered to allow responses of varying 
intensity: 1) an alert threshold prompting further investigation/ 
intervention beyond routine surveillance, and 2) an
epidemic threshold, which may entail contact tracing and 
community education. 
4:30 Q Fever Endocarditis — United States, 1999–2015
 
Authors: Anne Straily, F.S. Dahlgren, C. Paddock 
Background: Q fever is a worldwide zoonosis caused by
Coxiella burnetii. In patients with pre-existing valvular
heart disease, C. burnetii infection can manifest as a life-
threatening endocarditis. Limited information exists on
Q fever endocarditis in the United States. We summarized
national Q fever surveillance data to better characterize the
epidemiology of Q fever endocarditis in the United States. 
Methods: We reviewed Q fever case report forms (CRFs) 
submitted to CDC during 1999–2015 to identify patients with
endocarditis. Cases were categorized as confirmed or probable 
according to laboratory criteria defined by the Council for State 
and Territorial Epidemiologists. Demographic, laboratory, and 
clinical data were reported as frequencies. Tests of comparison
were conducted using Chi-square and Fisher’s exact tests.  
Results: Of 991 CRFs submitted, 46 confirmed and 11 probable 
cases of Q fever endocarditis were identified. The majority of
patients were male (79%) and the median age was 57 years 
(range: 22–87 years). Fifty-five patients (84%) were hospitalized; 
four deaths (7%) were reported. Thirty-four patients (60%) had 
previous history of valvulopathy; where the affected valve was 
identified (n = 7), six (85.7%) had stenosis or replacement of the 
aortic valve. The most frequently reported symptoms included 
fever (30, 53%), malaise (27, 47%), and myalgia (22, 39%). 
Conclusions: Q fever endocarditis is a rare but serious and 
life-threatening complication of Q fever infection. This case
series represents the largest description of Q fever endocarditis 
in the United States to date. However, Q fever is historically 
underreported in the United States, and the true burden of
disease may be much greater. Improved surveillance is necessary
to better understand the magnitude of Q fever endocarditis. 
















4:50 Northern Trajectory of Human Tularemia — United States, 1965–2013
 
Authors: Natalie A. Kwit, P. Mead 
Background: Tularemia is an uncommon but debilitating
arthropod-borne zoonosis caused by Francicella tularensis. 
Although human infection occurs sporadically throughout
the continental United States, historically, cases have been 
concentrated in the south central states of Louisiana, Arkansas, 
and Missouri. We used two methods to assess changes in the 
geographic distribution of human tularemia cases reported to
CDC through the Nationally Notifiable Diseases Surveillance 
System during 1965–2013. 
Methods: Reported cases were geocoded to centroids for the 
county of patient residence. A linear model was fit comparing 
latitude and longitude of all cases by year, adjusted for population
using annual, county-level U.S. Census estimates. To further 
evaluate geographic trend, a spatial scan cluster detection
method based on log likelihood ratio [LLR] tests was used to
identify the location of the highest risk spatial cluster of cases for 
each of nine 5-year intervals. 
Results: During 1965–2013, mean latitude of human tularemia
cases in the lower 48 states moved northward 444 km, from 37°N
to 41°N (P <.0001), with no change in mean longitude
(P =.5). Overall, spatial scan methods identified an area 668 km
in diameter centered over northwestern Arkansas as the area of
greatest risk (LLR: 6663; P <.0001). When evaluated in 5-year
intervals, the centroid for this cluster moved from 35°N in
1965–1969 to 39°N in 2005–2009, also a change of 444 km. 
Conclusions: The distribution of human tularemia cases in 
the United States has moved progressively northward since 
1965. This trajectory suggests areas of likely emergence 
where educational efforts may be most needed. The trend is 
independent of changes in population and may reflect shifts in 
























CONCURRENT SESSION D2: Reproductive Health 
3:45–5:10PM 
Concurrent Session Room 
Moderators: Wanda Barfield and Cheryl Broussard  
3:50 	 Intracytoplasmic Sperm Injection (ICSI) Use Among States With and Without Insurance 
Coverage for Infertility Treatment — United States, 2000–2014 
Authors: Ada Dieke, A. Mehta, D. Kissin, A. Nangia,  
L. Warner, S. Boulet 
Background: Intracytoplasmic sperm injection (ICSI), an
in vitro fertilization (IVF) procedure involving single sperm 
injection into an egg to address male factor infertility, is 
increasingly used for non-male factor indications without 
notable benefits, despite evidence of potential risks to offspring. 
ICSI use may increase among states with insurance mandates 
that require IVF reimbursement. We examined recent trends in 
ICSI usage among 8 states with an insurance mandate for IVF 
versus remaining states without such mandates. 
Methods: : Data were analyzed from the 2000–2014 National 
Assisted Reproductive Technology Surveillance System. We
used linear regression to assess trends in ICSI use among fresh 
(unfrozen) IVF cycles conducted among states with and without 
an insurance mandate during the study period, stratified by
male factor infertility. For 2010–2014, we compared ICSI use by
mandate status and used log-binomial regression to calculate 
adjusted rate ratios (aRR) for associations between ICSI use and 
insurance mandates, accounting for clustered clinic outcomes 
with generalizing estimating equations. P-values below .05 were
significant. 
Results: During 2000–2014, ICSI use in non-male factor 
infertility cycles increased more within non-mandate (34.6% to
71.4%) compared with mandate states (39.5% to 62.3%), (P < 
.0001). From 2010–2014, ICSI use was higher in non-mandate
than mandate states for cycles without non-male factor infertility 
(68.4% vs. 59.6%, aRR 0.86; 95% CI, 0.75-0.99, P = .04) and those 
with male factor infertility (94.5% vs. 90.9%, aRR 0.96; 95% CI, 
0.93-1.00, P = .03). 
Conclusions: In non-male factor cycles, the increase in ICSI use 
was greater for states without an IVF insurance mandate than
those with one. During 2010–2014, mandates were associated 
with decreased ICSI use, suggesting that reimbursement may 
affect IVF treatment decisions. 




















4:10 Antiviral Treatment Among Hepatitis B Virus–Infected Pregnant Women — New York City 
and Michigan, 2013–2015 
Authors: Ruth Link-Gelles, A. Koneru, J. Lazaroff, P. Fineis,  
N. Nelson, S. Schillie 
Background: Individuals with chronic hepatitis B virus (HBV) 
infection are at increased risk for cirrhosis and hepatocellular
carcinoma. Chronic HBV infection develops in 90% of infants 
infected at birth. Although postexposure prophylaxis prevents 
up to 95% of perinatal HBV infections, breakthrough infections 
occur, especially among infants born to women with high viral 
loads (VLs). Maternal antiviral treatment during pregnancy can 
reduce perinatal HBV transmissions by 70% above the effect
of infant postexposure prophylaxis alone. We assessed factors
associated with maternal antiviral treatment in a cohort of HBV-
infected pregnant women with high VL. 
Methods: During 2013–2015, the U.S.-funded Supplemental 
Perinatal Hepatitis B Prevention Program collected demographic, 
clinical, and maternal antiviral treatment information from
medical charts of HBV-infected pregnant women in Michigan 
and New York City. We included only the first birth from
multiparous women. We assessed the association of demographic 
and clinical factors with maternal antiviral treatment, with
Fisher’s exact tests of significance at p<0.05. 
Results: Among 1,610 women with maternal antiviral treatment 
and VL data, 138 (8.8%) had high VL (>200,000 IU/mL). Among 
138 women with high VL 33.3% received antiviral treatment. 
Among women with high VL, 46 (35.1%) of 131 Asian/Pacific 
Islanders and 0 of 7 women of other races were treated (P =0.10). 
Receipt of treatment was not associated with insurance type, 
pregnancy length, or infant birth weight. 
Conclusions: No factor assessed was significantly associated 
with antiviral treatment among women with high VL. Because 
two-thirds of women with high VL did not receive antiviral 
treatment during pregnancy, opportunities to reduce perinatal 








4:30 Distribution of Severe Maternal Morbidity by Comorbidity Status Among Delivery
Hospitalizations — Massachusetts, 1998–2013 
Authors: Nicholas J. Somerville, T. Nielsen, H. Diop, S. Manning 
Background: Limited information is available about the
burden of severe maternal morbidity (SMM) among low-
risk pregnancies, which has prevention implications. We
assessed proportion of SMM by comorbidity status among
Massachusetts delivery hospitalizations to describe how
distribution of risk changed over time. 
Methods: The Massachusetts Pregnancy to Early Life
Longitudinal (PELL) data system links infant birth certificates 
and fetal death records to the corresponding maternal and 
infant hospital discharge records for Massachusetts resident 
mothers during 1998–2013. SMM was identified from PELL 
delivery-related hospital discharge records by using CDC’s 
SMM algorithm; blood transfusion was excluded because of
concerns about specificity. PELL deliveries were assigned a 
comorbidity score (range: 0–45) on the basis of maternal age 
and International Classification of Disease, Ninth Edition clinical 
modification codes by using a validated index that predicts 
maternal morbidity. Mean yearly comorbidity score and overall 
proportions of SMM by comorbidity score were calculated.  
Results: A total of 1,185,182 delivery hospitalizations and 5,325 
SMM occurred in Massachusetts during 1998–2013. A total of
687,406 (58%) delivery hospitalizations and 1,358 (26%) SMM 
had a comorbidity score of zero. Rate of SMM/10,000 delivery
hospitalizations increased from 50 in 2008 to 65 in 2013; the 
mean yearly comorbidity score increased from 0.58 (σ = 0.95) 
in 1998 to 0.78 (σ = 1.14) in 2013. Rate of SMM/10,000 delivery
hospitalizations by comorbidity score ranged from 20 (score = 0) 
to 1,942 (score ≥10). 
Conclusions: Approximately one quarter of SMM occur among 
deliveries without comorbidities in Massachusetts, indicating that
all levels of birth facility need to anticipate SMM occurrences. 
The increasing mean delivery comorbidity score during 1998– 
2013 is consistent with the increasing statewide SMM rate.













4:50 Attention-Deficit Hyperactivity Disorder Medication Use During Pregnancy and Risk for 








Authors: Kayla N. Anderson, A. Arth, C. Broussard, S. Farr,   
J. Lind, S. Visser, J. Reefhuis, S. Tinker 
Background: Attention-deficit hyperactivity disorder (ADHD) 
is a neurodevelopmental disorder affecting individuals across 
the lifespan, including an estimated 10 million adults. Given 
increasing diagnosis and treatment of ADHD, rates may be
increasing among pregnant women. Little is known about 
ADHD medication safety during pregnancy. Analysis objectives 
were to assess prevalence of overall ADHD medication use 
(i.e., psychostimulant and non-stimulant medications) at any 
time during pregnancy and estimate associations between early 
pregnancy use (one month before through third month of
pregnancy) and specific birth defects. 
Methods: We analyzed data from the National Birth Defects 
Prevention Study (1997–2011), a U.S. population-based 
multicenter case-control study. Birth defects surveillance systems
were used to identify cases (n=32,000); controls were randomly-
sampled live-born infants without major defects representing
the same geographic regions (n=11,892). Mothers of cases and 
controls completed a computer-assisted telephone interview.
We calculated prevalence of ADHD medication use anytime 
during pregnancy and used logistic regression to estimate the 
association between early pregnancy ADHD medication use and 
14 birth defects. For gastroschisis, we adjusted for maternal age. 
Results: Overall, 0.2% of women reported any ADHD medication
use during pregnancy, and 20 control mothers and 65 case mothers
reported early pregnancy use. Early pregnancy ADHD medication
use was associated with gastroschisis (odds ratio [OR]: 3.24; 95%
confidence interval [CI]: 1.32–7.92), omphalocele (OR: 3.99; 95%
CI: 1.18–13.47), and transverse limb deficiency (OR: 3.23; 95% CI:
1.10–9.49) in infants. 
Conclusions: ADHD medication use during pregnancy was 
rare, but early use was associated with 3 of 14 birth defects 
investigated. Additional research is needed to confirm 
observations and help clinicians provide appropriate counseling 
to women of reproductive age who use ADHD medications. 

















CONCURRENT SESSION D3: Global Health: Treatment and Strategy 
3:45–5:10 PM 
3rd Floor Room 203 AB 
Moderators: Rebecca Martin and Wences Arvelo
3:50 	 Efficacy of Artemether-Lumefantrine for Treatment of Uncomplicated Plasmodium 
falciparum Malaria — Cruzeiro do Sul, Brazil, 2015 
Authors: Megumi Itoh, S. Valle, S. Farias, T. Souza, G. Viana,  
N. Lucchi1, P. Marchesini, M. Póvoa, A. Santelli,  
A. Macedo de Oliveira 
Background: Brazil has the highest number of malaria cases 
in the Americas and adopted artemisinin-based combination 
therapy in 2006 for the treatment of Plasmodium falciparum
malaria. The World Health Organization recommends 
routine monitoring of antimalarial efficacy. We conducted a 
therapeutic efficacy study of artemether-lumefantrine (AL) for 
uncomplicated P. falciparum malaria in Cruzeiro do Sul, Brazil 
during December 2015–May 2016. 
Methods: Febrile patients ≥5 years old with microscopically 
confirmed P. falciparum monoinfection and asexual parasitemia 
250–200,000 parasites/μ were treated with a supervised 
3-day course of AL. Clinical and parasitological response was 
monitored for 28 days. Treatment failure, called recrudescence, 
was differentiated from reinfection by microsatellite genotyping. 
We calculated treatment success rates with and without 
microsatellite correction. Additionally, molecular analysis for 
K13 gene mutations, associated with artemisinin resistance,  
was conducted.
Results: Out of 131 patients offered participation, 80 were
enrolled and 75 completed Day 28 follow-up. One patient
had recurrent infection with low-level parasitemia on Day 28.
The associated parasite was not isolated on molecular testing;
therefore, this patient was excluded from the microsatellite­
corrected analysis. The uncorrected and microsatellite­
corrected AL efficacy was 98.7% (74/75) (95% confidence
interval: 93.2–100%) and 100% (74/74) (95% confidence
interval: 95.4–100%), respectively. Although no treatment
failure was detected before Day 28, 5 patients (6%) remained
parasitemic on Day 3, which may suggest artemisinin
resistance. No K13 mutations were identified.
Conclusions: AL remains efficacious for falciparum malaria 
in Cruzeiro do Sul. Day 3 parasitemia rate was higher than
expected, raising concern for delayed parasite clearance,
but remains <10%, the threshold for suspected artemisinin 
resistance. Routine monitoring of in vivo drug efficacy and 





















4:10 Effect of Mass Drug Administration Regimen on Schistosoma mansoni Morbidity Among 








Authors: Anita D. Sircar, P. Mwinzi, I. Onkanga,  
W. Secor, S. Montgomery, R. Wiegand 
Background: Schistosomiasis results from exposure to
contaminated freshwater and predominantly affects school-
aged children. Pathology is associated with parasite eggs in
tissue and is controlled by mass drug administration (MDA) 
with praziquantel. The study objective was to compare MDA
strategies for reducing Schistosoma mansoni infection-
associated morbidity. 
Methods: Stunting, wasting, anemia and presence and intensity 
of infection were assessed in village cohorts of 7-9 year old 
children at baseline. Communities were randomized to either 
four years of annual community-wide MDA (4CWT) or biennial 
school-based MDA (2SBT). Measures were repeated at year 5 to
compare impact of MDA approaches. 
Results: 802 children were enrolled at baseline; 512 (64%) 
remained at year 5 with population migration responsible for loss 
to follow-up. S. mansoni prevalence and morbidity was similar 
between MDA cohorts at baseline. In the 4CWT cohort, year 5 
prevalence was significantly reduced compared to baseline (OR 
0.2, 95% CI: 0.2, 0.4). Prevalence of high intensity infections (≥ 
400 eggs per gram per stool slide) was also significantly reduced 
by 4CWT at year 5 (OR 0.19, 95% CI: 0.08, 0.47). By contrast, 
2SBT did not significantly decrease overall prevalence or high 
intensity infections (OR 0.86, 95% CI: 0.55, 1.34) and (OR 0.59, 
95% CI: 0.30, 1.17) respectively. Stunting [adjusted odds ratio 
(aOR): 1.64 (0.69-3.89)], wasting [(aOR): 1.32 (0.49-3.57)] and 
anemia [(aOR): 0.842 (0.45-1.57)] were not significantly different
between cohorts at year 5 when adjusted for age and sex.) 
Conclusions: Significant infection reduction occurred within 
the 4CWT cohort but not with 2SBT. However, morbidity at 5 
years was similar for children in both groups. In this study, less 
frequent, less expensive, school-based MDA, achieved similar 
health outcomes as yearly CWT. 
4:30 Improving Injection Safety in Cambodia: A Public Health Response to the 2014–2015 HIV 
Outbreak in Roka Commune 
Authors: Ugonna C. Ijeoma, S. Samson, S. Sok, H. Vannara,  
S. Sanith, T. Sopheap, R. Newman, L. Vanthy, A. Saadani,
A. Moffitt, M. Chevalier, B. Drammeh, D. Selenic 
Background: From December 2014-February 2015, an
outbreak of 242 new cases of HIV occurred in Roka Commune,
Battambang province, Cambodia. Results from the subsequent 
EPI-AID identified unsafe injection practices by unlicensed 
practitioners as the likely source, highlighting the potential for 
unsafe injection practices to contribute to the spread of HIV in 
Cambodia. In September 2016, we conducted a rapid assessment
to identify existing gaps in injection safety knowledge and 
practices among licensed healthcare workers (HCW). 
Methods: We conducted a cross-sectional study at 15 
government healthcare facilities in Battambang and Pursat 
provinces. We utilized a World Health Organization (WHO) 
standardized injection practices assessment tool to interview 
and observe injection administration by 39 licensed HCWs 
(physicians, nurses and laboratory technicians). We calculated 
descriptive statistics using EpiInfo 7.2.0.1. 
Results: Preliminary analysis demonstrated that 111/115 (96.5%) 
observed injection events were administered with needles/ 
syringes taken from unopened, sterile packs; 52/105 (49.5%) 
of available sharps containers for needle disposal were not 
appropriately placed within arm’s length of the HCW. During
most injection events, 91/115 (79%), hand hygiene was not 
performed prior to injection administration and 66/104 (63.5%) 
of the needles were recapped after use; 33/66 (50%) of which 
were recapped with two hands. All 39 HCWs interviewed knew
HIV could be transmitted through unsafe injection practices, 
but fewer were aware of hepatitis B (80%) and hepatitis C (62%) 
transmission through this route. Finally, 11/39 (28%) reported 
ever experiencing a needle stick injury and 19/39 (48.7%) 
reported ever receiving formal injection safety training. 
Conclusions: There are existing gaps in injection practices in 
Cambodia, particularly in hand hygiene and safe disposal of
needles. Intensive training for HCWs is needed to address  
these gaps. 























4:50 Misuse of Antibiotics for Childhood Diarrhea Case Management — Western Kenya, 
2009–2016 
Authors: Chulwoo Rhee, G. Aol, A. Ouma, S. Muema, J. Auko, 
G. Odongo, R. Wiegand, J. Montgomery, Widdowson, G. Bigogo, 
J.R. Verani 
Background: Antibiotics are essential treatment for
many childhood infections; however overuse contributes
to antimicrobial resistance. For childhood diarrhea, the
Integrated Management of Childhood Illness (IMCI)
guidelines recommend antibiotics only for dysentery (bloody
diarrhea). We evaluated the appropriateness of antibiotic
treatment for childhood diarrhea case management in western
Kenya. 
Methods: We analyzed data from the Population Based
Infectious Disease Surveillance system in a rural, malaria-
endemic setting in western Kenya (Asembo); participants
receive free care for acute illness at a surveillance clinic. We
examined records of children <5 years with diarrhea (≥3
loose stools in 24 hours) from August 2009 to May 2016.
After excluding those with non-diarrheal IMCI guidelines
recommendations for antibiotic use, we examined antibiotic
misuse including overuse (antibiotic prescription for
non-dysentery) and underuse (no antibiotic prescription
for dysentery) using multivariate logistic regression with
generalized estimating equations. 
Results: Of 2,826 diarrheal visits, 2,702 (95.6%) were non-
dysentery; there was antibiotic overuse in 1,426 (52.8%). Of 
124 (4.4%) dysentery visits, there was antibiotic underuse in 33 
(26.6%). In non-dysentery patients, overuse was associated with
gastroenteritis diagnosis (adjusted odds ratio [aOR]: 7.08, 95% 
confidence interval [95%CI]: 3.28–15.3); appropriate use was 
associated with malaria diagnosis (aOR: 0.36; 95%CI: 0.24–0.53) 
and oral rehydration solution treatment (aOR: 0.51, 95%CI: 
0.36–0.73). In dysentery patients, underuse was associated with
malaria diagnosis (aOR: 1.83, 95%CI: 1.06–3.16) and vomiting
(aOR 4.43, 95%CI: 1.99-9.84). 
Conclusions: Antibiotic misuse was common in childhood
diarrhea management in Asembo, likely contributing to
antimicrobial resistance; efforts are needed to promote rational 
use. Interventions to improve antibiotic use for diarrhea should 
consider the influence of malaria diagnosis on clinical decision-














44 2017 EIS Conference 







Tuesday, April 25, 2017 
CONCURRENT SESSION E1: STDs and HIV 
8:30–9:55 AM 
Frieden Plenary 
Moderators: Gail Bolan and Bob Kirkcaldy 
8:35 Syphilis Screening Among Pregnant Women — Guam, 2014 
Authors: Susan Cha, T. Malik, B. Schumann, W. Abara,  
M. DeSimone, A. Santos, V. Aguon, E. Mallada, M. Klemme,
T. Peterman, M. Kamb
Background: U.S. guidelines recommend early prenatal 
screening for syphilis because untreated infections can lead 
to adverse perinatal outcomes. In Guam, a 385% increase in 
primary and secondary syphilis rates among women from 2010 
to 2013, and an unexpected case of congenital syphilis in 2013 
prompted an assessment of syphilis screening and maternal
characteristics of inadequate screening. 
Methods: We reviewed medical records for a randomly selected 
sample of mothers with 966 live births at Guam Memorial 
Hospital in 2014. We excluded 101 records without prenatal or
laboratory information on gestational age at syphilis screening. 
We defined “late” syphilis screening after 24 weeks’ gestation 
and “very late” screening after 32 weeks. We abstracted 
sociodemographic, prenatal care, delivery, and laboratory data
from the records. We calculated prevalence of syphilis screening 
among pregnant women and conducted bivariate analysis using 
Poisson regression and chi-square significance tests to determine 
factors associated with very late or no prenatal screening. 
Results: Overall, 809 women (93.5%) received syphilis screening: 
232 (26.8%) were screened late; 110 (12.7%) were screened 
very late. Among women who received prenatal care (N = 
773), records included risk factors for very late or no syphilis 
screening: uninsured (28.9% vs. 8.5% insured; P <.0001) and 
unemployed (14.3% vs. 5.5% employed; P = .0003). More women 
with public prenatal providers had very late or no syphilis 
screening (16.7%) than did those with private providers (5.8%), 
P <.0001. 
Conclusions: Although the majority of women received prenatal 
care, many were not tested or not tested early enough to prevent 
potential adverse perinatal outcomes caused by syphilis. 
Improved prenatal care and earlier syphilis screening are  






















8:55 Prevention of Mother-to-Child Transmission of HIV Service Utilization Among Adolescents 






Authors: Amanda B. Burrage, A. Mushavi, R. Shiraishi,  
B. Tippett Barr, G. Shambira, J. Nyakura, S. Balachandra,  
P. Kilmarx, T. Dinh 
Background: Vertical transmission accounts for 90% of pediatric
HIV cases. Prevention of mother-to-child HIV transmission
(PMTCT) services include antenatal care (ANC), HIV testing, and
provision of maternal and infant antiretroviral medication (ARV).
HIV vertical transmission is higher in adolescents than older
mothers. We assessed uptake of PMTCT services in adolescents
(age ≤19) and young women (ages 20–24) in Zimbabwe. 
Methods: A PMTCT evaluation used multistage sampling to
recruit a nationally-representative sample of 6051 mothers and 
their 4–12-week-old infants from 151 immunization clinics 
from February to August 2013. We analyzed data collected from
maternal interviews, child-health cards, and infant HIV test 
results. An HIV-positive mother was defined by (1) maternal 
self-report and ANC documentation, or (2) presence of infant
HIV antibody. Findings were weighted and adjusted for complex 
survey design and non-responses and analyzed with STATA 14.1. 
Results: Among mothers, 16.3% were adolescents and 29.8% 
were young women. HIV prevalence was 7.5% (95% confidence 
interval [CI]: 6.1–9.3) and 14.8% (95% CI: 12.8–16.9), 
respectively. Across all ages, 95% of mothers had ≥1 ANC visit, 
97% had ≥1 HIV test, and 99% knew their HIV status. No
difference in gestational age at first ANC visit was found. HIV-
positive adolescents, compared to HIV-positive young women, 
reported no ARV use during pregnancy (20.6%, 95% CI: 12.6– 
31.7 vs. 13.5%, 95% CI: 9.9–18.1). Infant ARV prophylaxis did 
not differ between the maternal groups (95%). 
Conclusions: Conclusions: Uptake of maternal ARVs is lower in 
adolescents than young mothers. Targeted approaches to increase
uptake of ARVs could reduce vertical transmission and pediatric 
HIV cases among adolescents. CDC Disclaimer:  The findings 
and conclusions in this report are those of the authors and do 
not necessarily represent the official position of the Centers 
for Disease Control and Prevention. Sources of Support: This 
evaluation was primarily supported by the President’s Emergency 
Plan for AIDS Relief (PEPFAR) under a Cooperative Agreement 
between Centers for Disease Control and Prevention (CDC)  
and the University of Zimbabwe through Department of
Community Medicine (U2GGH00315-01). CDC assisted with
protocol development, managing the study, data analysis, and 
manuscript writing. 























9:15 Infant HIV Diagnosis and Testing Turnaround Time — Malawi, 2012–2015
 
Authors: Hammad Ali, P. Minchella, G. Chipungu,  
J. Nkengasong, A. Kim, M. Swaminathan, D. Singer 
Background: Globally, 50% of human immunodeficiency
virus (HIV) infected children were not receiving antiretroviral 
treatment (ART) in 2015. Without treatment, many perinatally 
infected children die within first year. Implementation of ‘Test 
and Start’ (starting ART upon diagnosis) requires increasing 
uptake of testing to identify undiagnosed infants. Delayed 
turnaround time (TAT) in testing delays initiation of ART 
leading to poorer health outcomes. Using Malawi’s national 
Laboratory Information Management Systems (LIMS), we
examine trends and factors associated with HIV-positivity in 
infants, and summarize TAT. 
Methods: We conducted a retrospective analysis of routinely 
collected LIMS data including patient demographics, sample 
transportation and test outcomes. HIV-positivity was assessed 
among infants aged 0–18 months via virologic testing based 
on detection of HIV nucleic acid. TAT was defined as time 
between dried-blood-spot collection to dispatch of results from
laboratory. Data were de-duplicated using various patient IDs. 
Logistic regression was used to identify factors associated with
HIV-positivity. 
Results: Between 2012 and 2015, 76,001 samples from HIV-
exposed children were tested. HIV-positivity decreased from
5.86% in 2012 to 3.15% in 2015. Multivariable analyses identified 
older age at testing (>3 months), being female, infant not on
ART at birth, infants with presumed severe HIV disease, and 
residing in central or southern regions as factors associated with
HIV-positivity. Median TAT was 19 days (IQR:12-31) in 2012 
but increased to 34 days (IQR:18-51) in 2015; despite, volume of
testing not increasing. 
Conclusions: HIV-positivity among infants decreased by
46%; whereas TAT increased by 79%. Factors associated with
HIV-positivity identify the need for testing of exposed and
immediate treatment for infected infants. Reducing the TAT
will lead to earlier availability of results enabling potential
earlier start of ART. 
9:35 Factors Associated with Condomless Anal Sex Among Black Men Who Have Sex with 







Authors: Erica L. Dawson, M. Mendoza, Z. Gaul, K. Buchacz,  
M. Sutton 
Background: Among 955,081 persons living with HIV infection
in the United States (2014), black men who have sex with men 
(MSM) are disproportionately affected. The New York City 
metropolitan area (NYC) has the second highest HIV prevalence 
nationally (695.1 per 100,000). Among 2,718 new HIV diagnoses 
in NYC (2014), 59.6% were among MSM, including black MSM. 
Condomless anal sex (CAS) is the primary risk factor for HIV 
transmission among MSM. The capacity to recover quickly from
difficulties (resilience) may be protective against HIV risk but has 
been understudied for black MSM. We assessed the association 
between resilience and CAS to inform HIV prevention efforts.. 
Methods: We analyzed data from a 2012 cross-sectional study 
that examined behavior and health among sexually active black 
MSM (aged 18–35 years) in NYC. Participants who reported 
sex with a man in the past 60 days were assessed on the Connor
Davidson Resilience Scale (CDRS) (lowest to highest, 0–100). We
used modified Poisson regression to estimate adjusted prevalence 
ratios (aPRs) and 95% confidence intervals (CIs), indicating 
the association between resilience and CAS (outcome variable), 
adjusted for number of sex partners. 
Results: Among 228 black MSM (mean age: 25 years; mean
CDRS score: 74.4), 127 (56.7%) reported CAS (past 60 days), and 
134 (58.8%) reported >1 sex partner. CAS was associated with
>1 sex partner (aPR: 1.49; CI: 1.15–1.94) but not with resilience 
(aPR: 0.99; CI: 0.99–1.00). 
Conclusions: After adjustment for number of sex partners, greater
resilience did not have a protective effect on engagement in CAS
for this sample. HIV prevention tools that support condom use and
decreased numbers of sex partners are warranted for black MSM. 
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Authors: Sophia K. Chiu, N. Burton, K. Dunn, M. de Perio 
Background: Employees and patrons of the 192 indoor
waterparks nationwide might be exposed to disinfection
byproducts that can cause respiratory and ocular symptoms. 
While investigating patron complaints, a municipal health
department requested CDC assistance to evaluate symptoms
and etiologies among employees at an indoor waterpark resort. 
Methods: We surveyed resort employees about symptoms and 
work in January 2016. We defined a case as an employee with ≥3 
symptoms in the past 4 weeks that began at and improved away
from work: cough, wheeze, shortness of breath, chest tightness, 
nose irritation, eye irritation, sore throat. We used log-binomial 
regression to identify factors independently associated with
illness. We measured area air concentrations of chlorine and 
chloroform (a disinfection byproduct) and air temperature
and relative humidity. We assessed the waterpark’s ventilation 
system. 
Results: Of 112 resort employees, 91 (81%) participated; 
45 (49%) worked in the waterpark area; 46 (51%) in other 
resort areas. Median age was 19 years (range: 15–65). Eye 
irritation (37%), cough (31%), and nose irritation (29%) were
most commonly reported. Twenty-nine (32%) employees 
met the case definition. Working in the waterpark (vs. other 
areas) was independently associated with illness (adjusted 
prevalence ratio: 3.7; 95% confidence interval: 1.4–11.4). 
Although low air chlorine and chloroform concentrations were
detected, temperature was below and relative humidity above 
recommended ranges. Five of six air handling units were not 
functioning properly. 
Conclusions: Employees’ symptoms were consistent with
disinfection byproduct exposures. Suboptimal ventilation  
and air quality conditions likely contributed to the higher rate
of illness among employees working in the waterpark. A  
properly functioning ventilation system is important to
protecting millions of employees and patrons in this rapidly 
expanding industry. 

























8:55 Respiratory Morbidity Among U.S. Coal Miners — States Outside of Central Appalachia, 
2005–2015 
Authors: Laura E. Reynolds, D. Blackley, A. Laney, C. Halldin 
Background: Inhalation of coal mine dust causes lung function
impairment and coal workers’ pneumoconiosis (CWP), a 
chronic, occupational lung disease. The Enhanced Coal Workers’
Health Surveillance Program (ECWHSP) monitors respiratory
disease among U.S. coal miners. Recent published research
focuses on coal miners in central Appalachia (Kentucky, Virginia, 
West Virginia), an area of concentrated coal mining, yet 57% of
coal miners work outside of this region. We analyzed ECWHSP 
data from active underground and surface coal miners working 
in the eastern (excluding Central Appalachia), interior, and 
western regions of the U.S. to characterize respiratory morbidity 
by region. 
Methods: Active coal miners working outside of central Appalachia
who received chest radiographs and spirometry through ECWHSP
during 2005–2015, were included. Chest radiographs were
classified according to International Labour Office standards for
pneumoconioses and spirometry was interpreted using American
Thoracic Society guidelines. Prevalence of CWP and lung function
impairment (obstructive, restrictive, or mixed patterns), were
compared by geographic region. 
Results: Of 4,985 coal miners, 103 (1.2%) had evidence of CWP
on chest radiograph.  Prevalence of CWP differed by region (P 
<.0001), with the highest prevalence in the eastern region (3.4%) 
and the lowest in the interior region (0.8%). Lung function
impairment was found in 9.3% of miners. The interior region
had the highest prevalence of an obstructive pattern (4.2%) 
and the eastern region had the highest prevalence of restrictive 
(6.3%) and mixed patterns (1.0%). 
Conclusions: CWP is an entirely preventable disease, but 
remains an urgent public health problem outside of Central 
Appalachia, particularly in the eastern region. Efforts to control 
respirable dust must be maintained or improved to prevent CWP 
and lung function impairment in U.S. coal miners. 
9:15 Occupational and Take-Home Lead Exposure Associated with a Lead Oxide 







Authors: Jessica L. Rinsky, P. Lauffer, K. Gaetz, S. Higgins,  
K. Squires, G. Dang, K. Musolin, J. Gibbins, A.T. Fleischauer 
Background: Lead exposure is associated with adverse health
effects among adults and  developmental delays among children. 
In May 2016, state surveillance coordinators noted elevated 
blood lead levels (BLLs) among most employees of a lead oxide 
manufacturer (Company A) and two of their children. We
investigated to identify risk factors associated with occupational 
and take-home lead exposures. 
Methods: We defined an elevated BLL as ≥5 μg/dL. We reviewed 
routine BLL surveillance records for Company A employees 
during 2012–2016. We visited Company A, reviewed policies, 
and interviewed employees about their work, personal hygiene,
and children. We matched reported children to surveillance data. 
Results: Eighty-four of 92 (91%) persons ever employed at
company A during 2012–2016 had ≥1 elevated BLL. Employees’
median BLLs increased from 19 (range: 4–40) μg/dL in 2012 to
37 (range: 9–53) μg/dL in 2016. Site visits identified inadequate 
exposure controls, including open lead sources, no routine 
line maintenance, and inadequate training and monitoring of
personal protective equipment (PPE) use and hygiene. Eighteen 
of 22 current manufacturing employees were interviewed; 17 
(94%) reported always wearing an air-purifying respirator,
but 13 (72%) did not consistently clean their respirator. All 18 
employees changed clothes, boots and showered after each shift 
in plant areas considered clean; however, these areas were visibly
contaminated. All employees reported bringing personal items 
home. Eight children (<1–8 years old) had elevated BLLs (range: 
7–40 μg/dL). 
Conclusions: Inadequate exposure controls and widespread 
lead contamination at Company A resulted in increased lead 
exposure to employees and their families. North Carolina Public 
Health is working with Company A to implement more effective 
engineering controls and enhanced PPE and hygiene policies. 










9:35 Occupational Distribution of Campylobacteriosis and Salmonellosis Cases — Maryland, 






Authors: Chia-Ping Su, M. de Perio, K. Fagan, M. Smith,  
E. Salehi, S. Levine, K. Gruszynski, S. Luckhaupt 
Background: Campylobacter and Salmonella are leading causes 
of bacterial gastroenteritis nationwide with >1 million cases 
annually. These pathogens are primarily transmitted through 
consumption of contaminated food; animal-to-human or
human-to-human transmission can also occur. Occupational 
transmission has been reported, but patterns of disease by
occupation have seldom been explored. We analyzed case
reports to describe their occupational distribution and identify
potentially high risk occupations. 
Methods: We obtained data for confirmed, probable, and 
suspect campylobacteriosis and salmonellosis cases in 2014 
among Maryland, Ohio and Virginia residents ≥16 years old 
from state notifiable diseases surveillance systems. We assigned 
a Standard Occupational Classification code to each employed 
case. The American Community Survey was used to estimate
the employed civilian population. We calculated risk ratios (RR) 
and 95% confidence intervals (CI) for associations between each
occupational group and each disease, contrasting each group 
with all other occupations. 
Results: Of 2,977 campylobacteriosis and 2,259 salmonellosis 
cases, 973 (33%) and 797 (35%) were employed and had 
codable occupation, respectively. Farming, fishing, and forestry
occupations (RR: 10.0 [CI: 7.0–14.4] and 3.2 [CI: 1.6–6.4]) and 
healthcare/technical occupations (RR: 1.5 [CI: 1.2–1.9] and 2.0 
[CI: 1.6–2.5]) were at increased risk for both campylobacteriosis 
and salmonellosis. The food preparation/serving-related 
occupations (RR: 1.6 [CI: 1.2–2.0]) and personal care/service 
occupations (RR: 1.5; [CI: 1.1–2.1]) were also at higher risk  
for salmonellosis. 
Conclusions: Workers in agriculture, healthcare, food, and 
personal care occupations appear at increased risk of enteric 
infection. Targeting education and prevention strategies, 
including proper hygiene techniques at work, could help reduce 
disease. Collecting occupational information systematically in 
disease surveillance systems provides a better understanding of
the extent of occupationally-acquired diseases. 
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10:20 Acute Zika Virus Infection as a Risk Factor for Guillain-Barré Syndrome — Puerto Rico, 
April–December 2016
 
Authors: Emilio Dirlikov, C. Major, N. Medina, D. Matos,  
R. Lugo-Robles, M. Garcia, M. Olivero-Segarra, G. Malave,  
M. Beltran, C. Colon, J.L. Munoz-Jordan, D. Thomas,  
C.A. Luciano, J. Sejvar, T. Sharp, B. Rivera-Garcia 
Background: Guillain-Barré syndrome (GBS) is an uncommon
autoimmune disorder characterized by progressive bilateral 
weakness and sensory abnormalities following an infection or
vaccine. During local Zika virus (ZIKV) transmission in 2016, 
the Puerto Rico Department of Health (PRDH) reported 66 GBS 
cases with laboratory evidence of ZIKV infection. A prospective 
case-control study was conducted to identify GBS risk factors, 
including ZIKV infection. 
Methods: Case-patients were defined as suspected GBS patients
reported to PRDH admitted at nine hospitals; GBS diagnosis 
was confirmed using standardized diagnostic criteria following 
chart review. Controls were matched 1:2 by case-patient’s 
residence and age group. Questionnaires and serum, urine, and 
saliva specimen collection were conducted within 1 month of
case-patients being reported. Acute ZIKV infection was defined 
as positive by reverse transcription-polymerase chain reaction
(RT-PCR) in any specimen; evidence of ZIKV infections was 
defined as positive by RT-PCR or immunoglobulin M (IgM) 
enzyme-linked immunosorbent assay (ELISA). Matched  
odds ratio (MOR) with 95% confidence intervals (95% CI)  
were calculated. 
Results: During April–December 2016, 42 case-patients and 
 84 controls were enrolled; 33 pair units had complete ZIKV 
testing. Risk factors for GBS were acute ZIKV infection
(8 [24%] cases vs. 3 [5%] controls, MOR: 14.0 [95% CI: 
 1.8–106.5]), evidence of ZIKV infection (19 [58%] cases vs.  
11 [17%] controls, MOR: 7.8 [2.7–22.0]), and reporting an acute 
illness within previous 2 months (29 [88%] cases vs. 15 [23%] 
controls, MOR: 15.3 [4.8–49.3]). 
Conclusions: Prospective reporting and enrollment of case-
patients provided the first identification of acute ZIKV infection
as a risk factor for GBS. During ZIKV outbreaks, clinical 
suspicion of GBS should be elevated to improve patient prognosis 


































10:40 Unusual Source of Gram-Negative Bloodstream Infections in Hemodialysis Patients — 
Illinois and Missouri, 2015–2016 
Authors: Shannon A. Novosad, J. Lake, E. Soda,  
H. Moulton-Meissner, K. Seiber, M. Pho, L. Bepo, N. Gualandi, 
M. Arduino, G. Turabelidze, D. Nguyen, J. Layden, P. Patel 
Background: Approximately 29,000 bloodstream infections 
(BSIs) occur in hemodialysis patients yearly; gram-negative
bacteria are an uncommon cause. In November 2016, we
investigated an unusually large cluster of gram-negative BSIs at
3 outpatient hemodialysis facilities (A, B, and C) owned by the 
same company.
Methods: We conducted a case-control investigation, infection
control review, and collected environmental samples. A case was 
≥1 gram-negative organism isolated from blood during July 1, 
2015–November 11, 2016, in Facility A, B, or C patients. Controls 
were patients without BSIs and matched 1:1 to cases by facility 
and treatment date. We calculated matched odds ratios  
(mORs) and 95% confidence intervals (CIs). Patient and 
environmental isolates were compared using pulsed-field  
gel electrophoresis (PFGE). 
Results: Fifty-eight cases occurred [Facility A (n=33), B 
(n=19), and C (n=6)]; 48 (83%) required hospitalization. The 
predominant organisms were Serratia marcescens (n=21) and 
Pseudomonas aeruginosa (n=12). Cases were more likely than
controls to use a central venous catheter (CVC) for dialysis (85% 
vs. 13%; mOR: 52.6; 95% CI: 7.1−390.0). Facility staff reported 
pooling of water in recessed wall boxes that house connections 
between dialysis machines and facility water. Environmental 
samples revealed S. marcescens and P. aeruginosa in dialysis 
treatment areas, including the wall boxes. S. marcescens from
a wall box at Facility C was indistinguishable, by PFGE, from a 
case-patient isolate. We identified opportunities for healthcare
workers’ hands to contaminate CVCs with water from the wall 
box connections.
Conclusions: Wall boxes were identified as a unique source 
of water contamination in this multi-facility BSI outbreak that
particularly affected patients with CVCs. The company is working 
with public health officials to remediate wall boxes and improve 
infection control practices. 
11:00 Integrating Epidemiologic and Molecular Data During an Outbreak of a Rare Strain of 






Authors: Megan C. Dillavou Jarashow, A. Kimura, G. Inami,
R. Mukhopadhyay, F. Arroyo, R. Reporter, M. Garcia, M. Shiozaki, 
A. Bicknese, N. Green, V. Chaturvedi, D. Vugia, B. Schwartz 
Background: Multidrug resistant Shigella outbreaks among men 
who have sex with men (MSM) have increased. In July 2016, the 
California Department of Public Health (CDPH) notified Los 
Angeles County of 7 Shigella flexneri cases, caused by serotype
7 (provisional 88-893), an uncommon strain. We investigated 
to find additional cases, determine risk factors and molecular 
relatedness of isolates, provide clinical guidance, and prevent 
additional cases. 
Method: Locally nontypable S. flexneri isolates were serotyped 
at CDPH’s microbial disease laboratory. Cases were defined 
as persons with confirmed S. flexneri serotype 7 in Southern
California with onset during March–October 2016. Patients were
interviewed about risk factors and medical records abstracted. Six 
isolates were tested for antimicrobial susceptibilities. Pulse-field 
gel electrophoresis and whole genome sequencing (WGS) were
conducted. Kruskal-Wallis and Fisher exact tests were used to
compare isolate subclusters. 
Results: Of 34 patients identified, 13 required hospitalization; 1 
died. All were male (median age 36 years); 97% self-identified 
as MSM; 80% (24/30) with known HIV status were positive, 
of whom 54% were not taking antiretrovirals consistently. All 
isolates were nonsusceptible to azithromycin and trimethoprim­
sulfamethoxazole, and 83% to amoxicillin. WGS of 28 isolates 
revealed all were ST-245 sequence type; 27 were clustered with
2-45 single-nucleotide polymorphisms (SNP) difference. Three 
subclusters were identified and differed by isolate date (P <0.001) 
and local health jurisdiction (P <0.04). 
Conclusions: This outbreak, caused by an uncommon Shigella
strain, provides important data on genetic relatedness of Shigella
isolates in a cluster with high selective pressure. Investigators
may want to consider molecular testing to identify clusters
and help guide investigation of risk factors and transmission.
Treatment guidance to clinicians should be determined by
antimicrobial susceptibility testing. 



























11:20 Hospital-Associated Outbreaks of Multidrug-Resistant Candida auris — Multiple Cities, 
Colombia, 2016 
Authors: Paige A. Armstrong, P. Escandon, D.H. Caceres,  
N. Chow, S. Rivera, MJ. Stuckey, C. Hilbert, J. Díaz, A. Gomez,  
N. Vélez, CM. Parra-Giraldo, I. Berrio, C. Varón,  
Grupo de Investigación en Enfermedades “GREINMIL”,
N. Villalobos, A. Ramírez, P. López, E. Berkow, L. Gade,  
R. Welsh, A. Litvintseva, O. Pacheco, S. Lockhart, R. Fagan,  
J. Díaz, A. Espinosa,  T. Chiller, C. Duarte, B. Jackson 
Background: The emerging multidrug-resistant fungus, 
Candida auris, has caused hospital-associated outbreaks with
high mortality in several countries. Reported cases of C. auris
infection in Colombia increased in 2016, prompting concern 
for further spread. We investigated to elucidate transmission 
mechanisms and inform infection control. 
Methods: A case was defined as isolation of Candida auris from
a patient’s blood with confirmation by molecular identification, 
isolated from a patient’s blood. We abstracted medical records 
and sampled patients, healthcare workers, and hospital surfaces. 
We performed antifungal susceptibility studies and whole 
genome sequencing (WGS) on isolates. 
Results: We identified 40 cases at 4 hospitals in 3 cities. 
In-hospital mortality was 56%. Nearly half (45%) of patients were
infants. All patient had a central venous catheter, two-thirds had 
recent surgery, and half received parenteral nutrition during
their stay. The median time from admission to collection of
blood culture yielding C. auris was 22 days. C. auris was isolated 
from 44 (14%) of 325 environmental samples, including from
transport equipment and rooms without a known case-patient 
present for up to 6 months. Of the 6 patients sampled, C. auris
was cultured from either the groin or axilla of 4. Samples from
2 nurses’ hands yielded C. auris. Nine (23%) of 40 isolates were
resistant to fluconazole and 7 (18%) of 40 were resistant to
amphotericin B; all isolates were highly related by WGS.  
Conclusions: C. auris caused outbreaks of invasive disease,
predominantly in young children, with high mortality in
several Colombian hospitals. C. auris was found on patient
and healthcare worker skin and on hospital surfaces,
suggesting that assiduous infection control practices are
needed to limit the spread of this emerging pathogen.
11:40 Unusual Pathogen Associated with Nonbiting Flies in a Person with Bacteremia — 







Authors: Jesse Bonwitt, E. Dykstra, M. Tran, K. Eckmann,  
J. Zambito, M. Bell, M. Sixberry, S. Lindquist, W. Glover 
Background: Wohlfahrtiimonas chitiniclastica is a rarely reported 
cause of bacterial infection associated with skin lesions and 
sepsis. It has been isolated in nonbiting flies that can cause 
myiasis (fly larvae infestation); however, it has neither been 
isolated from fly larvae on patients with W. chitiniclastica 
infection, nor from insects in the Americas. In August 2016, 
a man was hospitalized in Washington State with necrosis of
the foot, myiasis, and Wohlfahrtiimonas spp. bacteremia. We
investigated to determine exposure source. 
Methods: We attempted to collect live and dead insects 
(including fly eggs and larvae) from the patient and patient’s 
home and culture them for Wohlfahrtiimonas spp. at different
lifecycle phases. Pulsed-field gel electrophoresis (PFGE) was 
performed on isolates to assess relatedness. Recent patient travel 
history was obtained through proxy interviews. 
Results: We collected 8 insect species from inside the patient’s 
home. Although larvae present on the patient when hospitalized 
were unavailable for testing, Wohlfahrtiimonas spp. was 
isolated from larvae collected from the carpet where the patient 
was found by emergency responders. These larvae were not 
taxonomically identified. Wohlfahrtiimonas spp. was also isolated 
from larvae hatched from eggs of a green bottle fly (Lucilia 
sericata) caught inside the home. PFGE results are pending. No
travel outside of Washington was reported. 
Conclusions: We report the first isolation of Wohlfahrtiimonas
spp. in insects in the Americas and a previously undescribed 
vector, the green bottle fly. Our investigation provides further 
evidence of fly larvae as vectors for human infection. Green 
bottle fly larvae are a common cause of myiasis; patients  
with myiasis should be considered at risk for Wohlfahrtiimonas
spp. infection. 













SPECIAL SESSION 1: Epidemiologic Investigations of Environmental Exposures 
12:05–1:20 PM 
3rd Floor Room 203 AB 
CIO Sponsor: National Center for Environmental Health 
This session highlights biomonitoring in environmental assessments and will discuss two examples of CDC-led environmental 
investigations which likely saved many children’s lives in India and Nigeria. This will be a presentation of how the investigations started,
the coordination between lab and field staff, and lessons learned. 
Relevance and Appropriateness for the EIS conference: A number of recent investigations have involved close 
communication and collaboration between epidemiologists in the National Center for Environmental Health and the laboratorians at 
the Division of Laboratory Science. Epidemiologic investigations often require collection of blood or urine of affected individuals in 
order to test for biomarkers of exposure.  However, the utility of a biomarker in such investigations requires careful sample collection, 
labeling, transport, storage, and analysis.  If any of these factors are compromised, the epidemiology results could lead to the null or
worse.
Speakers: 
• 	  Session overview (5 minutes)
 Jerry Thomas, MD 
• 	 Outbreak of Fatal Childhood Lead Poisoning Related to Artisanal Gold Mining in Northwestern Nigeria, 2010 (20 minutes)
Tony Neri, MD, MPH  
Kathy Caldwell, PhD 
• 	 Association of Acute Toxic Encephalopathy With Litchi Consumption in an Outbreak in Muzaffarpur, India, 2014:  
A Case-Control Study (20 minutes)
Josh Schier, MD  
Melissa Carter, PhD 
• 	 Q&A session with the panel members and speakers (20 minutes)  
Carrie Dooyema, MPH, MSN, RN 
Padmini Srikantiah, MD, Center for Global Health 






POSTER SYMPOSIUM I 
1:30–2:45 PM 
Concurrent Session Room 
Moderators: Douglas Hamilton and Michael King 
P1.1 	 Mental Health and HIV-Related Sexual Risk Behaviors Among Adolescent Sexual-Minority 
Males — Chicago, New York City, and Philadelphia, 2015 
Authors: Christine B. Agnew-Brune, D. Broz, B. Hoots, A. Wise, 
J. Smith, G. Paz-Bailey, A. Balaji 
Background: Adolescent sexual-minority males (ASMM) in 
the United States are disproportionally affected by HIV and 
mental health problems. However, the strength of the association 
between mental health problems and HIV sexual risk behaviors 
in this population is unknown. To inform HIV prevention
interventions, we assessed the association between mental health
problems and sexual risk behaviors among ASMM in 3 cities. 
Methods: For the 2015 National HIV Behavioral Surveillance 
pilot project, we interviewed ASMM, defined as males aged 
13–18 years who reported ever having sex with another male, 
gay/bisexual identity, or same-sex attraction. Participants 
were asked about ever attempting suicide. Anxiety and 
depression were measured by using the 4-item Patient Health
Questionnaire-4 (PHQ-4) scale; a score of ≥3 indicates probable 
depression and anxiety. We used log-linked Poisson regression 
to calculate adjusted prevalence ratios for associations between 
mental health problems and past-year sexual risk behaviors: 
≥4 sex partners and condomless anal sex (CAS). Models were
adjusted for age, race/ethnicity, and city. 
Results: Of 548 ASMM, 22% reported ever attempting suicide 
(mean PHQ-4 score: 3.06; standard deviation = 2.7; range: 0–12). 
Twenty-nine percent reported ≥4 sex partners, and 39% reported 
CAS. Ever attempting suicide was associated with ≥4 sex partners
and CAS (adjusted prevalence ratio [aPR]: 1.71, confidence 
interval [CI]: 1.31–2.21; aPR: 1.31; CI: 1.06–1.63, respectively). 
For each 1-point increase in the PHQ-4 score, prevalence of CAS 
increased 4% (aPR: 1.04; CI: 1.02–1.07). 
Conclusions: Anxiety, depression, and suicide attempts are 
common among ASMM and are associated with sexual risk 
behaviors. Including mental health in comprehensive HIV 
























P1.2 Characteristics and Predictors of Inflammation Among Infants Aged 6–23 Months — 
Nepal, 2012 
Authors: Victor Akelo, R. Whitehead Jr., Z. Mei1, S. Chitekwe,  
P. Dahal, N. Paudyal,  R. Pokharel, Y. Addo, M. Jefferds 
Background: Inflammation from immune response can mask 
micronutrient deficiencies. Population-based micronutrient 
surveys often exclude or adjust data among subjects with
inflammation. However, the best method for defining 
inflammation is under debate. We compared prevalence and 
predictors of inflammation by definition. 
Methods: A population-based representative micronutrient 
survey conducted among 2,549 children aged 6–23 months in 2 
districts of Nepal assessed acute and chronic inflammation by
using elevated C-reactive protein (CRP >5 mg/L) and α-1-acid 
glycoprotein (AGP >1 g/L), respectively. A 4-stage inflammation 
variable was calculated as follows: (a) normal CRP and normal 
AGP (noninflamed; referent); (b) high CRP and normal AGP 
(incubation); (c) high CRP and high AGP (acute); and (d) 
normal CRP and high AGP (chronic). Stepwise-adjusted, 
generalized logistic regression models, weighted and accounting
for complex survey design, were used to examine predictors of
inflammation in 4 models: (a) elevated CRP or AGP; (b) only
elevated CRP; (c) only elevated AGP; and (d) the 4 stages of
inflammation. 
Results: Inflammation prevalence was 43% by CRP or
AGP, 18% by only CRP, 39% by only AGP, and 42% by the 4 
stages, and distributed as follows: 3% incubation; 15% acute; 
and 24% chronic. In all models, anemia and fever (past 2 
weeks) predicted inflammation. Other predictors varied by
model with underweight and recent deworming predicting
acute inflammation, whereas underweight, lower paternal 
education, and lower household wealth rank predicted chronic 
inflammation. In addition, underweight and lower household 
wealth rank predicted inflammation by CRP or AGP.
Conclusions: Among infants in Nepal, prevalence of any 
inflammation was high. Chronic inflammation varied by
definition, which may affect estimates of micronutrient 
deficiency. Understanding predictors of inflammation may help 
target interventions. 







Authors: Meng-Yu Chen, J. Williams, L. Yeung, K. Newsome,
K. Brinker, A. Flores, E. Petersen, M. Honein, D. Meaney Delman 
Background: Zika virus (ZIKV) infection during pregnancy can 
cause microcephaly and serious brain abnormalities. As part of
the public health response to Zika, CDC established the US Zika 
Pregnancy Registry (USZPR) in collaboration with state/local 
health departments to monitor pregnancy and infant outcomes 
following ZIKV infection during pregnancy. We evaluated this 
new surveillance system. 
Methods: The outcome measures, based on CDC guidelines, 
included usefulness, simplicity, flexibility, data completeness, 
acceptability, sensitivity, representativeness, timeliness, and 
stability of the system. We conducted document reviews, 
stakeholder interviews with CDC leadership (n=9) and state/ 
territorial health officials (n=4), focus group discussions (n=3) 
with USZPR staff, and analysis of data reported to USZPR. 
Results: As of October 6, 2016, USZPR included 969 pregnant
women with laboratory evidence of possible recent ZIKV 
infection. All 63 jurisdictions participated. USZPR provides 
important information to update clinical guidance, is flexible 
and accommodates evolving needs in the response, but does 
collect complex information. Data completeness varied; highest 
for laboratory data (complete information of specimen type, 
collection date, results, 872/969 [90%]) and lowest for infant data
(follow-up information at two months of age, 30/220 [14%]). 
Reporting timeliness for eligible pregnant women (median 
time from symptom onset/exposure to reporting to USZPR) 
improved: from 84 to 72 days before and after July 1, 2016. 
Conclusions: USZPR provides critical population-based 
surveillance of pregnant women with possible recent ZIKV 
infection and informs national public health guidance for clinical 
management of pregnant women and infants affected by ZIKV. 
CDC and other stakeholders continue to improve data collection
and reporting to USZPR. Achieving more complete follow-up 
of infants of mothers registered in USZPR is essential to fully 
characterize the outcomes of congenital ZIKV infection. 
















P1.4 Correlates of Blood Lead Testing and Test Results in Young Children — Southern California, 
2008–2015 
Authors: Gloria C. Chi, S. Tartof, L. Chen, J. Slezak, J. Lawrence 
Background: Targeted testing of young children at risk for 
lead exposure can aid primary prevention efforts. California 
requires lead testing for children with Medicaid. We examined 
associations between sociodemographic characteristics, blood
lead testing, and elevated blood lead levels (EBLLs). We defined 
EBLLs to be ≥4.5 μg/dL, which when rounded up per California’s 
criteria is consistent with the Centers for Disease Control and 
Prevention’s recommended reference level of 5 μg/dL. 
Methods: We identified Kaiser Permanente Southern
California members aged 6–30 months during 2008–2015,
their characteristics, and their lead tests from electronic
health records. We used multivariable log-binomial regression
to assess associations with testing and logistic regression
to assess associations with EBLLs. Models included birth
year, sex, race/ethnicity, Medicaid status, and neighborhood
deprivation index (NDI). 
Results: We identified 292,235 children. Approximately half 
were female, and one-fifth received Medicaid. Among 169,064 
children tested, 158,840 (94.0%) had blood lead levels <2 μg/ 
dL, 8,968 (5.3%) had blood lead levels between 2–4.4 μg/dL, 
and 1,256 (0.7%) had EBLLs. Compared with not receiving
Medicaid, receiving Medicaid was associated with testing (67.6% 
versus 54.4%, relative risk [RR]: 1.12; 95% confidence interval 
[CI]: 1.11–1.13) and EBLLs (0.9% versus 0.7%, odds ratio [OR]: 
1.16; 95% CI: 1.02–1.32). Compared with being in the lowest 
NDI quartile (least deprived), being in the highest quartile was 
associated with testing (65.4% versus 48.3%, RR: 1.18; 95% CI: 
1.17–1.19) and EBLLs (0.9% versus 0.4%, OR: 1.56; 95% CI: 
1.29–1.88). 
Conclusions: The positive association between Medicaid and 
EBLLs supports California’s requirement of testing Medicaid-
insured children. Residence in disadvantaged neighborhoods 
is associated with EBLLs and can guide targeted lead-screening 
programs for young children. 








Authors: Rena Fukunaga, D. Morof, C. Blanton, A. Ruiz,  
G. Maro, F. Serbanescu 
Background: In Tanzania, the use of locally-grown herbs during
pregnancy is common. Some herbs used during pregnancy 
have been found to cause uterine contractions, which may 
increase pregnancy, delivery, and postpartum complications. The 
prevalence of use and characteristics of women in Kigoma who 
use herbs during pregnancy is unknown. 
Methods: We analyzed the 2014 Kigoma Tanzania Reproductive
Health Survey, a regionally representative, population-based 
survey of reproductive age women (15–49 years) about fertility,
contraception, and maternal and newborn health. We conducted 
weighted descriptive analyses of herb use and reasons for use 
during pregnancy. We used multivariable logistic regression 
to calculate adjusted odds ratios (aOR) and 95% confidence 
intervals (CI) for factors associated with use of local herbs  
during pregnancy. 
Results: Of 2,408 parous women who responded, 14.8% 
(CI: 12.3–17.8) reported use of local herbs during their last 
pregnancies. Women reported taking local herbs for stomach 
pain (40.7%) and to avoid miscarriage (25.8%). Controlling for 
residence, age, and household wealth, women reporting any 
primary education (aOR: 1.4, CI: 1.0–1.9) and home delivery
at last birth (aOR: 1.7, CI: 1.2–2.3) had higher odds of local 
herb use during pregnancy than women without education and 
women delivering in a facility. Local herb use was significantly 
lower (aOR: 0.6, CI: 0.4–0.8) among multiparous women with
greater than 3 children. 
Conclusions: In Kigoma, approximately one in seven women 
reported using local herbs during their last pregnancy; use  
was associated with education level, home delivery, and  
parity. To help guide potential public health prevention efforts, 
future research is needed to uncover any associations between  
local herb usage and specific pregnancy, delivery or
postpartum complications. 



















P1.6 Epidemiology of Railway Suicide Deaths: National Violent Death Reporting System,  
18 States — United States, 2003–2014. 
Authors: Amanda G. Garcia-Williams, D. Stone, K. Holland,
B. Bartholow, S. Gabree, J. Reed 
Background:  In 2014, 42,766 individuals, 10 years of age and 
older, died by suicide in the United States. Approximately 270 
individuals, of any age, used train as the method of suicide 
in 2014. Railway suicide impacts individuals, families, and 
communities; however, limited information about circumstances 
precipitating these deaths are available. We examined
characteristics and precipitating circumstances of railway suicide 
to inform suicide prevention strategies. 
Methods: Data from 18 states from the National Violent Death 
Reporting System from 2003–2014 were used. Although no 
ICD-10 code for train as method of suicide is available, railway 
suicide cases were identified using a combination of narrative 
word searches and hand coding. Demographic characteristics 
were examined using chi-square tests. Odds ratios (OR) and 
95% confidence intervals (CI) were calculated using logistic 
regression to compare precipitating circumstances among railway 
and non-railway suicide decedents. 
Results: A total of 846 railway suicide decedents, 10 years of
age and older, were identified. Railway suicide decedents were
more likely than non-railway suicide decedents to be aged 15 
to 24 and never married. Railway suicide decedents were more
likely to have been homeless (OR: 6.4; CI: 4.6–8.9) and to have
a known history of suicide attempts (OR: 1.3; CI: 1.1–1.5) than
non-railway decedents. Railway decedents were less likely to have
a depressed mood prior to death (OR: 0.5; CI: 0.5–0.7), to have
left a suicide note (OR: 0.5; CI: 0.4–0.6), or to have known job 
problems (OR: 0.6; CI: 0.5–0.8). 
Conclusions: Differences in railway and non-railway suicide 
decedents suggest populations to focus railway suicides 
prevention efforts, including adolescents and young adults, the 
homeless, and those with a history of suicide attempt. 







Authors: Sarah M. Hatcher, S. Joshi, T. Weiser 
Background: The Northwest Tribal Registry (NTR) is a database
of American Indian/Alaska Native (AI/AN) patients treated by
Indian Health Service (IHS), Tribal, and Urban Indian Health
clinics in Idaho, Oregon, and Washington. NTR is compiled by
using IHS Resource and Patient Management System (RPMS) 
electronic health record (EHR) data. Because Tribal clinics 
can adopt non-RPMS EHRs, NTR is less able to detect racial 
misclassification in state databases, including death certificate
data. Underestimation of disease in the AI/AN population affects 
prioritization of health concerns, prevention efforts, and funding 
allocation. We assessed whether updating NTR by using the IHS 
General Data Mart (GDM), which contains user population data
from IHS, Tribal, and Urban Indian Health clinics regardless 
of which EHR is used, improves accuracy of AI/AN race 
classification in Washington state death certificates. 
Methods: To identify death certificates with misclassified AI/ 
AN race, we conducted 2 probabilistic record linkages with
2012–2014 Washington state death certificate data; 1 with the 
RPMS-generated NTR and 1 with the GDM-generated NTR. 
We compared number of sites and records, linkage matches, and 
percent misclassification of AI/AN race. 
Results: The GDM-generated NTR included more sites (46 
versus 34) and more AI/AN persons (231,060 versus 180,794) 
than the RPMS-generated NTR. The GDM-generated NTR 
resulted in more linkage matches, compared with the RPMS NTR 
(243 versus 183) and identified more records with misclassified 
race among Washington state death certificates, compared 
with the RPMS-compiled NTR (7.4% [243/3,270] versus 5.7% 
[183/3,210]). 
Conclusions: The GDM-generated NTR might increase
reporting accuracy for AI/AN race and AI/AN morbidity and 
mortality in state databases. We recommend the IHS GDM be
considered as the source of NTR updates. 













P1.8 Comparison of Vaccination Coverage Among U.S.-Born and Foreign-Born Adolescents 
Aged 13–17 Years — United States, 2012–2014 
Authors: Jessica M. Healy, A. Rodriguez-Lainz, H.A. Hill,  
D. Yankey, L.D. Elam-Evans, S. Reagan-Steiner 
Background: Healthy People 2020 seeks to increase vaccination 
coverage among U.S. adolescents. Although coverage increases 
were reported during 2012–2014, unbiased estimates of coverage
among potentially vulnerable subgroups (e.g., foreign-born 
adolescents) do not exist. We estimated and compared coverage
among U.S.-born and foreign-born adolescents to potentially 
identify disparities. 
Methods: Deidentifed data from the National Immunization
Survey-Teen collected during 2012–2014 were combined to
assess percent coverage among adolescents aged 13–17 years for 
recommended dosages of tetanus-diphtheria-acellular-pertussis 
(Tdap), meningococcal (MenACWY), measles-mumps-rubella 
(MMR), varicella, human papillomavirus (HPV), and hepatitis 
B (HepB) vaccination. Coverage of U.S.-born and foreign-born 
adolescents were calculated, along with adjusted prevalence 
ratios (aPRs), after adjusting for factors related to access to care
and demographics. 
Results: Results after adjustment no significant difference was 
reported in vaccination coverage between foreign-born and 
U.S.-born adolescents for Tdap, MenACWY, MMR or HepB. 
Both female and male foreign-born adolescents were at least 
21% more likely to receive the HPV vaccine than were U.S.­
born adolescents (female aPR: 1.23 [95% CI: 1.13, 1.34] for ≥1 
dose, 1.21 [1.08, 1.36] for ≥2 doses, and 1.06 [0.9, 1.25] for ≥3 
doses; male aPR:1.37 [1.17, 1.61] for >1 dose, 1.46 [1.18, 1.81] 
for ≥2 doses, and 1.69 [1.25, 2.28] for ≥3 doses). Foreign-born 
adolescents were less likely to receive the varicella vaccine (aPR: 
0.89 [0.84, 0.93] for ≥1 dose and 0.91 [0.84, 0.98] for ≥2 doses). 
Conclusions:: Foreign-born adolescents have similar vaccination 
coverage rates compared with U.S.-born adolescents for 4 of
6 recommended vaccines, have higher coverage for HPV, and 
lower coverage for varicella vaccination. Analyses incorporating 
country-specific incidence and vaccination rates might identify
reasons for reported discrepancies in HPV and varicella 
vaccination coverage. 








Authors: Rebecca L. Laws, A. Schnall, S. Burrer, A. Hanchey,
J. Wurster, T. Bayleyegn, S. Smorodinsky, J. Wilken,  
G.C. Windham, D. Tafoya, E. Sergienko 
Background: California is in its fifth year of the most severe 
drought in its recorded history. In 2014, the governor proclaimed 
a state of emergency and convened interagency Drought and Tree 
Mortality Task Forces to address environmental, economic, and 
health effects of water shortages. In Mariposa County, a forested 
and rural county, drought has depleted surface and ground water 
and caused tree deaths, resulting in economic losses. We assessed 
drought-associated effects concerning property and chronic 
disease exacerbation to guide response and recovery efforts. 
Methods: In October 2016, we used the Community Assessment
for Public Health Emergency Response (CASPER) methodology 
to conduct household surveys. CASPER is a 2-stage cluster 
sampling with probability of selection proportional to the 
number of housing units. Our goal was to interview 210 of
Mariposa County’s 7,693 housing units. Frequencies and 
confidence intervals (CIs) were weighted to account for the 
sampling design. 
Results: Of 189 surveyed households, 67% (95% CI: 50%–74%) 
reported dead or dying trees on their property, and 19% (95% 
CI: 12%–27%) reported drought had negatively affected their 
finances. Twenty-one percent (95% CI: 14%–28%) reported 
decreased well water production during the past year, and 20% 
(95% CI: 11%–30%) reported problems with the quality of
their tap water. Fifteen percent (95% CI: 8%–22%) reported a 
worsening of ≥1 chronic health condition because of drought, 
most commonly asthma, allergies, and hypertension. 
Conclusions: Drought is a complex, prolonged disaster that can 
exacerbate chronic diseases and result in negative economic 
effects from property damage, particularly tree mortality.
Mariposa County might consider facilitating tree removal and 
well assistance and expanding health services to drought-affected 
persons. 
















P1.10 Seoul Searching: Outbreak of Seoul Virus among Ratteries and Pet Owners — 
Illinois, 2017 
Authors: Janna L. Kerins, A. de St. Maurice, L. Purpura, J. Klena, 
A. Straily, S. Genzer, C. Tansey, E. Jackson, G. Langham,  
D. Weiss, C. Austin, J. Layden, M. Choi, E. Ervin, T. Shoemaker,
C. Manning, J. McQuiston, J. Kazmierczak, S. Nichol, B. Knust,  
P. Rollin 
Background: Human Seoul virus infections (SVIs) rarely occur 
in the United States, despite documented outbreaks in wild 
Norway rats. Pet rat ownership in the U.S. has not previously
been associated with SVIs. In December 2016, a Wisconsin 
rattery owner hospitalized with febrile illness tested positive
for acute SVI. Initial trace-out investigations implicated three 
ratteries; two were Illinois facilities. Further investigation aimed 
to identify additional human and rat cases. 
Methods: Rat facilities (i.e. rattery breeder or private pet 
owner) were considered confirmed if recent human or rat SVI 
was identified and suspect if rats were received from/sent to
confirmed facilities. In confirmed and suspected facilities, 
blood samples were obtained from rats and human contacts (i.e. 
possible cases) and analyzed using RT-PCR and ELISA serology.
Trace-forward and trace-back investigations of rat movements 
from confirmed facilities were performed to identify additional 
suspected facilities throughout the U.S. and Canada. 
Results: In Illinois, the investigation identified 33 facilities (10 
ratteries and 23 pet homes); of those, 6 (60%) ratteries and 3 
(13%) pet homes were confirmed. Among possible human cases 
in confirmed facilities, Seoul virus attack rates were 87.5% (7/8) 
for ratteries and 0% (0/8) for pet homes. Human infections 
were significantly higher in ratteries than pet homes (χ2=12.4, 
p=0.0004). Trace-out investigations identified over 60 suspected 
facilities in 16 states and Canada, with 16 recent human 
infections. 
Conclusions: To date, the source of this outbreak remains 
unknown. Frequent trade and sale of rats led to widespread Seoul 
infection, making outbreak control challenging. Higher infection
rates among rattery owners might indicate elevated risk in that
environment. Pet rat breeders should be aware of SVI risks and 
take appropriate control measures. 







Authors: Julie K. O’Donnell, M. Younkin, N. Somerville,  
R. Gladden, J. Zibbell, A. DeMaria, H. Babakhanlou-Chase,
S. Ruiz, T. Green, B. Callis, M. Shang, A. Walley 
Background: Opioid-related overdose deaths in Massachusetts 
more than doubled from 698 during 2012 to an estimated 
1,747 during 2015, in part, attributable to the introduction
of illicitly manufactured fentanyl (IMF). Medical examiner 
charts were reviewed to describe opioid-related overdose death 
characteristics, focusing on identifying IMF-related overdose 
characteristics and identifying opportunities for targeted 
interventions to help prevent deaths. 
Methods: Charts were reviewed for unintentional opioid 
poisoning deaths that occurred during October 1,  
2014–March 31, 2015, for decedents who overdosed, died, or
resided in 3 high-burden counties in southeastern Massachusetts 
(Barnstable, Bristol, and Plymouth Counties). Deaths were
classified as fentanyl-related, heroin or morphine-related (no 
fentanyl), or other opioid-related, on the basis of postmortem 
toxicology. Death scene evidence, such as absence of
prescription fentanyl, was used to classify fentanyl source as 
suspected IMF. Demographic and overdose characteristics were
analyzed by drug classifications. 
Results: During the investigation period, 196 overdose deaths
occurred in the 3 counties; 64% of overdose deaths were fentanyl­
related, and 82% of fentanyl-related deaths had evidence of IMF. 
Among fentanyl-related decedents, the majority (86%) overdosed 
in their home or another private residence, 77% were alone at
time of overdose, 36% had signs of rapid unresponsiveness after 
using fentanyl, and 90% had no pulse when emergency medical 
services arrived. Six percent of deaths had evidence of bystander 
administration of naloxone, an opioid overdose antidote. 
Conclusions: During a surge of opioid-related overdose deaths, 
IMF contributed to a substantial portion of overdose deaths in 
southeastern Massachusetts. Enhancement of harm reduction 
strategies to address IMF-related overdose characteristics, 
including messaging to avoid using opioids while alone and 
widespread community naloxone distribution and education, 
might help save lives in Massachusetts. 












P1.12 Under-Five Mortality Reporting Following the Ebola Virus Disease Epidemic — Sierra 
Leone, 2015–2016 
Authors: Amanda L. Wilkinson, N. Houston-Suluku, A. Kamara, 
U. Kamara, M. Jalloh, P. Raghunathan, D. Blau, B. Kamara,  
A. Jambai, R. Kaiser 
Background: Sierra Leone has among the highest estimated 
under-five years-of-age child mortality rates (U5MR) globally
(120/1000 live births).  Due to limited vital registration and 
inconsistent mortality surveillance, the 2014-2015 Ebola 
Virus Disease (EVD) epidemic in Sierra Leone necessitated 
rapid establishment of death reporting mechanisms that are 
maintained post-outbreak.  We assessed ascertainment of
stillbirths and under-5 years-of-age (U5) deaths through multiple 
data sources to prepare for implementation of a Child Health a 
nd Mortality Prevention Surveillance (CHAMPS) site – a 
network currently in seven countries to determine etiologies of
child mortality. 
Methods: Documented deaths in Bombali Sebora chiefdom 
between January 1st, 2015 and November 25th, 2016 were
retrospectively reviewed.  The catchment area included 
approximately 160,000 persons, an overestimate due to unclear 
delineation of Makeni town between two chiefdoms.  Using 
Sierra Leone’s U5MR, 1209 deaths were expected.  Data were
abstracted into Excel spreadsheets from three sources: eight
health facilities’ (HF) inpatient registers, district vital records, 
and a community-based telephonic death notification system 
established during the EVD epidemic.  Cases were defined as U5 
deaths and stillbirths. 
Results: Overall, 930 U5 deaths were identified (77% of
expected deaths), with 98 deaths identified in >1 source: 
250 from HF registers, 103 from vital records, and 683 from
telephone notifications.  Overall, 172 stillbirths were identified, 
with 11 identified by >1 source: 62, 4, and 117, via the respective
source.  All data sources had periods of incomplete and/or 
inconsistent reporting. 
Conclusions: Death reporting data sources were minimally
overlapping.  HF and vital records incompletely captured 
U5 mortality in Bomabli Sebora, but telephone notifications 
markedly improved completeness of death recording.  To
increase U5M ascertainment, CHAMPS Sierra Leone should 
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Authors: Anna C. Llewellyn, C. Lucas, S. Roberts, E. Brown,  
B. Raphael, J. Winchell 
Background: Legionnaires’ disease (LD) is a severe pneumonia 
caused by Legionella bacteria, which are commonly transmitted 
via aerosols from inadequately managed cooling towers (CTs). 
The rate of reported cases of LD increased 286% from 2000 to
2014. During this time, CTs were the source of several large
LD outbreaks. This study aimed to determine the geographic 
prevalence of Legionella in CTs in the United States (US). 
Methods: Water from cooling towers in 196 sites representing
eight of the nine continental U.S. climate regions were screened 
for Legionella DNA using multiplex real-time polymerase
chain reaction (PCR). Samples positive for Legionella DNA 
were cultured. Resulting Legionella isolate species (spp.) and 
serogroup (sg) were characterized using PCR, antibody testing, 
and gene sequencing.
Results: PCR identified Legionella DNA in 164 (84%) CT 
waters, including samples from every region studied. Legionella
was isolated from 79 (48%) PCR-positive samples, 37 (47%) of
which had more than one type of Legionella. Overall, 144 unique 
Legionella isolates were recovered; 76 (53%) were Legionella
pneumophila (Lp) and 51% of these were Lp sg 1 (Lp1), the most
commonly detected cause of LD. Sixty-eight isolates (47%) were
non-Lp spp., including L. anisa (50%), L. feeleii (12%), and  
L. rubrilucens (6%), all of which cause LD. 
Conclusions: In this study, the largest Legionella CT survey to
date, pathogenic Legionella spp. were detected in and isolated 
from samples from diverse regions, indicating the ubiquity of
this pathogen in U.S. CTs. These results underscore the potential 
for LD outbreaks to occur throughout the U.S. and the need for 
public health laboratory, epidemiological, and environmental 
health strategies to help prevent and respond to outbreaks from
a CT source. 














1:55 Emergence of 23S Mutations Associated with Macrolide Resistance in Group B 
Streptococcus — Georgia, 2015 
Authors: Jessica N. Ricaldi, S. Chochua, B. Metcalf, M.M. Farley, 
L. McGee, G. Langley, B. Beall 
Background: Group B Streptococcus (GBS) is a leading agent of
newborn sepsis and a rising cause of severe infections in elderly
and immunocompromised adults. Concurrently, resistance 
to first-line antibiotics for this pathogen (macrolides and 
clindamycin) is increasing. To characterize the GBS genetic 
diversity associated with this resistance, we investigated strains 
that showed high-level resistance to macrolides (>32) and 
clindamycin (≥8) by phenotypic testing but were negative for 
known determinants of resistance recognized by our Whole 
Genome Sequencing (WGS) pipeline. 
Methods: In 2015, clinical isolates were obtained from 2257 
invasive GBS cases. Antibiotic resistance was assayed using two 
simultaneous approaches: 1) phenotypic test via liquid-based
Minimum Inhibitory Concentration and Etest and 2) genetic 
resistance determinants detection via our WGS pipeline. Isolates 
that exhibited antibiotic resistance but that were not identified 
by our WGS pipeline were characterized by manual genetic 
analyses. 
Results: Out of 520 highly resistant isolates, we identified 3 
phenotypically resistant strains without a pipeline-predicted 
resistance mechanism. Two contained a mutation in position
2062 of the 23S gene (A2062G). Modification at this methylation 
site blocks antibiotic binding, conferring resistance as previously
reported in S. pneumoniae and other pathogens. Both strains 
were from the state of Georgia, and shared the same multilocus 
sequence type (ST8) and serotype (Ib), but they were not closely 
related phylogenetically. We have not identified a resistance 
mechanism for the third strain. 
Conclusions: We report the emergence of a mutation in the 23S 
gene in two GBS strains, undetected by our current pipeline. To
our knowledge, this mutation has not previously been detected in 
GBS, highlighting the value of joint phenotypic and WGS testing 
for timely detection of emerging resistance-associated mutations. 
2:15 Comparative Risk Assessment of Laboratory Response Network (LRN) Methods to Process 







Authors: Diana Riner, J. Turner, M. Mattioli, J. Murphy, V. Hill 
Background: Laboratory Response Network (LRN) Method
1114 was developed by CDC for following a biothreat­
associated drinking water incident. LRN laboratories received 
and processed up to 100 L of potentially contaminated water 
via ultrafiltration. In response to concerns involving potential 
exposure while handling large volumes in the biosafety cabinet, 
a revised method was developed with ultrafiltration occurring 
at the event site.  LRN laboratories would then receive smaller 
volume samples (filters or concentrates); collection of 1 L 
samples was also included. A risk assessment was conducted to
compare the two methods. 
Methods: Methods were divided into three components: 
primary concentration, secondary concentration and 
sequential filtration. Using a new tool, a risk score (likelihood
x consequence) was calculated for each step in a component, 
with risks classified as low, moderate, high, or extreme. For 
each method, risk scores were summed per component and 
component scores summed to give a total risk score allowing 
comparison between methods. 
Results: The original method received a higher total risk score 
due to the number of steps and high risk steps required during
primary water concentration. The revised method total risk 
score was lower due to the removal of handling large volumes 
of water in the BSC and a reduction in overall number of
steps. Mitigations around sharps usage were proposed for both
methods to reduce risk scores. 
Conclusions: The risk assessment indicates that the revised 
method reduces risks posed to LRN laboratorians by eliminating 
the handling of large volumes of contaminated water. However,
that risk is ultimately transferred to first responders, highlighting 
the need for a future integrated risk assessment to maximize the 
worker safety at each step of the response process. 














2:35 Understanding Antimicrobial Resistance in Neisseria gonorrhoeae: 






Authors: Brunilís White, A.J. Abrams, J. Cartee, S. Johnson,  
D. Trees 
Background: Gonorrhea, caused by Neisseria gonorrhoeae (Ng), 
is the second most commonly reported infectious disease in the 
United States, and Ng has progressively developed resistance 
to prescribed drugs. Antimicrobial resistance (AMR) in Ng
is an urgent public health threat, and AMR has historically
been associated with the accumulation of mutations in various 
chromosomal genes. The mosaic form of the penA gene is 
thought to be responsible for Ng treatment failures with various 
cephalosporins, including ceftriaxone, which is prescribed in 
combination with azithromycin as the recommended treatment. 
Methods: To understand AMR mechanisms in Ng, 10 penA 
mosaic strains, including 1 ceftriaxone susceptible parental
and 9 isogenic mutants with varying degrees of ceftriaxone 
resistance, were selected for genomic examination. The
methylation patterns of the penA parental and isogenic mutants 
were analyzed using PacBio base modification detection to
elucidate potential resistance mechanisms. 
Results: Whole genome analyses of the isogenic mutants did not 
result in the identification of shared novel genomic mutations. 
Thus, genomic mutations alone did not fully explain the 
observed resistance patterns. Methylation analyses revealed that
the isolates contained several methylated sites. Additionally, the 
number of detected methylated sites increased as ceftriaxone 
resistance increased, and novel methylation patterns were
identified. The methylated sites were associated with genes 
involved in transcription, translation, putative restriction-
modification systems, membranes, piliation, and phase variation. 
Conclusions: Data from the isogenic mutants suggest that
methylation might play a role in AMR. Methylation patterns
of clinical isolates with varying degrees of AMR are currently 
in progress. Future steps include transcriptomic analyses to
better understand if methylated sites correspond to changes 
in gene expression. These results will help elucidate the role of
epigenetics in AMR. 
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and Disease Prevention 
3:00–4:45 PM 
Frieden Plenary 
Moderators: Kimberley Fox and Susan Chu 
3:05 	 Ascertaining Infant Measles Mortality and Risk Factors During a Prolonged Nationwide 
Measles Outbreak — Mongolia, 2015–2016 
Authors: Christopher T. Lee, J. Hagan, B. Jantsansengee,
A. Samdan, B. Yadamsuren, S. Demberelsuren, C. Tserendorj,  
O. Munkhtogoo, D. Badarch, J.L. Goodson 
Background: A prolonged measles outbreak in Mongolia, 
with ~50,000 suspected cases, started in March 2015. Measles 
surveillance data suggested a substantial increase in case fatality 
ratio (CFR) in 2016 and health care-associated infection as 
a possible risk factor for mortality. As part of the outbreak 
response, we enhanced mortality ascertainment and conducted a 
case-control study to identify risk factors for measles death. 
Methods: We linked national vital records with surveillance data
of clinically confirmed (fever, maculopapular rash, and cough, 
coryza, or conjunctivitis) or laboratory-confirmed (positive
measles immunoglobulin M antibody) infant measles cases (aged 
<12 months) during March 2015–June 2016 using probabilistic 
record linkage. We abstracted charts of 96 fatal measles cases 
and 276 nonfatal control subjects, with rash onset after October 
1, 2015, matched by sex and date of birth. We used conditional 
logistic regression, adjusting for age, sex, and preexisting 
conditions, to calculate adjusted matched odds ratios (aMORs) 
and 95% confidence intervals (CIs) for risk factors. 
Results: Infant case fatality increased from 8 deaths among 2,641 
cases (CFR: 0.3%) in 2015 to 108 deaths among 4,467 cases (CFR: 
2.4%) in 2016 (P <.001). Inpatient admission 7–21 days before
rash onset (measles incubation period) (aMOR: 5.0; CI: 2.3–10.9) 
and hospitalization in provinces versus the capital city (aMOR: 
2.8; CI: 1.0–7.8) were significantly associated with mortality. 
Conclusions: We successfully used vital records linkage to verify
a significant CFR increase among Mongolian infants in 2016. 
Measles mortality was associated with hospitalization outside the 
capital and health care-associated infection. We recommended 
measures to standardize care and strengthen infection prevention
and control practices to the Mongolian Ministry of Health to



















3:25 Epidemic Cholera and Micronutrient Deficiency — Grande Saline, Haiti, 2011
 
Authors: Sae-Rom Chae, J. Boncy, A. J. Gerard, P. S. Suchdev,
S. Kim, E. D. Mintz, B. R. Jackson 
Background: Epidemic cholera typically affects poor
communities with unsafe water and inadequate nutrition. 
Most Vibrio cholerae infections are asymptomatic, and risk of
symptomatic cholera is thought to increase with micronutrient 
deficiencies. Following introduction of cholera into Haiti in 
October 2010, we conducted a cross-sectional seroepidemiologic 
survey in Grande Saline, Haiti, to assess risk factors for cholera, 
including micronutrient deficiencies, to guide future responses. 
Methods: We tested sera of participants ≥2 years of age for 
ferritin, a marker of iron deficiency; retinol-binding protein 
(RBP), a marker of vitamin A deficiency; and C-reactive 
protein (CRP) and alpha-1-acid glycoprotein (AGP), markers 
of inflammation. We adjusted ferritin and RBP for CRP and 
AGP using a previously-described regression model to account 
for potential confounding effects of inflammation. We used 
multivariable logistic regression to examine associations between 
micronutrient deficiencies and both self-reported cholera 
diagnosis and V. cholerae seropositivity (using antibodies as 
markers of past infection), adjusting for age, sex, and education. 
Results: Of 772 participants tested (age range 2–90 years; 19% <5 
years), 150 (21%) reported a cholera diagnosis during October 
2010–April 2011; 466 (60%) were seropositive. Low ferritin was 
found in 19%; 3% had low RBP. No associations between cholera 
diagnosis and micronutrient-deficiency measures were observed. 
Participants with low ferritin, but not low RBP, had higher odds 
of seropositivity than those with normal measures (odds ratio 
2.1; P <0.001). 
Conclusions: Iron and vitamin A deficiencies were common but 
not associated with cholera diagnosis. Although we adjusted for 
education, residual confounding from socioeconomic status may 
explain associations between iron deficiency and seropositivity. 
Improved access to nutritious foods and safe water are needed in 
impoverished communities. 
3:45 Measles-Rubella Vaccination Campaign Coverage and Use of Campaign-Related Mobile 






Authors: Saleena Subaiya, C. Tabu, S. Khamati, A. Styczynski,  
S. Thuo, H. Gary, R. Kaiser, S. Chu, S. Mahugu, H. Scobie 
Background: In May 2016, the Kenya Ministry of Health
conducted a measles-rubella (MR) supplementary immunization
activity (SIA) targeting 18.9 million children aged 9 months–14 
years, with a goal of ≥95% vaccination coverage. We evaluated 
the impact of mobile phone short message service reminders 
(SMSR) on coverage, a topic not previously studied. 
Methods: We sent 35.5 million SMSR to mobile subscribers in 22 
of 47 counties and conducted a national multi-cluster household 
survey to evaluate vaccination coverage and SMSR acceptability. 
Accounting for survey design, we calculated point estimates and 
95% confidence intervals (95% CI) for outcomes from 20,011 
children in 8,253 households and used logistic regression to
calculate odds ratios (ORs). 
Results: Overall, 89% (95% CI: 88%-90%) of caregivers had 
mobile phone access.  Twenty-nine percent (95% CI: 27%–30%) 
reported receiving SMSR; fewer caregivers (P<.001) in high-
risk groups (e.g., pastoralists, low socioeconomic status) 
reported receiving SMSR. Out of those who received SMSR, 
90% (95% CI: 88%–91%) reported them useful in deciding to
vaccinate their child.  National MR vaccination coverage was 
95% (95% CI: 94%–96%); coverage was higher among children
whose caregiver reported receiving SMSR (OR: 1.88; 95% CI: 
1.32–2.70). After controlling for other factors, we detected a
significant interaction between relative wealth quintile and 
receipt of SMSR, with higher odds of vaccination associated with
receiving SMSR among the second (OR: 2.58; 95% CI: 1.06-6.25) 
and third (OR: 2.15; 95% CI 1.05-4.41) lowest quintiles. 
Conclusions: In Kenya, mobile phone access and the 
acceptability of receiving SIA-related SMSR were high. SMSR
might be useful to improve coverage in SIAs, particularly among 
children living in middle wealth quintile households. 




















4:05 Sustained Use Of Portable Handwashing And Drinking Water Stations In Health Care 
Facilities — Siaya County, Kenya, 2016 
Authors: William W. Davis, A. Odhiambo, J. Oremo, R. Otieno,
S. Faith, A. Mwaki, R. Quick 
Background: Data from 54 middle and low income countries 
showed that 38% of health care facilities (HCFs) lacked improved 
water supplies and 35% lacked handwashing facilities, increasing 
the risk of healthcare-associated infections. To address this 
problem in Siaya County, Kenya, portable handwashing and 
drinking water stations were provided, along with soap and 
sodium hypochlorite for water treatment, to all 109 HCFs in 
2005. We evaluated this program in 2016 to assess acceptability 
and use of these interventions. 
Methods: We interviewed staff and conducted observations in 28 
randomly-selected HCFs on water sources; use and maintenance 
of handwashing and drinking water stations; and water treatment 
practices. We tested water from each facility’s source and one 
drinking water storage container for chlorine residuals  
and E. coli. 
Results: HCF water supplies included rainwater (53.6%), 
boreholes (35.7%), and public taps (10.7%). Of 28 HCFs, 26 
(92.9%) had functioning handwashing and drinking water 
stations. Among responding HCFs, 17/27 (63.0%) had replaced 
broken taps, and 11/18 (61.1%) had replaced broken containers.  
No source water was chlorinated. Of 28 source water samples, 13 
(46.4%) tested positive for E. coli; 15 (53.6%) had no detectable 
contamination. Of 28 stored water samples, 7 (25%) had 
detectable chlorine residuals.  Overall, 26 (92.9%) stored water 
samples had no detectable E. coli, including all 15 obtained 
from uncontaminated sources and all 7 with detectable chlorine 
residual. 
Conclusions: After 12 years, water stations were maintained
and used in all but 2 HCFs. Evidence of chlorination was
observed in 25% of stored water samples; no treated samples
yielded E. coli. Untreated water from uncontaminated sources
stored in drinking water stations remained free of E. coli, but
chlorination is recommended. 








Authors: Michelle Morales, K. Zaman, M. Yunus, C. Estivariz,  
C. Snider, H. Gary, S. Wassilak, M. Pallansch, M.S. Oberste,
W. Weldon, A. Anand 
Background: After removal of poliovirus type 2 from oral 
poliovirus vaccine (OPV) in May 2016, monovalent OPV type
2 (mOPV2) and inactivated poliovirus vaccine (IPV), which 
contains all three poliovirus serotypes, will be used to respond to
type 2 poliovirus outbreaks. This study assessed immunogenicity 
of mOPV2 with shortened intervals between mOPV2 doses 
(at 1 and 2 weeks compared to the standard 4 weeks) and 
co-administration of IPV. 
Methods: An open-label, non-inferiority, four-arm,
randomized controlled trial was conducted in Bangladesh.
Healthy infants aged 6 weeks were recruited and randomized
to receive 2 mOPV2 doses beginning at age 6 weeks at a 1, 2,
or 4 week interval with or without IPV administered at age 6
weeks. Serum antibody titers against poliovirus type 2 were
determined from blood collected pre- and post-vaccination.
Results: Of 760 infants randomized, 737 (97%) completed all 
study visits and were included in the analysis. Seroconversion 
following two mOPV2 doses was 93% (95% CI: 88%-96%), 95% 
(95% CI: 91%-98%), and 97% (95% CI: 94%-99%) at 1, 2, and 4 
week intervals, respectively. Seroconversion was 91% following 
one mOPV2 dose (95% CI: 86%-95%), and 91% following one 
mOPV2 dose with IPV (95% CI: 86%-95%). Seroconversion was 
97% following two mOPV2 doses at a 4 week interval (95% CI: 
94%-99%), and 97% following two mOPV2 doses at a 4 week 
interval with IPV (95% CI: 93%-99%). 
Conclusions: mOPV2 has high type 2 immunogenicity at
varying intervals between doses. IPV co-administration did not 
improve immunogenicity. Based on these results, type 2 outbreak 
response guidelines could be modified to reduce the number of
mOPV2 campaigns and limit the use of IPV. 
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3:05 Burden of Extrapulmonary Nontuberculous Mycobacterial Disease and Utility of Statewide 







Authors: David C. Shih, M. Cassidy, P. Cieslak, R. Leman 
Background: Nontuberculous mycobacteria (NTM), ubiquitous 
in soil and water, comprise >100 species. Multiple species 
can infect the lungs, skin, bone, joints, and lymphatic system. 
Trauma, surgeries, and tattooing can inoculate NTM into soft
tissue, potentially resulting in substantial morbidity and death. 
Eight states, including Oregon, require NTM reporting. We
sought to characterize extrapulmonary NTM infection burden 
and assesses usefulness of Oregon’s NTM surveillance system in 
detecting outbreaks. 
Methods: Confirmed cases are culture-confirmed 
extrapulmonary NTM infections involving a wound or abscess, 
lymph node, or normally sterile site (e.g., blood or spinal fluid).  
Using surveillance data collected through laboratory reporting, 
patient interview, and chart review, we assessed demographic, 
risk, and clinical characteristics of Oregon extrapulmonary NTM 
cases and reviewed investigation of data-identified clusters. 
Results: Of 117 confirmed extrapulmonary NTM cases (0.98 
cases/100,000 persons annually), 53% were female; median
age was 49 years. Commonly identified species included 
Mycobacterium avium complex (46%), Mycobacterium fortuitum
(15%), and Mycobacterium chelonae (8%). Reported exposures 
included potting soil (30%), surgery (24%), trauma (19%), 
and infusions (19%). Wounds or abscesses were reported in 
68% of patients; 31% were hospitalized; 14% were septic; and 1 
died. Three clusters by time, place, and mycobacterial species 
were identified; subsequent investigation identified common
exposures leading to public health action, including 4 cases 
associated with artificial joints from a common supplier, 2 
with use of unsterile tattoo diluent at a single venue, and 2 with
abdominoplasty at a single venue. 
Conclusions: Extrapulmonary NTM infections cause substantial 
morbidity in Oregon. NTM surveillance proved useful in 
detecting NTM outbreaks amenable to public health action. 
States should investigate the utility of NTM surveillance for 
outbreak detection. 

















3:25 Shiga Toxin-Producing Escherichia coli. Convalescent Testing by Using Multiplex 
Polymerase Chain Reaction Panel and Culture Methods — Kansas, 2016 
Authors: Jessica Nadeau Tomov, L. Webb, C. Robertson,  
C. Masters, C. Hunt 
Background: Kansas regulations exclude persons with Shiga 
toxin-producing Escherichia coli (STEC) infection from
delivering health care, handling food, and providing or attending 
daycare until 2 consecutive negative convalescent stool culture 
results are obtained.  Increasingly, laboratories use multiplex 
polymerase chain reaction (PCR) panels to detect presence of
STEC instead of classic biochemical culture methods. Use of
PCR to confirm absence of STEC in convalescent specimens has 
not been assessed. We compared culture with PCR for testing 
convalescent specimens to determine the potential effect of
PCR use on persons excluded from work or daycare (“excluded 
persons”). 
Methods: Required convalescent stool specimens collected 
≥48 hours after symptom resolution from excluded persons 
(previously diagnosed by any method) and submitted during
August–November 2016 were evaluated. Specimens were
tested for STEC using classic biochemical culture and PCR. 
Specimens from excluded persons were collected and tested until 
2 consecutive negative cultures were obtained and the exclusion 
was lifted. 
Results: Seven excluded persons submitted 26 specimens; 46% 
(12/26) were culture and PCR positive; 19% (5/26) were culture 
and PCR negative; and 35% (9/26) were culture negative and 
PCR positive. Among each person’s last 2 culture-negative
specimens, PCR test results were both negative (n=2), positive
followed by negative (n=1), and both positive (n=4). 
Conclusions: PCR detected Shiga toxin nucleic acid targets in a 
majority of culture-negative convalescent specimens. If PCR was 
used instead of culture, 5 of 7 exclusions would not have been 
lifted. PCR can detect Shiga toxin nucleic acid in non-viable 
bacteria, thus culture remains the preferred method for STEC 
testing on convalescent specimens in Kansas.  As laboratory
capacity for PCR increases further evaluation of PCR use for 
convalescent testing is warranted. 








Authors: Noemi B. Hall, P. H. Langlois, K. Broussard, N. Evert, 
M. Canfield 
Background: Zika virus infection during pregnancy has been 
linked to adverse pregnancy outcomes. To better understand 
the burden of Zika in pregnancy, the Texas Department of State 
Health Services (DSHS) established enhanced surveillance to
identify pregnancy outcomes with congenital anomalies among 
women with laboratory evidence of Zika virus infection during
pregnancy since January 1, 2016. 
Methods: As part of routine surveillance, arboviral disease 
case investigation forms, laboratory testing results, and other 
relevant epidemiologic information are collected and reviewed 
by the DSHS Zoonosis Control Branch. As part of the enhanced 
surveillance, data on pregnant women with laboratory evidence 
of Zika virus infection and their offspring are shared with the 
DSHS Birth Defects Epidemiology and Surveillance Branch
(BDESB). BDESB staff then review neonatal medical records for 
documented congenital anomalies. Additionally, within 3 months
of delivery, BDESB staff review hospital discharge data using 
International Classification of Diseases, Tenth Revision codes to
identify neonates with birth defects consistent with Zika virus 
infection during pregnancy (e.g. brain abnormalities with and 
without microcephaly, neural tube defects, and arthrogryposis). 
Results: Between January 1 and November 30, 2016, 103 
pregnant women with laboratory evidence of Zika virus 
infection were identified. All infections were travel-associated.
Of the 30 pregnancies where delivery outcomes are known, 2 
neonates presented with microcephaly and additional congenital 
anomalies; one with intraventricular hemorrhage and the other 
with holoprosencephaly and severe lower limb deformities. Both
had laboratory evidence of Zika virus infection at delivery. 
Conclusions: Through surveillance, we identified 2 neonates 
with Zika-related congenital anomalies and laboratory confirmed 
Zika virus infection. To assist in targeting resources for neonates 
affected by Zika virus infection and their families, continued 
enhanced surveillance is needed. 
























4:05 Evidence of Health Care Transmission of Candida auris: An Investigation of 2 Cases — 
Chicago, Illinois, 2016 
Authors: Janna L. Kerins, S. Kemble, M. Pacilli, R. Welsh,  
N. Chow, L. Gade, S. Tsay, S. Vallabhaneni, A. Kallen, E. Landon, 
J. Ridgway, R. Marrs, D. Pellegrini, B. Jackson, S. Lockhart,  
A. Litvintseva, T. Patel, J. Lepinski, S. Black 
Background: Candida auris is an emerging, multidrug-resistant 
yeast causing invasive infections globally but not reported in 
the United States before 2016. In August 2016, the Chicago 
Department of Public Health was notified of 2 patients with
C. auris infections who were treated at the same acute care
hospital (ACH) and long-term acute care hospital (LTACH). We
investigated possible health care transmission to guide control 
measures. 
Methods: Cases were defined as C. auris isolated from clinical 
cultures. We reviewed medical records to identify overlaps 
in time and location; sampled patients’ rooms; and screened 
patients, ACH ward mates, and LTACH patients for colonization.
Isolates were analyzed using whole genome sequencing (WGS). 
Results: C. auris was isolated from Patient 1’s bloodstream
in May and Patient 2’s urine in July. These patients had 3 
overlapping ACH admissions during March–July, but wards 
differed. In April, 3 days separated their hospitalizations on the 
same LTACH ward. In August, we detected C. auris colonization
of index patients’ skin, nares, vagina, and rectum. C. auris was 
present on mattress, bed rail, chair, table, and window ledge 
surfaces in Patient 1’s hospital room. Three (6%) of 50 sampled 
LTACH patients, hospitalized on the same ward as both index 
patients, exhibited C. auris colonization; no ACH ward mates 
were colonized. All available patient isolates were highly related 
(<10 single nucleotide polymorphisms) by WGS. 
Conclusions: Nearly indistinguishable C. auris strains were
isolated from patients exposed to a single Chicago LTACH
ward, indicating likely health care-associated transmission.
Persistent colonization of patients, health care environment
contamination, and ward mate colonization necessitate
ongoing patient and environmental surveillance, strict
adherence to Standard and Contact Precautions, and thorough






4:25 Food-Related Anaphylactic Deaths — New York City, 2000–2014
 
Authors: Eugenie A. Poirot, H. Gould, J. Hadler 
Background: Food-induced anaphylaxis is potentially fatal, but 
preventable. Considerable public health attention has been given 
to preventing anaphylaxis from nut exposure among school-aged 
children. We characterized food-related anaphylactic fatalities in 
New York City (NYC) and examined changes in incidence during
2000–2014, beginning four years before NYC started supplying 
epinephrine auto-injectors to schools in 2004. 
Methods: We identified food-related anaphylaxis deaths by
using death certificates. A case was defined as a death in a NYC 
resident during 2000–2014 with an ICD-10 code or literal text 
indicating mortality attributable to food. To obtain further details 
regarding circumstances leading to death, we reviewed medical 
examiner reports. Rates were calculated by using U.S. Census 
Bureau annual population estimates and compared by using 
Poisson regression. 
Results: Twenty-four food-related deaths were reported among 
NYC residents during 2000–2014, an average of 1.6/year (range: 
0–5); rate of 2.0/10 million person-years. Seafood was the most 
common cause (9 deaths), followed by nuts (5). Other foods 
were milk, eggs, chickpeas, and chocolate (1 death each); food
was unknown in 6 reports. All seafood-related deaths occurred 
among persons aged ≥18 years (median age 65 years). Of 5 nut-
related deaths, 3 were among persons aged <18 years, including 1 
where exposure occurred at school. Rates of fatal anaphylaxis did 
not differ with regard to time period, age, sex, race/ethnicity, or
nativity (U.S. versus non-U.S.). 
Conclusions: Preliminary results indicate that deaths from
food-related anaphylaxis in NYC are rare, with no substantial
rate change during the 15-year span studied. In NYC,
prevention of anaphylaxis deaths in adults with seafood
allergies should become a focus of public health efforts to help
further reduce food-related anaphylaxis deaths. 
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8:35 Zika Virus Infection in a Patient with No Known Risk Factors — Utah, 2016 
Authors: Elisabeth R. Krow-Lucal, A. Dunn, S. Novosad,
C. Brent, H. Savage, D. Peterson, A. Dibbs, B. Vietor,  
K. Christensen, J. Laven, M. Godsey, B. Beyer, M. Cortese,
A. Panella , M. Rubin, S. Fridkin, J.E. Staples, A. Nakashima 
Background: In 2016, a 73-year-old male patient (index patient) 
died of Zika virus disease following travel to an area with
ongoing transmission. After his death, an adult male family
contact (Patient A) developed Zika virus disease despite having
no known risk factors. An investigation was launched to define 
Patient A’s exposures and source of infection. 
Methods: We asked family contacts and healthcare personnel 
about types, timing, and duration of contact with the index 
patient. We surveyed community members living near the index 
patient’s residences about exposures and symptoms of Zika. 
Samples were obtained and tested for evidence of Zika virus 
infection. Mosquito traps were placed at Patient A’s and the index 
patient’s households.  
Results: Of 19 family contacts identified, all reported similar 
exposures to the index patient; only Patient A had evidence of
recent Zika virus infection. Of 86 healthcare personnel with
direct contact with the index patient, 57 (66%) reported 128 
separate encounters with body fluids, including 10 without 
personal protective equipment. No healthcare personnel tested 
positive. Eighty-nine (40%) of 226 households in the community 
participated, representing 218 individuals; 132 (61%) provided 
a sample. Twenty-eight (13%) reported having Zika virus-like
symptoms in the prior month. None had confirmed evidence of
recent Zika virus infection. Of 5,875 adult mosquitoes collected,
none were the primary vectors of Zika virus and all tested 
negative for Zika virus. 
Conclusions: The mechanism of Zika virus transmission to
Patient A remains unknown but was likely person-to-person 
from the index patient. Because there was no transmission 
to other close contacts, healthcare personnel, or community 
members, contacts of Zika patients should follow current 



























8:55 Prediction of the Zika Virus Infection Burden in Puerto Rico Using Bayesian Methods, 
November 2015–October 2016 
Authors: Jessica M. Healy, D.M. Rodriguez Vargas,  
E. Dirlikov, B. Rivera, B. Greening, Jr.,  
S. Waterman, M.A. Johansson 
Background: Bayesian methods offer rapid, cost-effective 
ways to estimate infection burden during an outbreak when a 
population-level serosurvey may be infeasible. During November 
2015–October 2016, the Puerto Rico Department of Health
(PRDH) reported 31,464 confirmed Zika virus (ZIKV) infections. 
Since ~80% of ZIKV infections are asymptomatic and mildly
symptomatic individuals might not seek care, the infection
burden is unknown. We used Bayesian methods to estimate the 
infection burden in the general and pregnant populations, and 
the rate of microcephalic births expected during the outbreak in 
Puerto Rico. 
Methods: Weekly ZIKV surveillance data for arboviral diseases, 
Guillain-Barré syndrome (GBS), and blood donations were
sourced from PRDH. These data and published rates of ZIKV 
infections per clinical or GBS case informed weekly distributions 
of ZIKV infection probability during November 2015–October 
2016. To estimate infections during pregnancy over time, weekly
infection probability was applied to simulated pregnancy cohorts 
based on the 2015 birth rate in Puerto Rico. Published trimester-
specific microcephaly risk estimates were applied to the simulated 
infected pregnancies to temporally predict microcephalic 
live-births. 
Results: During November 2015–October 2016, we estimated 
440,000–1,100,000 (interquartile range [IQR]) ZIKV infections 
to have occurred and 2,900–4,100 (IQR) pregnant women were
presumed to be infected. We predicted one microcephalic live-
birth would occur per week starting in late August 2016. 
Conclusions: Using Bayesian statistical methods which 
incorporate uncertainty and variability in the data to reduce  
bias, we estimated the infection burden during the ZIKV  
outbreak in Puerto Rico to be 15–37 times the number of
reported infections, thus providing more realistic estimates to
inform the public health response, including the planning for 
ZIKV-associated birth defects. 









Authors: Annabelle de St. Maurice, R. Orone, J. Fankhauser,  
J. Brown, D. Williams, K. Dokubo, P. Rollin, M. Choi, B. Knust 
Background: Following the 2014–16 Ebola virus disease (EVD) 
epidemic, thousands of EVD survivors have sought care for 
sequelae. Located in Monrovia, Liberia, The ELWA clinic provides 
free, comprehensive primary/specialty care to EVD survivors. 
We describe the demographics, symptoms, and care costs of EVD 
survivors at ELWA clinic. 
Methods: Medical records of EVD survivors visiting ELWA
clinic from January 2015–June 2016 were abstracted; symptoms
and diagnoses were categorized by organ system. Symptom 
frequencies were documented on a per-patient basis. Descriptive 
analysis was performed using STATA 13. 
Results: 305 EVD survivors were seen at ELWA clinic for a 
total of 728 visits and per patient mean of 2.4 visits; 59% were
female, and mean age was 33 years (range 1-85). Median days 
from ETU discharge to first recorded clinic visit was 281 (range
4-680). EVD survivors most commonly experienced the following 
symptoms by organ system: neurologic: headache (46%) and 
insomnia/fatigue (28%); gastrointestinal: abdominal pain (37%) 
and appetite loss (30%); musculoskeletal: arthralgia (27%) 
and myalgia (26%); ophthalmologic: visual changes (15%) and 
decreased visual acuity (8%); and reproductive: amenorrhea (5%), 
and erectile dysfunction (3%). EVD survivors also frequently 
developed malaria (23%) and UTI (11%) which were unlikely
related to survivor status. Total monthly indirect and direct costs 
for all the patients cared for at the ELWA clinic were estimated to
be $6,625. 
Conclusions: EVD survivors continued to seek care at ELWA
clinic for a variety of complaints beyond 6 months after ETU 
discharge, and support of these patients was done with a limited 
budget. Considering the symptoms reported, EVD survivors 
may benefit from specialty ophthalmologic, rheumatologic, or
neurologic care. 




















9:35 It’s Not Polio! Acute Flaccid Myelitis — United States, August 2014–October 2016
 
Authors: Tracy Ayers, A. Lopez, A. Kambhampati,
A. Lee, S. Rogers, W.A. Nix, M.S. Oberste, M. Pallansch, J. Routh, 
J. Sejvar, M. Patel 
Background: Acute flaccid myelitis (AFM) is a serious but rare
condition characterized by sudden onset of limb weakness or
paralysis.  In August 2014, reports of this mysterious  
polio-like illness occurring concurrently with outbreaks of
severe respiratory illness caused by enterovirus D68 prompted 
establishment of surveillance under a standardized case
definition.  After a decrease in 2015, AFM cases increased during
2016 raising concerns of a resurgence.  We compared clinical and 
laboratory profiles of cases in 2014 and in 2016. 
Methods: Confirmed cases were defined as acute flaccid limb 
weakness and spinal cord gray matter lesions on magnetic 
resonance imaging (MRI).  Cases >21 years of age were excluded 
because of changes in case definition in 2015. Clinical and 
laboratory characteristics of cases from August – December 2014 
and January – October 2016 were compared using Wilcoxon rank 
sum and Fisher’s exact test. 
Results: A total of 311 confirmed AFM cases have been reported: 
120, 21, and 96 cases for August – December 2014, 2015, and 
January – October 2016, respectively. Cases in 2016 had a lower 
median age (5 vs 7 years; p<0.001), were more likely to present 
with altered mental status (AMS) (26% vs 11%; p=0.01), have
more than two limbs affected (48% vs 32%; p=0.02), and require 
mechanical ventilation (33% vs 20%; p=0.04) compared to cases 
in 2014. Despite extensive testing since 2014, no consistent
etiology has been identified to date. 
Conclusions: AFM cases in 2016 tended to be younger and had 
more severe clinical presentations compared to those in 2014. 
Continued surveillance and reporting of suspected AFM cases 
remain critical to further understand and characterize this 
disease.  Testing protocols have shifted to explore both infectious 
and non-infectious causes. 
9:55 The First Eight Reported Cases of Candida auris, an Emerging, Multidrug-Resistant  
Yeast — New York, 2013–2016 
Authors: Sharon Tsay, E. Poirot, N. Chow, S. Chaturvedi,  
J. Greenko, R. Fernandez, K. Southwick, E. Lutterloh, M. Quinn, 
L. Gade, R. Welsh, E. Berkow, B. Jackson, S. Lockhart,  
A. Litvintseva, T. Chiller, A. Kallen, S. Vallabhaneni, E. Adams 
Background: Candida auris is a globally emerging, multidrug­
resistant yeast that has caused hospital-associated outbreaks of
invasive infections with high mortality. CDC issued a clinical alert 
to U.S. healthcare facilities in June 2016 requesting notification
of C. auris cases. As of September 2016, eight of twelve U.S. 
cases reported were from New York, prompting investigation
to determine risk factors and assess relatedness of cases to limit 
transmission.  
Methods: A case was defined as C. auris isolated from any 
patient specimen at a NY healthcare facility before October 2016. 
We reviewed clinical records, characterized isolates, examined 
infection control practices at affected facilities, and swabbed case-
patients, their rooms, and ward mates. 
Results: Eight cases occurring during May 2013–October 2016 
were identified at six healthcare facilities. Case-patients had 
multiple indwelling devices, including urinary catheters (75%), 
gastrostomy tubes (63%), tracheostomy tubes (63%), and central 
venous catheters (63%). All had ≥3 healthcare facility encounters
within 90 days of diagnosis; two patient pairs had overlapping 
stays at two different facilities. Three (38%) died within 28 days 
of diagnosis. Most isolates were highly related by whole-genome 
sequencing and 5 (63%) were resistant to two antifungal drug 
classes. Three of four patients sampled had C. auris colonization
in multiple body sites weeks after first positive culture; C. auris
was also found in patient rooms and colonizing a ward mate.
Inadequate Contact Precaution adherence was found at some 
involved long-term care facilities. 
Conclusions: Epidemiologic and laboratory evidence suggest that
multidrug-resistant C. auris may have been transmitted within 
NY healthcare facilities. To curb further spread, adherence to
recommended infection control practices, particularly in long­
term care facilities, coupled with public health surveillance and 
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8:35 Mental Health Related Emergency Department Visits After a Noncasualty Terrorist Event — 
New Jersey, September 2016
 
Authors: Faye M. Rozwadowski, S. Dietz, S. Tsai, T. Hamby,
C. Tan 
Background: Two pipe bombs exploded in September 2016 
in 2 separate New Jersey (NJ) locations and were linked to
domestic terrorism; no physical injuries were sustained. Because 
the purpose of terrorism is to invoke physical harm and fear, 
psychological distress after an event can potentially increase
mental health visits to local emergency departments (EDs) in 
the absence of physical injuries. We sought to determine if an
increase occurred. 
Methods: Reports of ED chief complaints by patients
meeting validated mental health key word groups residing
in the same zip codes as the bombings were analyzed. Cases
from September 2016 and 2015 were obtained from the NJ
Department of Health’s syndromic surveillance system. T-tests
were used to compare the same weekend in 2016 to 2015. A
moving median and interquartile range (IQR) was calculated
for each date in September 2016. Daily observed counts were
compared against the expected moving median. 
Results: Mental health ED visits increased an average 1.2% 
(95% confidence interval: 0.17%–2.23%; P = 0.031) from 2015 
to 2016, of the same weekend. We observed an increase outside 
the expected IQR 2 days after the first bombing with a count (n 
= 7) that is 2.3 times higher than the moving median for that
day (median = 3). This count is the only statistical outlier in 
September 2016 (IQR = 2). 
Conclusions: On the basis of the significant t-test and observed 
increase over the expected median, ED visits for mental health
symptoms increased <48 hours after these terrorist events. This 
finding supports the needs for health departments and hospitals 
to have adequate mental health preparatory responses and action






























8:55 Risk and Protective Factors for Driving After Five or More Alcoholic Drinks Among College 
Students — Fall National College Health Assessment, United States, 2011–2014 
Authors: Alexis B. Peterson, B. West, E. Sauber-Schatz 
Background: In 2015, 2,684 persons aged 18–28 died in alcohol-
impaired motor vehicle crashes. This study’s purpose was to
determine the prevalence and associated risk and protective
factors for driving after binge drinking among college students. 
Methods: National College Health Assessment data from
2011–2014 were used. Undergraduate college students aged 
≤28 were asked to report drinking any alcohol within the 
previous month, binge drinking (five or more alcoholic drinks 
in one sitting) within the last two weeks, and driving after 
binge drinking in the previous month. Adjusted odds ratios 
(aOR) and 95% confidence intervals (CI) were calculated using 
multivariable logistic regression for the outcome driving after 
binge drinking, adjusting for gender, year in school, race/ 
ethnicity, and school region. 
Results: Overall, 2.5% (n=1,012) of 40,502 alcohol using 
students drove after binge drinking. Compared with those not 
reporting any binge episodes within the last two weeks, the odds 
of driving after binge drinking were higher among respondents 
who reported 1–2 (aOR: 6.4; CI: 4.9–8.4) and ≥3 binge drinking
episodes (aOR: 12.4; CI: 9.3–16.5). Drinking on ≥10 days 
increased the odds of driving after binge (aOR: 1.26; CI: 1.1–1.5), 
compared with drinking 1–5 days. Odds of driving after binge
drinking were lower among those “always” using a seat belt (aOR: 
0.8; CI: 0.7–0.9) and a designated driver (aOR: 0.06; CI: 0.05– 
0.08), compared with “less than always”. 
Conclusions: There are clear risk and protective factors for 
driving after binge drinking among college students, including 
alcohol use frequency. Results suggest the application of proven 
strategies including sobriety checkpoints, enforcement of 0.08% 
blood alcohol concentration laws, and liability for retail alcohol 
establishments are warranted.
9:15 Fatal Injuries in the Alaska Logging Industry, 1991–2014
 
Authors: Yuri P. Springer, D. Lucas, L. Castrodale, J. McLaughlin 
Background: During 2006–2014, the fatality rate for the U.S.
logging industry was 23 times the national all-occupations rate.
Alaska has among the highest work-related fatality rates across
multiple industries; logging injuries have not been examined since
the early 1990s. We investigated fatalities in the Alaska logging
industry during 1991–2014 to assess industry safety. 
Methods: To estimate annual fatality rates, we used fatality
data from the Alaska Occupational Injury Surveillance System
and workforce data from the Alaska Department of Labor and
Workforce Development (ADLWD). We estimated rates as
fatalities/100,000 positions (individual jobs) and calculated 5-year
moving averages of annual rates to examine trends. Fatality
characteristics were analyzed. 
Results: During 1991–2014, a total of 51 fatalities were reported 
among an annual average of 840 positions. Annual fatality 
rate range was 0/100,000–717/100,000 positions. A plot of
the 5-year moving average of annual fatality rates by year was 
parabolic, decreasing from 1993 (341.6/100,000 positions) to
2005 (0/100,000 positions), then increasing to a high in 2010 
(383.2/100,000 positions).  Analyses of fatality characteristics 
including source, event, nature, and affected body part(s) did not 
indicate a mechanism for this rate reversal. 
Conclusions: After declining during 1991–2005, Alaska logging
industry fatality rates rose during 2006–2014; rate for this 9-year 
period was twice the U.S. logging industry rate and 42 times the 
national all-occupations rate. In response, the Alaska Division  
of Public Health is collaborating with ADLWD and the 
University of Alaska–Anchorage to develop a safety education 
program; our investigation findings will be used to guide 
recommendations. Changes in size, structure, and operation
of Alaska logging companies will be examined as potential 

































9:35 Investigation of Fatal and Nonfatal Suicidal Behavior, Ages 10–24 — Santa Clara County,
California, 2016 
Authors: Amanda G. Garcia-Williams, J. O’Donnell, E. Spies,  
X. Zhang, A. Azofeifa, K. Vagi, R. Young 
Background: Suicide is the second leading cause of death for 
youth age 10-24 in Santa Clara County (SCC). Suicide is a 
preventable cause of death. To inform ongoing suicide prevention
efforts in SCC, we examined characteristics of youth suicide 
decedents, and risk and protective factors for nonfatal suicidal 
behavior.
Methods: Suicide among SCC youth, age 10-24, was examined 
using vital statistics data, and precipitating circumstances for 
suicide were characterized using medical examiner reports. 
Nonfatal suicidal behavior, and associated factors, was examined 
among SCC high school students using self-reported youth 
survey data. Odds ratios (OR) and 95% confidence intervals 
(CI) were calculated to identify factors associated with past year
suicidal ideation using bivariate logistic regression. 
Results: From 2003-2015 there were 196 deaths by suicide 
among youth aged 10-24 in SCC. Decedents tended to be male 
(75.0%); 38.3% were white, non-Hispanic; 28.6% were Hispanic, 
of any race; and 26.5% were Asian, non-Hispanic. Common
methods of suicide were hanging/suffocation (47.6%) and use of
a firearm (21.0%). Known precipitating circumstances for suicide 
included recent crisis (52.6%), mental health problems (47.4%), 
and a history of suicidal thoughts (37.1%). Risk factors for past 
year suicidal ideation included depressive symptoms (OR: 11.3; 
CI: 10.2–12.6); lesbian, gay or bisexual orientation (OR: 4.4; 
CI: 3.8–5.1); and victim of psychological bullying (OR: 3.5; CI: 
3.2–3.8). Protective factors included perceiving that a teacher or
adult cares (OR: 0.6; CI: 0.5–0.7) and school connectedness (OR: 
0.4; CI: 0.3–0.4). 
Conclusions: Results suggest multiple factors are related to fatal 
and nonfatal suicidal behavior among youth in SCC. Use of
comprehensive, coordinated approaches that focus on multiple 








9:55 Adherence of Media Reporting of Suicides to Suicide Reporting Guidelines — Santa Clara 
County, California, 2008–2015 
Authors: Julie K. O’Donnell, A. Garcia-Williams, E. Spies,  
A. Azofeifa, K. Vagi 
Background: In Santa Clara County (SCC), California, 128 
youth suicides were reported during 2008–2015, garnering 
considerable media attention. Elements of media reporting of
suicide are recognized suicide risk factors, and the American
Foundation for Suicide Prevention (AFSP) developed guidelines 
for safe reporting of suicide in 2001. We retrospectively examined 
how closely media reporting of suicides in SCC followed these 
guidelines to guide ongoing local suicide prevention strategies. 
Methods: Media articles, published during 2008–2015, were
identified from print and online sources by using search terms 
for suicide and SCC, with source selection recommended by
SCC public health officials. Articles that reported on specific 
suicide deaths or attempts in SCC or surrounding counties were
systematically scored on the basis of AFSP reporting guidelines. 
Positive and negative reporting characteristics included in 
articles were quantified. 
Results: Two hundred forty-six articles were scored. Only 8 
articles were published in 2008; these were included in overall 
analyses but excluded from comparisons across years. Articles 
included a mean of 4.3 (range: 0–11) negative characteristics. 
Common negative characteristics included descriptions of
suicide methods (93%) and locations (83%). Proportion of
articles with a sensational headline declined from 40% in 2009 to
21% in 2015. Proportion including any suicide hotline number 
increased from 4% in 2009 to 40% in 2015. Inclusion of strong
language and provocative photographs, which are negative
reporting characteristics, fluctuated over time. 
Conclusions: Media reporting of suicides in SCC during
2008–2015 deviated from suicide reporting recommendations. 
Ongoing partnership with media outlets, to encourage
continuation of positive reporting trends and to work to improve 
negative trends, can be part of a more effective suicide prevention
strategy in SCC. 
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P2.1 Multistate Epidemiologic Description of Histoplasmosis in the United States, 2011–2014 
Authors: Paige A. Armstrong, K. Benedict, D. Haselow, V. Fields, 
C. Austin, M. Ireland, K. Signs, V. Fialkowski, R. Patel, C. Pedati, 
P. Iwen, J. Anderson, T. Dobbs, S. Gibbons-Burgener, K. Warren, 
S. Davidson, M. McIntyre, J. Midla, N. Luong, B. Jackson 
Background: Histoplasmosis is one of the most common
endemic mycoses in the United States. It is reportable in 10 
states and Puerto Rico; however, a standardized case definition
is not used, and incidence and distribution nationwide remain 
poorly understood. This study summarizes available state 
surveillance data to better understand the epidemiologic features 
of histoplasmosis. 
Methods: Thirteen states provided de-identified data. 
Contributing states included 10 (Arkansas, Delaware, 
Illinois, Indiana, Kentucky, Michigan, Minnesota, Nebraska, 
Pennsylvania, Wisconsin) in which histoplasmosis is currently 
reportable, 2 (Alabama, Mississippi) in which it was previously
reportable, and 1 (Ohio) in which it is not reportable. We
examined epidemiologic data during 2011–2014 (years for which 
data were available in all states), and calculated county-specific 
mean annual incidence rates. Some data elements were only
available from certain states. Cases were included if they were
classified as a confirmed or probable case by the state. 
Results: A total of 3,409 cases were reported. Median patient 
age was 49 years (IQ range: 33–61), and 2,079 (61%) patients 
were male. Of 1,729 patients for which race data was available,
most were white (62%) or unknown (26%) race. Common
symptoms reported by patients were cough (74%), shortness of
breath (65%), and fever (56%). Thirty percent of 1,154 patients 
were immunocompromised and 57% of 2,218 patients were
hospitalized. County incidence ranged from zero to 39 per 
100,000. 
Conclusions: The large proportion of hospitalized patients in 
this sample suggests that current surveillance underestimates 
the true burden of histoplasmosis. County-level incidence data
enhances our understanding of endemic regions in the United 
States. Expanding reporting to additional states would allow
























P2.2 Adaptation of the County-Level Vulnerability Assessment for Rapid Dissemination of HIV 
or Hepatitis C Virus Infections Among Persons Who Inject Drugs — Colorado, 2011–2015 
Authors: Alexis W. Burakoff, A. Rosenthal, B. McNair, D. Shodell 
Background: After a 2015 HIV outbreak among persons who 
inject drugs (PWID) in Scott County, Indiana, a 2016 CDC study 
used national data to identify indicators to predict a county-level 
risk for nonsterile injection drug use (IDU) and vulnerability for 
HIV or hepatitis C virus (HCV) outbreak. One Colorado county 
(Crowley) was identified as highly vulnerable. We sought to
replicate CDC’s model for all 64 Colorado counties with state-
level data to identify counties at highest risk. 
Methods: We collected data from the Colorado Department
of Public Health and Environment and other local, state, and 
national agencies to create a set of 43 possible indicators. We
used zero-inflated Poisson regression to model effects of these 
indicators, selected by using backwards elimination, on county 
rates of acute HCV diagnosis during 2011–2015 to approximate 
IDU. A common zero-inflation rate was estimated across all 
counties. We ranked counties on the basis of their vulnerability 
according to these indicators. 
Results: Nine indicators were included as follows: drug overdose 
deaths, per capita income (median), percent Native American, 
uninsured population, households with access to a vehicle, 
proximity to an interstate highway, rate of heroin possession 
offense, high prescription rates of opiates, and presence of
a syringe exchange program. The 5 most at-risk counties in 
Colorado were Montezuma, Douglas, Denver, Jefferson, and 
Gilpin. 
Conclusions: Methods from a vulnerability assessment can be
used at the state level to guide public health action and help 
identify at-risk counties to focus future prevention efforts.  
The difference in results from the original study might be
attributable to differing demographics of PWID, as reflected in 
our state-level data. 
P2.3 Risk Factors for Zika Virus Infection Identified Through Household Cluster Investigations — 








Authors: Rachel M. Burke, M. Lozier, J. Muñoz-Jordan, J. López, 
A. Jara, J. Read, B. Rivera-García, T. Sharp 
Background: The first locally acquired case of Zika virus (ZIKV) 
disease in Puerto Rico was detected in November, 2015. As
of December 2, 2016, the Puerto Rico Department of Health
(PRDH) had reported 33,752 laboratory-positive ZIKV cases. 
We used household investigations to estimate the proportion of
asymptomatic ZIKV infections and identify risk factors for ZIKV 
infection. 
Methods: We offered participation to residents of all households 
within a 100-meter radius of the residences of a convenience 
sample of 19 laboratory-positive ZIKV disease cases reported 
to PRDH (“index participants”; 12 interviewed). Participants 
answered a questionnaire and provided serum and urine.
Current and recent ZIKV infection were preliminarily defined 
by detection of ZIKV nucleic acid by RT-PCR or anti-ZIKV IgM 
by ELISA. ZIKV infection status was regressed on covariates 
using generalized estimating equations to account for clustering. 
Results: Of 446 households contacted, 242 (54.2%) accepted. Of 
462 present individuals, 379 (82.0%) participated. Among 367 
non-“index participants,” 113 (30.8%) had evidence of ZIKV 
infection. Of these 113, 57 (50.4%; vs. 19.7% of uninfected 
participants; P <.001) reported having rash, fever, arthralgia, or
conjunctivitis in the past 6 months; among these, 33 (57.9%) 
sought care. Never leaving doors or windows open was negatively
associated with ZIKV infection (adjusted odds ratio [aOR]: 
0.32; 95% confidence interval [CI]: 0.14–0.71]). Reporting daily 
mosquito bites was a risk factor for ZIKV infection (aOR: 2.87; 
CI: 1.10–7.51). No demographics were significant. 
Conclusions: At most half of ZIKV infections we detected were
symptomatic. Preliminary results demonstrated the importance 
of mosquito avoidance to prevent ZIKV infection. Residents 
of and visitors to Puerto Rico should keep windows and doors 
closed or ensure intact screens. 


















P2.4 Characteristics of Persons with Repeat Syphilis Infection — Idaho, 2011–2015
 
Authors: Ahmed M. Kassem, J. Bartschi, K. Carter 
Background: During 2011–2015, Idaho’s syphilis incidence rate
increased from 2.65/100,000 persons to 6.16/100,000 persons. 
Since January 2015, southwestern Idaho has been experiencing a 
syphilis outbreak, with 3 persons having repeat infections during
2015. We sought to characterize persons with repeat syphilis 
infection in Idaho. 
Methods: We analyzed sexually transmitted disease (STD) 
surveillance data maintained by the Idaho Division of Public 
Health. We defined repeat cases as having ≥2 early syphilis 
infections (primary, secondary, or early latent stages), and 
nonrepeat cases as having 1 early syphilis infection reported 
during 2011–2015. To reduce misclassification, we excluded 
one person who had early syphilis infection during 2006–2011 
from persons with nonrepeat cases. We reviewed demographic, 
clinical, and epidemiologic information collected during syphilis 
investigations. We used Median and Fisher’s exact tests to
describe and compare characteristics of persons with repeat and 
nonrepeat cases. 
Results: During 2011–2015, early syphilis infections were
reported in 193 Idaho residents, including 14 (7%) repeat cases. 
Among persons with repeat cases, 100% were male, 93% were
white, 85% [11/13] were non-Hispanic, and 91% [10/11] had 
male sex partners. Compared with nonrepeat cases, persons with
repeat cases more likely had secondary or early latent syphilis 
(93% [13/14] versus 64% [114/179]; P = 0.037), were HIV-
positive (85% [11/13] versus 30% [39/129]; P <0.001), and had a 
history of STD (82% [9/11] versus 39% [51/132]; P = 0.009). No
persons with repeat cases were incarcerated or exchanged sex for 
drugs or money. 
Conclusions: Repeat syphilis infection in Idaho was associated 
with HIV infection and history of STD. These characteristics 
could be used to enhance STD/HIV testing, interview, and 
partner services to prevent syphilis reinfection. 
P2.5 Streptococcus equi Subspecies zooepidemicus Fatal Infection Associated with Equine 
Exposure — King County, Washington State, 2016 
Authors: Vance Kawakami, K. Rietberg, B. Lipton, K. Eckmann, 
M. Watkins, H. Oltean, M. Kay, J. Duchin 
Background: Streptococcus equi subspecies zooepidemicus
(S. zooepidemicus) is an opportunistic commensal bacterium in 
horses that rarely causes human illness. In March 2016, Public 
Health—Seattle & King County (PHSKC) was notified of 2  
S. zooepidemicus infections, 1 fatal, in persons with horse contact 
at a King County horse facility (Facility A). PHSKC investigated 
to determine outbreak magnitude, identify risk factors, and 
prevent further illnesses. 
Methods: We interviewed Facility A owner who was 1 of 2 
index patients, facilitated nasal swab collection from all 6 horses 
on-site, and identified other Facility A patrons with horse contact 
during February–March 2016. A standardized questionnaire 
concerning horse contact and throat culture collection was 
conducted among patrons. Pulsed-field gel electrophoresis 
(PFGE) analysis was performed on all human and horse  
S. zooepidemicus isolates, including both index cases. We
analyzed the association between contact with a particular
horse and a positive S. zooepidemicus culture by using Fisher’s
exact test. 
Results: Of 33 patrons, 16 (48%) completed questionnaires  
and provided a throat culture; 3 (19%) grew S. zooepidemicus; 
one of three indicated a sore throat 2.5 weeks before culture 
collection. Four of 6 (67%) horses grew S. zooepidemicus.  
S. zooepidemicus isolates from 3 patrons, both index patients,  
and 2 horses had an indistinguishable PFGE pattern. Close 
contact to a particular horse was not significantly associated with
a positive S. zooepidemicus culture (P >0.1). 
Conclusions: Epidemiologic and laboratory evidence linked a 
fatal S. zooepidemicus infection to close horse contact. Although
zoonotic transmission risk factors and illness spectrum of
human S. zooepidemicus infection are largely unknown, 
consistently practicing hand washing after contact with horses, a 



















P2.6 Antimicrobial Resistance Among Pediatric Central Line–Associated Bloodstream Infections 
Reported to the National Healthcare Safety Network, 2011–2014 
Authors: Jason G. Lake, L. Weiner, I. See, S. Magill 
Background: Approximately 15% of the 30,000 central line– 
associated bloodstream infections (CLABSIs) that occur annually 
in U.S. hospitals affect pediatric patients. Because children are 
usually cared for by different providers in different locations 
than adults, pediatric-specific antimicrobial resistance (AR) 
data are needed to inform infection control and antimicrobial 
stewardship priorities. We describe and compare CLABSI AR in 
different pediatric locations. 
Methods: We used CDC’s National Healthcare Safety Network 
2011–2014 CLABSI surveillance data from four pediatric 
locations: neonatal and pediatric intensive care units (NICUs and 
PICUs), oncology units, and wards. Hospitals reported CLABSIs
and AR using standard surveillance definitions. Chi-squared and 
Fisher’s exact tests were used to compare the proportion resistant 
or nonsusceptible (%NS) for NICU vs non-NICU, and between 
non-NICU locations. 
Results: Overall, 15538 pediatric location CLABSIs were
reported. AR for Enterococcus faecalis, Escherichia coli, 
Enterobacter, and Klebsiella pneumoniae/oxytoca was 
significantly lower in NICUs compared to other locations, and 
similar between remaining locations.  For example, Klebsiella 
pneumoniae/oxytoca %NS to extended-spectrum cephalosporins
was 5% (NICU), 16% (PICU), 17% (oncology), and 12% 
(ward) (NICU vs non-NICU, P<.0001; P=.33 across non-NICU 
locations). AR was significantly higher in wards for some 
pathogens, including Pseudomonas aeruginosa where %NS to
piperacillin/tazobactam was 7% (NICU), 16% (PICU), 15% 
(oncology) and 32% (ward) (NICU vs non-NICU, P<.0001; 
P=.02 across non-NICU locations). 
Conclusions: AR was lower in NICUs for many CLABSI 
pathogens. For some pathogens, AR was highest in wards, 
which was unexpected as extensive healthcare exposures and 
antimicrobial use are typically more prevalent in critical care
and oncology locations. These findings demonstrate the value 
of pediatric-specific AR data and suggest a need for increased 








P2.7 Gastrointestinal Illness Surveillance in Peace Corps Volunteers: An Evolving Epidemiologic 
Surveillance System, 2013–2016 
Authors: Jarred B. McAteer, G. Appiah, C.E. O’Reilly,  
L. Deng, R. Bishop, R. Ferguson, D. Murphy, S. Poe, E. Mintz,  
S. Henderson, P. Jung. 
Background: Since implementation of the Epidemiologic 
Surveillance System (ESS) in 1985, the Peace Corps has 
monitored health and morbidity trends of volunteers. 
Gastrointestinal (GI) conditions have the highest reported 
yearly incidence. Peace Corps transitioned to a new electronic 
surveillance system in November, 2015. ESS data from 2013 
through June, 2016 were analyzed to identify reporting 
challenges with the new system.  
Methods: We analyzed monthly GI illness trends across  
all Peace Corps countries using data from the paper-based  
(2013–2015) and electronic ESS (January–June, 2016). Case
counts for reportable conditions were stratified by region, month, 
and diagnosis. We electronically surveyed 131 Peace Corps 
Medical Officers (PCMO) in all 66 current Peace Corps countries 
to assess reporting practices, system acceptability, and usefulness. 
Results: Surveillance data from 2016 show reported GI illness 
counts were highest for the Africa region.  Compared with
averages from 2013–2015, global data on 1,592 reported cases 
of GI illness in 2016 showed a 26% decrease (231 vs. 311) for 
January, and 24% decrease for February (223 vs. 291). Case
counts for these months fall outside the normal range for  
2013–2015 data (mean +/- 2SD). From January–June, 2016, viral 
diarrhea counts fall above, while giardiasis counts fall below the 
normal ranges. Of survey respondents, 20 (27%) of 77 (59%) 
reported being very familiar with GI surveillance codes, and 18% 
reported codes are definitely easy to apply. 
Conclusions: Variability in the new ESS reflects imprecise 
surveillance codes and knowledge gaps among users. The  
ESS is an evolving surveillance system that, with refinement, 
could identify priority diseases among a unique population
of long-term international travelers, and inform targeted  
prevention measures, including water treatment and improved 
empiric therapy. 





















P2.8 Assessment Of The Sensitivity Of Group A Streptococcal Necrotizing Fasciitis Surveillance 
From Alaska’s Laboratory-Based Surveillance System, 2015–2016 
Authors: Emily Mosites, A. Frick, T. Zulz, L. Castrodale,  
J. McLaughlin, M. Bruce, T. Hennessy, P. Gounder 
Background: Compared to the rest of the United States, Alaska 
has a high incidence of Group A Streptococcus necrotizing 
fasciitis (GAS-NF), a severe invasive bacterial disease. Laboratory
surveillance for invasive disease in Alaska relies on sterile site
(e.g. blood, cerebrospinal fluid, or an internal site) isolation of
the pathogen. However, a GAS-NF case is defined as either a 
positive GAS isolate from a sterile site or a non-sterile wound 
culture in a patient diagnosed with NF. The objective of this 
study was to evaluate the sensitivity of Alaska’s laboratory
surveillance for capturing GAS-NF cases. 
Methods: We requested a list of patients with discharge 
diagnosis codes for both GAS and NF from July 2015 through 
October 2016 from all Alaska hospitals. We compared this 
list to the list of GAS-NF cases in the laboratory surveillance 
system over the same time period. We estimated the number of
expected cases in the catchment area to calculate the sensitivity 
of laboratory surveillance for detecting GAS-NF. 
Results: Of 22 hospitals contacted, 15 responded to identify
4 cases of GAS-NF. Seven cases of GAS-NF were identified in 
laboratory surveillance and 2 cases were common to both data
sources. Twelve cases were estimated to have occurred in the 
catchment area of these hospitals (95% confidence interval: 
7–19 cases), yielding a sensitivity of 56%. The two cases missed 
by laboratory surveillance had positive wound cultures but no 
positive sterile site cultures. 
Conclusions: Alaska’s laboratory surveillance had low sensitivity 
for GAS-NF cases, which may lead to an underestimate of
the burden of disease. The sensitivity could be improved with
standardized guidance to laboratories for reporting GAS-NF 
cases according to the case definition. 
P2.9 Evaluating Interest In An H5N1 Vaccine Among Highly Pathogenic Avian Influenza Laboratory
Workers In The United States 
Authors: Kate Russell, J. Bresee, J.M. Katz, S.J. Olsen 
Background: Highly pathogenic avian influenza A (HPAI) 
viruses found in poultry and wild birds occasionally infect 
humans and cause serious disease. In 2014, the Advisory
Committee on Immunization Practices reviewed data from one 
licensed influenza A(H5N1) vaccine for consideration of use in 
inter-pandemic periods in persons with occupational exposure.
To guide vaccine policy decisions, we conducted a survey of
laboratory workers to assess demand for HPAI vaccination. 
Methods: We designed an anonymous web survey (EpiInfo 7.0) 
to collect information on demographics, work type, and interest
in HPAI vaccination. The survey was exempted by a CDC 
institutional review board. Eligible participants were identified 
from 42 entities registered with United States Department of
Agriculture’s Agricultural Select Agent program and emailed 
electronic surveys. Personnel with Biosafety Level 3 enhanced 
(BSL-3E) laboratory access were surveyed. Descriptive analysis 
was performed (SAS 9.3). 
Results: Overall, 131 responses were received from 33 
principal investigators, 26 research scientists, 24 technicians, 15 
postdoctoral fellows, 6 students, and 27 others. The response rate
was 20% among the labs of responding PI’s. Forty-five percent of
respondents spent ≥4 hours per week in the BS-3E area. Overall, 
48% were interested in receiving a H5N1 vaccine. By role, 
interest was highest among students (80%) and by time, among 
those who spent >50% of their time in a BSL-3E area (64%). 
Most (59%) of those who said they might or did not have vaccine 
interest believed it would not provide additional protection to
current safety practices. 
Conclusions: Half of responding laboratory workers were
interested in HPAI vaccines. HPAI vaccination of laboratory
workers at risk of occupational exposure could be used alongside 




























P2.10 High Rates of Active Tuberculosis Among Immigrants from the Philippines — Hawaii, 
2010–2014 
Authors: Kristine M. Schmit, R. Brostrom, A. Pyan, A. Largen, 
Z. Wang, S. Mase, S. Morris 
Background: Immigrants to the United States undergo
preimmigration evaluation for tuberculosis (TB): test for 
infection, chest radiograph, sputum evaluation. Immigrants 
whose chest radiographs are abnormal but whose cultures test 
negative are considered disease-free and allowed to immigrate,
but are more likely to be diagnosed with disease after arrival.
These immigrants are instructed to undergo postimmigration
evaluation. Hawaii noted high rates of TB disease among Filipino 
immigrants with abnormal preimmigration screening results. 
We compared disease rates among such Filipino immigrants to
Hawaii with national rates and assessed differences in rates of
postimmigration evaluation. 
Methods: Because Hawaii did not routinely report data
nationally, we used local surveillance data to determine rates 
in Hawaii; nationwide rates (excluding Hawaii) were based on
national surveillance data. For all Filipino immigrants with
abnormal pre-immigration screening results during 2010–2014, 
we used chi-square tests to compare rates of diagnoses of TB 
disease ≤1 year after arrival and postimmigration evaluation. 
Results: In Hawaii, TB disease was diagnosed for 44 of 1,618 
(2.7%) Filipino immigrants with abnormal preimmigration
screening results ≤1 year after arrival, compared with 179 of
15,232 (1.2%) nationwide (P <.001); 1,618 of 1,681 (96.3%) were
evaluated ≤1 year of arrival, compared with 15,232 of 21,128 
(72.1%) nationwide (P <.001). All such immigrants to Hawaii 
received a chest radiograph compared with 13,438 of 15,232 
(88.2%) nationwide. 
Conclusions: During 2010–2014, among Filipino immigrants 
with abnormal preimmigration screening results, rates of
diagnosed TB disease ≤1 year after arrival were over twice 
that of similar immigrants nationwide. A significantly 
greater proportion of such immigrants to Hawaii received 
postimmigration evaluation, including chest radiograph, 
which suggests missed opportunities for diagnosing TB in this 








P2.11 Healthcare-Associated Legionnaires’ Disease — United States, 2014 

Authors: Elizabeth A. Soda, A. Barskey, P. Shah, L. Cooley 
Background: Legionella, the bacterium causing Legionnaires’ 
disease (LD), a severe pneumonia, can be transmitted through 
a building’s water system. However, transmission is preventable 
through environmental infection control. Healthcare facilities 
with vulnerable populations pose known risks for Legionella
transmission, but the burden of healthcare-associated LD is 
unknown. We used national reporting data to describe the 
burden and outcomes of potentially healthcare-associated LD. 
Methods: We analyzed data from 12 states that included 
comprehensive exposure data for ≥95% of legionellosis cases 
reported to CDC in 2014. We defined confirmed cases as those 
meeting Council of State and Territorial Epidemiologists criteria. 
Potentially healthcare-associated cases reported inpatient, 
outpatient, visitor/volunteer, or work-related exposures to
healthcare facilities during some portion of the ten days before
illness onset. Case-fatality rates (CFRs) were compared using 
Fisher’s exact test. 
Results: We identified 1,181 confirmed cases (1.8/100,000 
population), of which 243 (20.6%) were potentially healthcare-
associated. CFR was higher for potentially healthcare-associated 
cases (10.3%) than for non-healthcare-associated cases (5.3%; P < 
.01). Among potentially healthcare-associated cases, 112 (46.1%) 
reported inpatient exposures (CFR 14.3%); 77 (31.7%) reported 
outpatient visits (CFR 9.1%); 25 (10.3%) reported visitor/ 
volunteer visits (CFR 0.0%); and 16 (6.6%) reported employee 
visits (CFR 0.0%). Ten (4.1%) reported >1 type of exposure (CFR 
10.0%). 
Conclusions: LD in those with healthcare exposures accounted 
for a substantial proportion of the total reported LD burden. 
Among persons with potentially healthcare-associated LD, 
patients experienced higher mortality than non-patients. New 
guidance for water management practices is available to reduce 
the risk of Legionella transmission in buildings with complex 
water systems including healthcare facilities. 








P2.12 Evaluation of the Case Definition for Suspected Yellow Fever Deaths in an Outbreak 
Setting — Angola, 2016 
Authors: Anna Q. Yaffee, G. Appiah, E. Manuel, J. Kipela,  
J. Kaiywa, E. Hunsperger, R. Arthur, T. Doyle 
Background: Starting in December 2015, Angola experienced 
an unprecedented outbreak of yellow fever (YF). Early in the 
outbreak, many suspected cases were reported, but true burden 
of YF was unclear as clinical diagnosis relied on nonspecific 
symptoms of fever and jaundice. Accurate YF diagnosis is 
challenging in settings such as Angola, where endemic diseases 
have similar clinical presentation (e.g., malaria) and there is 
limited laboratory capacity. To more fully understand true YF 
burden in Angola, we evaluated clinically-diagnosed YF deaths
to assess feasibility of excluding patients positive for other 
infections from the surveillance case definition. 
Methods: In March 2016, we abstracted charts for clinically-
diagnosed YF deaths from 5 tertiary hospitals in Luanda 
Province to determine if the case met World Health
Organization’s (WHO) suspected YF case definition of fever 
and jaundice <14 days of symptom onset. We cross-referenced 
infectious disease testing results in hospital and Ministry of
Health laboratory databases. 
Results: Of all 101 clinically-diagnosed YF deaths, 86 (85%) met 
WHO’s suspected YF case definition. Only 9 of 86 patients (10%) 
had YF testing; 3 (33%) were confirmed positive. Forty-eight
patients were tested for malaria by smear or rapid diagnostic 
test; 26 (54%) were positive for malaria, and 2 were also Widal 
positive for typhoid. Two of 3 laboratory-confirmed YF patients 
were also positive for malaria. 
Conclusions: Applying a more specific case definition excluding 
deaths laboratory-positive for other infections would have
excluded confirmed YF cases from consideration as suspected 
cases. YF deaths with coinfections would also be missed. To
capture all possible YF cases to guide outbreak response, we
recommended continued use of existing WHO case definition, 
improved diagnostic capacity and increased YF testing. 




















SPECIAL SESSION 2: Zika Virus Infection 
11:50 AM–1:05 PM 
3rd Floor Room 203 AB 
Moderators: Steve Monroe and Robert Tauxe 
Sponsor: National Center on Birth Defects and Developmental Disabilities 
(NCBDDD), National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID) 
This session will cover CDC’s response to the Zika virus outbreak in the Americas, with a focus on the risks to pregnant women and babies. 
Relevance and Appropriateness for the EIS conference 
In 2016, CDC recognized the causal link between Zika virus infection during pregnancy and brain abnormalities and microcephaly,
and growing evidence of an association with other birth defects, including eye abnormalities and arthrogryposis.  CDC activated its 
Emergency Operation Center (EOC) to respond to the Zika virus outbreak on January 22, 2016, and the EOC is still activated. CDC
has worked closely with state, local, tribal, and territorial partners to prevent Zika virus infections during pregnancy, to implement 
surveillance of pregnant women and their infants with evidence of possible Zika virus infection during pregnancy, to create and
distribute innovative tests to improve diagnostics, and to respond to local transmission of Zika virus in the United States. Throughout
the response, EIS officers have played a central role in rapidly responding to this public health emergency. 
Speakers 
• Accomplishments in the first 15 months of the Zika Response (10 min)  
Denise Jamieson, MD, Incident Manager, CDC Zika Response 
• Zika virus disease: epidemiology and response (10 min) 
Susan Hills, MBBS Medical Epidemiologist, Arboviral Diseases Branch, NCEZID 
• Zika and pregnancy: surveillance and research activities in the U.S. states and territories, and Colombia (20 min).  
Margaret Honein, PhD Branch Chief, Birth Defects Branch, NCBDDD, Dana Meaney-Delman, MD Medical Officer, NCEZID 

Co-Leads, Pregnancy and Birth Defects Task Force, CDC Zika Response
 
• Perspective on Zika virus response from NYC (10 min) 
Annie Fine, MD New York City Department of Health & Mental Hygiene 









CONCURRENT SESSION K1: Healthcare-Associated Outbreaks 
1:15–3:00 PM 
Frieden Plenary 
Moderators: Mike Bell and Isaac See 
1:20 Careful of the Wound: Group A Streptococcus Outbreak in a Skilled Nursing Facility — 
Chicago, 2015–2016
 
Authors: Sana S. Ahmed, K. Diebold, J. Brandvold, W. Clegg,  
S. Ewaidah, R. Leidig, S. Kemble, S. Black, A. Ogundimu,
B. Beall, N. Stone, C. Van Beneden 
Background: Older adults living in nursing homes are 
vulnerable to severe group A Streptococcus (GAS) infections; 
approximately one-third of those affected die. From July 2015­
January 2016, the Chicago Department of Public Health (CDPH) 
identified 4 severe GAS infections among residents with wounds 
at a skilled nursing facility. Despite use of antibiotic prophylaxis, 
additional infections occurred. In March 2016, CDPH requested 
an Epi-Aid to evaluate risks related to wound care and 
recommend prevention measures. 
Methods: We defined cases as lab-confirmed GAS infections in 
residents. We conducted a case-control study among residents 
with wounds, matching residents without GAS infection to
case-residents by age and facility stay (within 15 days from case
culture); P-values were calculated using conditional logistic 
regression. Using direct observation, we evaluated wound care
and infection control practices. We placed agar plates adjacent to
5 residents during wound care to assess possible  
GAS dissemination. 
Results: From July 2015–March 2016, 7 resident cases were
detected. Compared to controls, case-residents more often 
received negative pressure wound therapy (NPWT) (86% [6/7]) 
vs. 10% [2/21]; mOR and P=undefined), and treatment with
antimicrobial wound cream (57% [4/7] vs 5% [1/14]; mOR 12.0; 
P=0.03). Inadequate hand hygiene following resident contact and 
inconsistent personal protective equipment (PPE, e.g., gowns, 
clean gloves) use were observed during wound care. Agar plates 
placed near one resident during wound care grew GAS. 
Conclusions: Inadequate infection control practices and local 
environmental contamination with GAS during wound care
likely contributed to GAS transmission, particularly among  
those receiving NPWT. This could result in colonization, 
infection, or transient hand contamination of health-workers. 
Reinforcing infection control practices, including hand hygiene 

























1:40 Fungal Bloodstream Infections Associated with Substandard Compounding Practices at an 
Outpatient Oncology Practice — New York City, 2016 
Authors: Amber M. Vasquez, N. Chow, S. Vallabhaneni,  
S. Ngai, C.T. Lee, K. Perkins, J. Lake, M.S. Keckler,  
H. Moulton-Meissner, S. Elkind, J. Haas, D. Zavasky, J. Greenko,
E. Adams, A. Litvintseva, T. Chiller, J. Ackelsberg
Background: In May 2016, the New York City (NYC) 
Department of Health and Mental Hygiene notified CDC of four 
cases of Exophiala dermatitidis bloodstream infections (BSIs) 
among patients at an outpatient oncology practice (Practice A). 
E. dermatiditis is an environmental fungus and rare cause of BSI. 
We conducted an investigation to identify possible sources and 
implement prevention measures. 
Methods: A case was defined as any non-Candida yeast or
mold identified on blood or central venous catheter (CVC) 
culture from a patient of Practice A during January–May 2016. 
Case finding included microbiology, medical record review, 
and screening blood or CVC cultures for patients who received 
intravenous medications at Practice A. A cohort analysis was 
performed to determine risk factors for infection. Whole genome 
sequencing (WGS) was performed on isolates and infection
control practices were assessed. 
Results: Seventeen cases of E. dermatitidis or Rhodotorula 
mucilaginosa BSIs were identified among 38 patients exposed to
intravenous medications. The only common exposure among 
cases was an intravenous flush solution compounded at Practice 
A. Case-patients received a median of 12 flushes (range=2– 
20) compared with four flushes for noncases (range=1–12) 
(p=0.004). WGS of 14 E. dermatitidis case-isolates showed 0-2 
single nucleotide polymorphism (SNP) differences between 
isolates from case-patients unrelated isolates from NYC had 
>100,000 SNP differences from case-isolates. Substantial lapses  
in infection control and medication compounding standards 
were found. 
Conclusions: The likely source of this outbreak was a 
contaminated compounded intravenous flush solution. Practice 
A ceased operations until lapses in infection control and 
medication preparation were corrected. This outbreak highlights 
gaps in knowledge of and adherence to infection control and 
sterile medication preparation standards in some outpatient 
oncology settings. 












2:00 Nontuberculous Mycobacteria Infections Among Breast Plastic Surgery Patients — 
Hospital A, South Carolina, 2014–2016 
Authors: Kimberly A. Skrobarcek, A. Vasquez, C. Margus,  
M. Arduino, L. Bell, I. Benowitz, L. Bullard, M. Crist,  
H. Houston, H. Moulton-Meissner, P. Kopp, R. Radcliffe,  
K. Richardson, N. Shrivastwa, J. Perz 
Background: Nontuberculous mycobacteria (NTM) are
environmental bacteria that have been increasingly
implicated in cosmetic surgical site infections (SSIs) worldwide.
In October 2016, South Carolina Department of Health and
Environmental Control requested assistance identifying risk
factors and control measures for an outbreak of NTM
infections primarily among reconstructive breast plastic
surgery (BPS) patients. 
Methods: We conducted a case-control study of Hospital A 
patients who underwent BPS from January 2014–October 2016. 
Case-patients had SSIs with positive or pending NTM cultures. 
Controls, time-matched 3:1 to case-patients, had no or negative
NTM cultures. We evaluated infection control practices (ICP) 
and conducted environmental assessments. 
Results: We identified 17 case-patients and 51 controls. Three 
NTM species were identified among case-patients. Statistically 
significant risk factors (P<.05) included various surgery types, 
surgery duration (median: 5.1 hours for case-patients, 2.5 hours 
for controls), operating room staff number (median: 9 for case-
patients, 7 for controls), and overnight admission (16/17 case-
patients, 26/51 controls). In multivariable analysis, only surgery
duration was significant. ICP review identified lapses in aseptic 
technique (e.g., breaks in sterile surgical field) and high traffic in/ 
out of operating rooms. In hospital water, total bacterial counts 
were 10^3–10^6 colony-forming units (CFU)/mL, exceeding 
Environmental Protection Agency’s drinking water standards, 
<500 CFU/mL. Four NTM species grew in 25/37 environmental 
samples; only Mycobacterium chelonae was common between 
clinical and environmental isolates. 
Conclusions: Risk of NTM infection in BPS patients increased 
with longer surgery duration. An environmental source was 
likely given that SSIs involved multiple NTM species and hospital 
water samples yielded NTMs and elevated bacterial colony
counts.  Effective water management and strict adherence to ICP 
are needed to interrupt potential water exposure pathways and 
prevent SSIs. 



























2:20 Cluster of Pseudomonas Infections Among Neonatal Intensive Care Unit Patients — 
Maryland, 2016 
Authors: Mark K. Weng, R. Brooks, J. Glowicz, M. Keckler,  
B. Christensen, V. Tsai, L. Wilson, R. Laxton,  
H. Moulton-Meissner, R. Fagan 
Background: Pseudomonas aeruginosa (PA) is common in 
healthcare environments and is a leading cause of serious 
healthcare-associated infections in neonatal intensive care unit 
(NICU) settings. From March–October 2016, nine confirmed 
cases (two deaths) of PA occurred in a neonatal intensive care
unit (NICU) at a Maryland hospital, resulting in its closure.
Earlier testing showed high burden of PA in facility water. We
investigated possible transmission pathways and identified 
potential control measures. 
Methods: We interviewed hospital leadership and NICU staff 
and performed targeted observations of infection prevention
practices in the NICU and other hospital areas. These 
observations guided environmental sampling in the NICU. 
Pulsed field gel electrophoresis (PFGE) was used to compare 
clinical and environmental isolates. 
Results: Observed risks included staff inadequate hand hygiene 
and procedures for cleaning of sinks, equipment, and breast milk 
collection supplies in the NICU. PA was isolated from stored 
breastmilk, tap water post-filtration, and staff bathroom and 
breakroom sinks. PA isolates from two patients and two sinks in 
the NICU were indistinguishable by PFGE, while a breastmilk 
isolate was closely related to a PA isolate from a third patient. 
Conclusions: PA transmission from contaminated hospital 
water sources to patients could have occurred via several 
pathways. Recommendations included improving hand hygiene,
supplemental measures to decrease PA concentrations in the 
hospital water system, avoidance of using tap water for cleaning 
equipment, and revised cleaning procedures for sinks, patient 
care and breastfeeding equipment in the NICU. PA surveillance 
should be conducted prospectively to help evaluate the 








2:40 Burkholderia cepacia Bloodstream Infections Among Skilled Nursing Facility Residents — 
United States, 2016 
Authors: Richard B. Brooks, P. Mitchell, J. Miller, M. Crist,  
A. Vasquez, J. Havlicek, M. Quinn, I. Daskalaki, R. Greeley,
K. Ross, H. Lee, R. Perlmutter, D. Baker, A. Longenberger,
C. Bicking Kinsey, J. Walrath, E. Adams, H. Moulton-Meissner,
S. Watkins, D. Blythe, K. Feldman, L. Wilson 
Background: On September 22, 2016, Maryland Department
of Health and Mental Hygiene was notified of 4 Burkholderia 
cepacia bloodstream infections among skilled nursing facility
(SNF) residents receiving intravenous therapy. Multistate
notification occurred on September 28; clusters were reported
in 4 additional states. We sought to determine outbreak scope,
identify source, and prevent additional cases. 
Methods: Cases were initially defined as blood cultures yielding 
B. cepacia in SNF residents receiving intravenous therapy after 
August 1. Jurisdictional health alerts were disseminated to
aid case finding. We abstracted patient medical records and 
visited affected SNFs in 2 states in late September to identify
possible infection sources. Suspect products were cultured; 
patient and product isolates were typed by using pulsed-field gel 
electrophoresis (PFGE). 
Results: All patients resided at SNFs supplied by Pharmacy A, 
which began distributing saline flushes from Manufacturer X 
on September 1. By using an updated case definition requiring 
residence at an SNF using Manufacturer X flushes, we identified 
153 cases from 57 facilities in 5 states with first positive blood 
cultures during September 10–November 11. On October 3, 
B. cepacia was isolated from unopened Manufacturer X saline 
flushes obtained from an affected facility. PFGE patterns were
indistinguishable in 111/127 (87.4%) patient isolates from all 5 
states and 6/7 (85.7%) product isolates. A second PFGE pattern 
from 1/7 (14.3%) product isolates and 8/127 (6.3%) patient 
isolates differed by 1 band. Implicated products were recalled  
on October 4. 
Conclusions: Epidemiologic and laboratory evidence indicates 
contamination of saline flushes produced by Manufacturer 
X was the outbreak source. Investigation into the cause of
contamination and surveillance for additional cases is ongoing. 












CONCURRENT SESSION K2: Environmental Health 
1:15–3:00 PM 
Concurrent Session Room 
Moderators: Patrick Breysse and Suzanne Beavers 
1:20 My Old Kentucky Home: Arsenic Contaminated Soil in a Kentucky Neighborhood and 
Response, 2016
 
Authors: Anna Q. Yaffee, B. Scott, C. Kaelin, J. Cambron,  
W. Sanderson, J. Chamness 
Background: Exposure to arsenic can occur through ingestion 
or inhalation of contaminated soil, increasing risk for cancer 
and other chronic health outcomes. A residential neighborhood
in Kentucky located on a former lumber treatment facility site
was found to have elevated levels of soil arsenic from improper 
disposal of lumber treatment waste. Emergency response was 
undertaken to conduct an exposure assessment. 
Methods: To identify exposure risk factors we administered 
an in-person survey to all residents; parents provided response
for children. Arsenic level was analyzed in washed nail clipping
samples self-collected from residents and residential soil samples. 
We used Pearson correlation (R) and Wilcoxon-Mann-Whitney
tests to assess association between arsenic level and exposures.. 
Results: All 84 (100%) persons in all 19 households were
surveyed. Seventy-six persons provided toenail samples; among 
70 who had adequate mass for analysis, median age was 25 years 
(range: 1–68 years). Median arsenic in toenail samples was 0.42 
micrograms/gram (μg/gm) (range: 0.04–6.97 μg/gm), twice the 
expected level of ≤0.2 μg/gm. Age was inversely correlated (R = 
–0.33, P = 0.01) and mean residence soil arsenic level positively
correlated (R = 0.30, P = 0.01) with elevated toenail arsenic level.
Playing sports outdoors (n=37) was positively associated (P = 
0.03) with higher toenail arsenic levels 
Conclusions: : Living in areas with high soil arsenic 
contamination can lead to increased exposure; younger age,
playing sports outdoors, and elevated residence soil arsenic level 
were associated with elevated toenail arsenic level. Correlation 
between younger age and higher arsenic levels is possibly
attributable to soil exposure through activities. Due to ongoing 
remediation efforts, recommendations to residents include 




































1:40 Project Coyote Water: Assessment of Unregulated Drinking Water on Tribal Lands Within 
the United States — January 2015–March 2016 
Authors: Gamola Z. Fortenberry, E. Taylor, G. Goodwin,  
K. Hickel, J. Temtel 
Background: Approximately 30,000 American Indian/ 
Alaska Native homes lack potable water. Consequently, tribal 
communities may rely more on unregulated water sources 
(UWS) than other communities in the United States. However,
little research has been done to substantiate these estimates. To
better characterize UWS use, the National Tribal Water Center 
and CDC’s Health Studies Branch collaborated on Project Coyote
Water, a survey to assess use of UWS within tribal communities, 
identify motivators for UWS use, and describe educational and 
outreach activities on tribal lands. 
Methods: A targeted sample of Indian Health Service (IHS)
and tribal environmental health employees from the 12 IHS
areas across the United States were surveyed about tribal
household UWS use, water quality concerns, and outreach
activities in their area using a standardized questionnaire.
Descriptive statistics were used to analyze survey data.
Results: At least one IHS and one tribal participant were
interviewed in each IHS area for a total of 44 employees (18 IHS
and 26 tribal organizations). UWS use among households was
reported by 95% of survey participants for their area. Additionally,
57% of participants reported UWS consumption by households
even when regulated water was available. Reported household
motivations for UWS consumption included trust or perception
of water quality (57%), inexpensive cost (35%), and culture or
tradition (35%). Lastly, 60% of participants reported a local well
testing program for their area. 
Conclusions: Project Coyote Water found nearly all participants 
reported some UWS use by tribal households in their area and 
many reported UWS use when regulated water was available.
Preliminary data allows for design of a strategic plan and 
additional testing to address public health concerns regarding 








2:00 Secondhand Exposure to E-Cigarette Aerosol in Public Places: Findings from the 2015 
National Youth Tobacco Survey 
Authors: Teresa W. Wang, K. Marynak, I. Agaku, B. King 
Background: Although secondhand aerosol (SHA) from
e-cigarettes can contain nicotine and other potentially harmful 
substances, the extent of exposure among U.S. youth is unknown. 
We assessed prevalence and correlates of exposure to SHA in 
public places among U.S. youth. 
Methods: Data came from the 2015 National Youth Tobacco 
Survey, a nationally representative school-based survey of U.S. 
middle and high school students in grades 6–12 (n = 17,711). 
Self-reported SHA exposure was defined as any response other 
than “0 days” to the question, “During the past 30 days, on
how many days did you breathe the vapor from someone who 
was using an electronic cigarette or e-cigarette in an indoor or
outdoor public place?” Point estimates were calculated overall 
and by sex, race/ethnicity, school grade level, e-cigarette use,
other tobacco product use, and secondhand tobacco smoke 
exposure. Adjusted prevalence ratios (aPRs) were calculated 
using multivariate Poisson regression. 
Results: Overall, 24.2% (95% confidence interval: 22.5%-25.9%) 
of students reported SHA exposure. The likelihood of SHA 
exposure was lower among non-Hispanic blacks than among 
non-Hispanic whites (aPR: 0.75; P< .05). The likelihood was 
higher among: females (aPR: 1.10; P< .05); past 30-day current 
(aPR: 2.71) and former (aPR: 1.29) e-cigarette users than never 
users (P< .05); and current (aPR: 1.30) and former (aPR: 1.27) 
users of other tobacco products than never users (P< .05). 
Furthermore, SHA exposure was more likely among students 
who also reported secondhand smoke exposure (aPR: 3.49; P< 
.05). 
Conclusions: Approximately 1 in 4 U.S. students (6.5 million) 
reported past 30-day SHA exposure. Efforts are warranted to
include e-cigarettes in comprehensive smoke-free policies, and to
educate parents, youths, and caregivers about the potential harms 
of SHA. 














2:20 The Burden of Asthma: Healthcare Use Patterns and Asthma Triggers — Puerto Rico, 2013
 
Authors: Lillianne M. Lewis, M. Mirabelli, S. Beavers, M. Lozier, 
J. Morales Gonzalez, C. Kennedy, J. Shriber, D. Stearns,  
M. Soto Santiago, J. Irizarry Ramos, K. Sircar, B. Rivera-García, 
B. Bolaños 
Background:  Asthma carries a substantial burden of disease 
in Puerto Rico (PR); prevalence is 14% among children and 
11% among adults. However, limited information is available 
concerning the public health burden of asthma-related healthcare
use patterns. To better understand populations accessing 
emergent and ambulatory healthcare for asthma and to identify
risk factors and magnitude for asthma-related healthcare use, we
examined asthma claims and potential asthma triggers in PR. 
Methods: By using all 2013 reported PR emergency department 
(ED), hospital, and outpatient asthma insurance claims (N = 
550,655), we analyzed demographic characteristics associated 
with asthma healthcare use (primary diagnostic ICD-9-CM 
code 493.*). We examined associations between environmental 
triggers and healthcare use by using daily mold and pollen 
measurements from the San Juan Allergen Bureau. Descriptive 
statistics were performed. 
Results: During 2013, 148 asthma claims/1,000 persons were
reported. Regional asthma claim rates ranged from 72/1,000 
persons (Ponce) to 142/1,000 persons (Caguas) with an overall 
rate of 108/1,000 persons across all regions. Among asthma 
claims, 71% were outpatient visits, 19% were hospitalizations, 
and 10% were ED visits. Females (63%), children aged <10 years 
(77% among children), and adults aged >44 years (80% among 
adults) accounted for a majority of asthma claims. In San Juan, 
35% and 52% of mold and pollen levels, respectively, were ranked 
as high or very high on the location-specific allergen bureau
scale. Decreases in asthma claims and pollen levels were noted 
from May–July. 
Conclusions: This study demonstrates that females, children, 
and certain adults carry the highest burden of asthma-related 
healthcare use in PR. These findings can be used to target 
public health messaging and interventions to these populations, 
specifically in ED and hospital settings. 
2:40 Community Assessment for Public Health Emergency Response (CASPER) After the Flint 
Water Crisis — Flint, Michigan, 2016 
Authors: Alice Wang, G. Fortenberry, P. Reynolds, S. Burrer,  
V. Johnson-Lawrence, A. Schnall, P. Pullins, S. Kieszak,  
T. Bayleyegn, A. Wolkin 
Background:  In April 2014, Flint, Michigan changed their 
municipal water supply, which resulted in corrosion of
distribution pipes, and leaching of lead into municipal drinking
water; this prompted an official advisory not to drink unfiltered 
municipal water. To assist with Flint Water Crisis recovery
efforts, Flint Community Resilience Group and CDC assessed 
physical and behavioral health concerns of the community. 
Methods: In May 2016, we used a three-stage cluster sampling 
design to conduct a Community Assessment for Public Health
Emergency Response. The questionnaire elicited information
about household- and individual-level physical and behavioral 
health concerns since the Flint Water Crisis. Individual-level 
behavioral health questions were adapted from the Behavioral 
Risk Factor Surveillance System (BRFSS). We conducted 
weighted cluster analysis with 95% confidence intervals (CI),  
and compared individual-level results to 2014 Michigan  
BRFSS findings. 
Results: We completed 182 questionnaires (completion 
rate=86.7%). Of households, 50.5% (CI: 43.4–57.5) reported 
worsened physical health of at least one household member. Half 
(50.0%, CI: 41.8–58.3) the households reported a lot of stress 
related to feeling overlooked by decision-makers. Of individuals, 
29.6 % (CI: 21.2–38.0) self-reported depressive symptoms, and 
33.7% (CI: 25.5–41.8) self-reported symptoms of anxiety. Of 
individuals, 38.0% (CI: 31.6–44.4) reported having poor mental 
health for 14 or more days within the last 30 days, compared to
12.9% (CI: 11.9–14.0) reported in the Michigan BRFSS. 
Conclusions: The percentage of those reporting behavioral 
health concerns was approximately three times higher than
reported by Michigan BRFSS. The increased percentage
reporting negative quality of life indicators and considerable 
percentage reporting symptoms of depression and anxiety 
supported the addition of behavioral health interventions and 


























SESSION L: Alexander D. Langmuir Lecture 
3:15–4:45 PM 
Freiden Plenary Room 
Moderator: Patricia Simone 
Presentation of the Alexander D. Langmuir Prize Manuscript Award and  
the Distinguished Friend of EIS Award 
Moving from Epidemiology to Quantitative Population Health Science 
Speaker: Sandro Galea, MD, MPH, DrPH 
Sandro Galea 
MD, MPH, DrPH Biography 
Dr. Sandro Galea is a physician and an epidemiologist. He is the Robert A. Knox Professor and Dean at the Boston University School
of Public Health. Prior to his appointment at Boston University, Dr. Galea served as the Anna Cheskis Gelman and Murray Charles
Gelman Professor and Chair of the Department of Epidemiology at the Columbia University Mailman School of Public Health. He
previously held academic and leadership positions at the University of Michigan and at the New York Academy of Medicine. 
In his scholarship, Dr. Galea is centrally interested in the social production of health of urban populations, with a focus on the causes 
of brain disorders, particularly common mood-anxiety disorders and substance abuse.  He has long had a particular interest in the 
consequences of mass trauma and conflict worldwide, including as a result of the September 11 attacks, Hurricane Katrina, conflicts 
in sub-Saharan Africa, and the American wars in Iraq and Afghanistan. This work has been principally funded by the National 
Institutes of Health, Centers for Disease Control and Prevention, and several foundations. He has published over 600 scientific
journal articles, 50 chapters, and 10 books and his research has been featured extensively in current periodicals and newspapers. His 
latest book, co-authored with Dr. Katherine Keyes, is Population Health Science, forthcoming from Oxford University Press in 2016. 
Dr. Galea has a medical degree from the University of Toronto, and graduate degrees from Harvard University and Columbia 
University; he has an honorary doctorate from the University of Glasgow.  He was named one of TIME magazine’s epidemiology 
innovators and has been listed by Thomson Reuters as one of the “World’s Most Influential Scientific Minds” for the Social Sciences.  
He is past-president of the Society for Epidemiologic Research and an elected member of the National Academy of Medicine and of
the American Epidemiological Society. 
Dr. Galea serves frequently on advisory groups to national and international organizations. He currently serves on the Advisory
Council on Minority Health and Health Disparities and has formerly served as chair of the New York City Department of Health and 
Mental Hygiene’s Community Services Board and as member of its Health Board.
Awards presented during session. 
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SESSION M: FETP International Night — Oral Presentations 
6:30–9:00 PM 
Concurrent Session Room 
Agenda provided during session 
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Thursday, April 28, 2017 
CONCURRENT SESSION N1: Respiratory Diseases 
8:30–9:55 AM 
Frieden Plenary 
Moderators: Mark Pallansch and Lindsay Kim 
8:35 	 Neighborhood-Level Poverty, Poverty-Associated Factors, and Severe Outcomes Among 
Adults Hospitalized with Influenza — United States, 2012–2015 
Authors: Rebekah S. Schicker, K. Yousey-Hindes, M. Rolfes,  
C. Cummings, E. Anderson, M. Bargsten, N. Bennett, S. Eckel,
K. Lung, M. McMahon, L. Miller, M. Monroe, I. Risk,  
W. Schaffner, A. Thomas, J. Watt, S. Zansky, C. Reed, A. Fry,
S. Garg 
Background: Recent studies demonstrated higher influenza-
associated hospitalization rates among individuals living in 
high-poverty neighborhoods. We explored the further impact of
neighborhood-level poverty and individual, poverty-associated 
factors, on severe outcomes among hospitalized patients  
with influenza. 
Methods: We linked 2012–2015 data on hospitalized adults 
from the influenza hospitalization surveillance network, 
by census tract, to American Community Survey’s federal 
poverty estimates. High-poverty neighborhoods were census 
tracts with ≥20% of households in poverty and low-poverty 
neighborhoods, <5%. We explored univariate associations
between neighborhood-level poverty and influenza vaccination, 
tobacco use, alcohol abuse, and extreme obesity. Using logistic 
regression and clustering by census tract, we examined the 
independent association of these factors with intensive care
unit (ICU) admission and death, controlling for age, race, sex, 
comorbid conditions, antiviral treatment, season, and time from
symptom onset to hospitalization. 
Results: Among 26,106 patients, 4,194 (16%) had ICU admission 
and 669 (3%) died. Those who currently used tobacco, abused 
alcohol, were extremely obese, or unvaccinated were more likely
to live in high-poverty (38%, 40%, 37%, 33%) than low-poverty 
neighborhoods (12%, 13%, 13%, 16%; P<.01). Living in a high-
poverty neighborhood was not independently associated with
ICU admission (OR: 0.97, CI: 0.87–1.10) or death (OR: 0.82, 
CI: 0.63–1.08). Being unvaccinated (OR: 1.24, CI: 1.15–1.35), 
tobacco use (OR: 1.31, CI: 1.19–1.45), and alcohol abuse (OR: 
1.68, CI: 1.41–2.00) increased odds of ICU admission; extreme 
obesity increased odds of death (OR: 1.35, CI: 1.02–1.78). 
Conclusions: Poverty-associated factors, but not neighborhood-
level poverty, were independently associated with severe 
outcomes among patients hospitalized with influenza. Increased 
vaccination and reductions in tobacco use, alcohol abuse,
and extreme obesity could reduce severe influenza-associated 
outcomes. 

















8:55 Influenza-Associated Pediatric Deaths in the United States, 2010–2016 

Authors: Mei Shang, L. Blanton, S. Olsen, A. Fry, L. Brammer 
Background: Influenza-associated pediatric deaths became a 
national notifiable condition in the U.S. in 2004. We described 
influenza-associated pediatric deaths after the 2009 pandemic, 
from 2010–11 through 2015–16. 
Methods: Deaths in children aged <18 years with laboratory-
confirmed influenza were reported to CDC on a standard case
report form with data on demographic characteristics, medical 
conditions, laboratory testing, and clinical diagnosis. We
estimated rates using population estimates from the U.S. Census 
Bureau and compared the characteristics of children between 
those with preexisting conditions and those without. We used a 
Wilcoxon rank-sum test to compare medians and a Chi-square 
test to compare proportions. 
Results: From 2010–11 through 2015–16, 675 deaths were
reported (annual range: 37–171). The median age was 6 years 
(interquartile range: 2–12). The average annual incidence rate
was 0.15 per 100,000 children (95% confidence interval [CI]: 
0.14–0.16) and was highest among children aged <6 months
(0.66; 95% CI: 0.53–0.82), followed by children 6–23 months
(0.33; 95% CI: 0.27–0.39). Only 22% (105 / 477) of children ≥6 
months had evidence of full vaccination. Half of the deaths (324 
/ 654) were in children without preexisting condition. These 
children were younger (5 years), less likely to be vaccinated 
(17%) and to be admitted to a hospital (48%), but died quicker 
(4 days) than children with preexisting conditions (8 years; 27%; 
77%; 7 days; P <.01 for all). 
Conclusions: Influenza-associated pediatric deaths occurred 
in the U.S. every year. Children <2 years had the highest 
mortality rate. Influenza vaccination coverage was very low 
among children who died. Increasing influenza vaccination 
among pregnant women and children might decrease influenza-
associated pediatric deaths. 
9:15 Epidemic Keratoconjunctivitis Outbreak Due to Human Adenovirus Type 8 —  
U.S. Virgin Islands, 2016 
Authors: Marie E. Killerby, M.J. Stuckey, I. Guendel, S. Sakthivel,
X. Lu, D. Erdman, R. Fagan,  M.S. Davis, J. Watson, S. Gerber,  
H. Biggs, E.M. Ellis 
Background:  Epidemic keratoconjunctivitis (EKC) is caused by
human adenoviruses (HAdV); outbreaks have been linked to eye-
care settings. In October 2016, increased cases were reported in 
St. Thomas, US Virgin Islands. We investigated factors associated 
with infection and provided infection control recommendations. 
Methods: A case was defined as a clinical diagnosis of acute 
conjunctivitis by an ophthalmologist or optometrist in a patient 
in St. Thomas during June 1‒November 10, 2016. Medical 
records were reviewed and conjunctival swabs from patients and 
environmental samples from high-contact surfaces and eye-care 
equipment were tested for HAdV using real-time PCR. 
Results: We identified 70 patients who met the case definition; 
of 12 tested for HAdV, 9 (75%) were positive for HAdV type 8.  
Median age was 46 years (range, 9 months‒90 years); 27 (39%) 
were male. Ocular symptoms included redness (66%), watery 
Conclusions: During this community outbreak of HAdV, prior 
practice visits among patients and positive environmental 
samples from eye-care clinics suggested healthcare-associated 
transmission. Recommendations included implementation of
strict infection control practices in healthcare settings, advising 
patients on HAdV infection prevention, and enhanced EKC 














9:35 Differences in Pneumococcal Carriage and Serotype Distribution Between Children With 
and Without Pneumonia — Maputo, Mozambique, 2014–2016 
Authors: Tolulope A. Adebanjo, B. Sigauque, A. Chauque,
H. Mucavele, B. Moiane, S. Massora, F. Pimenta, M.G. Carvalho, 
C. Whitney, F.C. Lessa 
Background:  Pneumococcal pneumonia causes 280,000 deaths
among children aged <5 years annually in Africa. In April 2013, 
Mozambique introduced a vaccine targeting 10 pneumococcal 
capsular serotypes (PCV10) to reduce this burden. Since 
nasopharyngeal (NP) pneumococcal carriage is a precursor for 
pneumonia, we evaluated whether children with pneumonia 
were more likely to carry pneumococcus and vaccine-type (VT) 
pneumococcus compared to children without pneumonia. 
Methods: From 2014–2016, we recruited from hospitals in 
urban and rural sites children born after December 10, 2012, 
with X-ray confirmed pneumonia based on World Health
Organization guidelines. Children without pneumonia were
recruited from the same communities and HIV clinics. For 
each child, we collected clinical data and an NP swab for 
pneumococcal detection and serotyping. We defined VT as 
serotypes in PCV10.  Chi-square was used to compare differences 
in baseline characteristics and pneumococcal carriage between 
groups. Multivariable analyses were performed to evaluate the 
association of pneumonia with overall and VT-pneumococcal 
carriage. 
Results: We enrolled 761 children with and 926 without 
pneumonia.  Children with pneumonia had a lower proportion
of pneumococcal carriage (79.1% vs 84.6%, P=.004) and higher 
proportion of VT-pneumococcal carriage (31.0% vs 23.0%, 
P=.0002) compared to children without pneumonia. Adjusting 
for differences in HIV status, site, vaccination status, and 
antibiotic exposure between the two groups, children with
pneumonia had more pneumococcal [adjusted OR (aOR): 1.57, 
95% CI: 0.93–2.64] and VT-pneumococcal carriage (aOR: 1.46, 
95% CI: 0.93-2.29) than children without pneumonia, but the 
differences were not statistically significant. 
Conclusions: We did not observe a definitive link between 
pneumococcal and VT-pneumococcal carriage and pneumonia.  
Other factors, such as host or environmental factors, may play a 
more important role in disease development. 





















CONCURRENT SESSION N2: Hepatitis and Tuberculosis 
8:30–9:55 AM 
Concurrent Session Room 
Moderators: Carla Winston and Larry Cohen 
8:35 Hepatitis A Outbreak from Imported Frozen Strawberries — 9 States, 2016 
Authors: Megan G. Hofmeister, M. Foster, L. Bottichio, K. Neil,  
A. Fields, Y. Lin, G. Xia, A. Moorman 
Background: Hepatitis A virus (HAV) is usually transmitted
by the fecal-oral route through person-to-person contact or
consumption of contaminated food. In August 2016, the Virginia 
Department of Health identified a cluster of HAV genotype 1B 
cases. Virginia, 8 other states that reported cases, the Food and 
Drug Administration (FDA), and CDC investigated the outbreak 
and took action to prevent further illness. 
Methods: Outbreak-associated cases were detected through 
routine surveillance and active case finding. Patients completed a 
hypothesis-generating questionnaire focused on food exposures 
in the 15–50 days before illness onset. Real-time polymerase chain 
reaction was used to test for HAV in clinical and food specimens, 
and traceback was conducted to investigate food items commonly
identified in questionnaire responses. 
Results: As of December 2016, 139 confirmed and probable cases 
were identified from 9 states. Median age of case-patients was 
33 years (range, 12–70); 78 (57%) were female; 55 (40%) were
hospitalized; no deaths were reported. In total, 125/132 (95%) 
of primarily infected persons reported patronage of restaurant
chain A: of these, 109 reported consumption of strawberries in 
fruit smoothies. Traceback identified an Egyptian supplier of the 
frozen strawberries, and FDA laboratory testing confirmed the 
presence of HAV in the frozen strawberries, leading to a voluntary 
recall of frozen strawberries imported from that firm since 
January 1, 2016, and issuance of an import alert. 
Conclusions: In this fourth-largest-recorded U.S. outbreak of
HAV infection, epidemiologic, traceback, and laboratory
evidence implicated frozen strawberries from Egypt as the source 
of many illnesses and hospitalizations, resulting in a nationwide, 
voluntary recall of the product. New guidelines might be needed 
to prevent HAV infection from food imported from HAV– 
endemic countries. 








Authors: Charlene R. Siza, T. Mckitt 
Background: Alabama's acute hepatitis B virus (HBV) infection
rates have fluctuated between 1.4 and 2.8 cases/100,000 persons 
since 1996, despite implementation of national elimination 
strategies. Through routine surveillance, a rural Alabama 
county (County X) was identified with a higher rate of acute 
HBV infection compared with other counties. We conducted an
investigation to characterize exposures among County X cases. 
Methods: Using data reported to Alabama’s National Electronic 
Disease Surveillance System (NEDSS) from 2012-2015 and 
population census data, we compared the average 4-year hepatitis 
B incidence rate in County X with the overall state rate and a 
demographically similar control county in Alabama. We estimated 
the prevalence of risk factors, including sexual activity, illegal drug 
use, exposure to blood, and drug-related arrests among reported 
cases, from NEDSS and other data sources. 
Results: From 2012–2015, the average 4-year incidence rate in 
County X of 58.2 cases/100,000 persons was significantly higher 
than Alabama’s rate of 8.0 cases/100,000 persons (risk ratio [RR]: 
7.3; 95% confidence interval [CI]: 5.2–10.1), and the control 
county’s rate of 24.4 cases/100,000 persons (RR: 2.4; CI: 1.4-4.1). 
Most frequently reported risk factors in County X included any 
illicit drug use (26.3%), injection drug use (21.1%), and receiving
a tattoo (21.1%). The drug-related arrest rate was significantly 
higher in County X compared with the state (RR: 1.4; CI 1.2-1.6) 
and control county (RR: 2.9; CI: 2.2-3.9). 
Conclusions: Although incidence rates of HBV infection in 
County X were significantly higher than the state as a whole,
a well-defined cause was not evident. Based on risk factors
reported, illicit drug use presents an area of concern; further 
efforts to understand these behaviors in County X are warranted.



















9:15 Hepatitis C-Associated Mortality Rates Among American Indian/Alaska Natives — 
Washington, 2009–2014 
Authors: Sarah M. Hatcher, S. Joshi, T. Weiser 
Background: American Indian/Alaska Native (AI/AN) 
populations have the highest hepatitis C virus (HCV)-related 
mortality rate in the United States; disparity in Washington State 
is unknown. Accurate estimates of HCV mortality are important 
for resource allocation for screening and treatment. We assessed 
health disparities in HCV-associated mortality among AI/AN in 
Washington residents from 2009-2014. 
Methods: : We corrected AI/AN race in death certificates by
using record linkage with the Northwest Tribal Registry (NTR) 
– a listing of AI/AN patients treated at Indian Health Service, 
Tribal, and Urban Indian Health clinics in Idaho, Oregon, and 
Washington. AI/AN race was classified as a record that was AI/ 
AN on a Washington death certificate or had a match with NTR. 
HCV-associated deaths were classified by using International
Classification of Diseases, Tenth Revision codes in the underlying 
and contributing cause of death fields. We calculated five-year 
aggregate age-adjusted HCV and HCV-associated mortality rates 
for AI/AN and non-Hispanic whites (NHW) by using National 
Center for Health Statistics bridged race estimates standardized to
the U.S. 2000 standard population. 
Results: The 2009–2014 age-adjusted HCV mortality rate was 
9.2/100,000 population (95% confidence interval [CI]: 7.1, 12.2) 
for AI/AN and 2.7/100,000 (95% CI: 2.5, 2.9) for NHW (rate
ratio [RR]: 3.4; 95% CI: 2.7, 4.3). The 2009–2014 age-adjusted 
HCV-associated mortality rate was 16.4/100,000 population
(95% CI: 13.6, 20.1) for AI/AN in Washington, compared with
4.4 (95% CI: 4.1, 4.6) for NHW in Washington (RR: 3.8; 95% CI: 
3.2, 4.5). 
Conclusions: Washington AI/AN residents have a higher rate of
HCV-associated mortality, compared with NHWs. The burden 
of HCV-associated mortality among AI/AN in Washington
highlights the need to expand AI/AN access to HCV screening 
and treatment. 
9:35 Demographic and Clinical Characteristics Associated with Tuberculosis/HIV  
Comorbidity — United States, 2011–2015 
Authors: Kristine M. Schmit, N. Shah, S. Kammerer, S. Morris 
Background: Tuberculosis (TB) is a leading cause of death 
among persons living with HIV (PLWH). Because PLWH with
TB disease may not have typical TB symptoms, diagnosing 
TB through routine screening tests such as tuberculin skin 
test (TST), interferon gamma release assay (IGRA), and chest 
radiograph may be difficult, and management complicated. 
We assessed TB diagnosis and outcomes of TB treatment in 
PLWH and identified demographic and clinical characteristics 
associated with TB/HIV in a recent US cohort. 
Methods: Data on HIV status and demographic/clinical 
characteristics of persons diagnosed with TB during 2011–2015 
came from the National Tuberculosis Surveillance system. We
used logistic regression to calculate adjusted odds ratios and 95% 
confidence intervals for TB/HIV status, adjusting for potential 
confounders, including variables previously shown to be
associated with TB/HIV. 
Results: HIV status was reported for 43,363/48,965 persons, 
2,818 (5.4%) of whom were PLWH. Persons with TB/HIV were
more likely than persons with TB/non-HIV to be non-Hispanic 
black (adjusted odds ratio [aOR]: 4.8; 95% confidence interval 
[CI]: 4.0–5.8) or Hispanic (aOR: 1.6; CI: 1.3–2.0) than to be
white. Persons with TB/HIV were also more likely to have a 
negative TST reaction (aOR: 1.9; CI: 1.2–3.0), a negative IGRA 
result (aOR: 2.8; CI: 2.3–3.5), or normal chest radiograph
interpretation (aOR: 1.9; CI: 1.5–2.2) but were less likely to
complete treatment (aOR: 0.5; CI: 0.4–0.6). 
Conclusions: Persons with TB/HIV are more likely than
persons with TB/non-HIV to have negative results from TB 
screening tools and less likely to complete treatment, suggesting
difficulty in diagnosis and management. Focusing on risk factors
associated with TB/HIV comorbidity may help to improve TB 





















CONCURRENT SESSION O1: Foodborne Outbreaks 
10:15 AM–12:00 PM 
Frieden Plenary 
Moderators: Robert Tauxe and Mike Jhung 
10:20 Botulism Outbreak at a Federal Correctional Facility — Mississippi, 2016 
Authors: Lindsey S. McCrickard, J. Self, M. Marlow,  
L. Francois Watkins, J. Anderson, S. Hand, K. Taylor, J. Hanson, 
K. Patrick, C. Luquez, J. Dykes, S. Kalb, K. Hoyt, J. Barr, R. Cox, 
M. Craig, J. Spurzem, J. Doherty, M. Allswede, P. Byers, T. Dobbs,
K. Chatham-Stephens 
Background: Botulism is a potentially fatal neuro-paralytic 
disease caused by toxin from Clostridium botulinum bacteria. 
On June 9, 2016, the Mississippi Poison Control Center and 
the Mississippi State Department of Health notified CDC of a 
suspected botulism outbreak in a federal correctional facility. We
investigated to determine the source and scope of the outbreak 
and prevent future outbreaks. 
Methods: We interviewed inmates and abstracted medical 
charts. A confirmed case was defined as cranial nerve palsy 
in a Prison A inmate beginning on or after June 1, 2016 and 
botulinum toxin or C. botulinum detected in a sample. Illnesses 
without laboratory confirmation were probable cases if cranial 
nerve palsy and extremity weakness were present and suspected 
cases if only cranial nerve palsy were present.  
Results: Our investigation identified common exposure to
hooch, an illicit prison-brewed alcoholic beverage, among ill 
inmates. We identified 31 cases (19 confirmed, 10 probable, 
and 2 suspected); all were men; median age was 36 years (range: 
23–47 years). Thirty (97%) reported known exposure to hooch. 
Twenty-four required hospitalization, and 9 required intubation; 
duration of ventilator support ranged from 18–75 days. Twenty 
patients received antitoxin; eleven had mild symptoms not 
requiring antitoxin. Among 30 patients interviewed, 27 (90%) 
had never heard of botulism, and 23 (77%) did not know hooch 
could make them sick. 
Conclusions: Hooch was the likely source of this botulism 
outbreak, the largest in the United States since 1978. Our 
investigation demonstrates the wide clinical spectrum of
botulism. Educating inmates and correctional facility staff on
risks associated with hooch could prevent future outbreaks. 














10:40 Undetermined Source of Salmonella Infantis Infections Among Detention Center Inmates — 
South Carolina, 2016 
Authors: Sarah V. Luna, S.R. Chae, J. Self, K. Waites, L. Bell,  
J. Chen, A. Bicknese, E. Trees, L. Francois Watkins, C. Friedman, 
C. Grigg 
Background: The emergence of highly antimicrobial-resistant 
strains of foodborne pathogens is a serious public health
threat. A gene conferring clinically-significant 3rd generation
cephalosporin resistance, blaCTX-M-65, was identified in a 
strain (PFGE pattern JGGX01.0787) of Salmonella Infantis 
causing infections among U.S. patients in 2015. In July 2016, 
CDC was notified of an outbreak of salmonellosis with this strain 
affecting 126 inmates at a South Carolina detention center. We
investigated to identify the source of the outbreak and determine 
whether this Infantis strain contained the resistance gene. 
Methods: We conducted a cohort study and evaluated food
handling practices in the detention center. Antimicrobial 
susceptibility testing and whole genome sequencing (WGS) 
provided phenotypic and molecular characterization of outbreak 
isolates, respectively. 
Results: Sixty-one symptomatic inmates and 34 asymptomatic 
inmates were interviewed about exposures to 81 foods. Ten 
inmates submitted stool samples; 6 were positive for the outbreak 
strain. Ill inmates reported eating meal items with ground 
poultry compared to non-ill inmates (94% vs. 88%; P=.18). 
Temperature violations and inadequate sanitation were observed 
in the kitchen. WGS showed that inmate isolates were genetically 
related to the historic Infantis strain from 2012 and a retail 
chicken isolate, both containing blaCTX-M-65. However, the 
isolates from this outbreak lacked blaCTX-M-65 and were not 
resistant to cephalosporins. 
Conclusions: Inmate interviews suggested ground poultry as a 
potential source of this outbreak. However, high inmate turnover 
limited cohort size, which, in addition to a lack of variety in 
food exposures, resulted in an underpowered study. None of
the outbreak isolates contained blaCTX-M-65 despite grouping
closely genetically with historical clinical and chicken isolates 
with the gene. We provided safe food handling recommendations 
to prevent future outbreaks. 
11:00 Fluoroquinolone-Resistant Campylobacter jejuni Infections Associated with Unpasteurized 
Milk from a Dairy Cow Herdshare — Colorado, 2016 
Authors: Alexis W. Burakoff, K. Brown, J. Knutsen, A. Cronquist 
Background: On August 23, 2016, the Colorado Department
of Public Health and Environment (CDPHE) was notified 
of Campylobacter jejuni isolation in 2 persons who reported 
consuming unpasteurized milk from the same herdshare dairy.
Sale of unpasteurized milk is illegal in Colorado, but it can 
be legally distributed through a herdshare without regulatory
oversight. Increased from past years, in 2014, ~27% of U.S. 
Campylobacter isolates were resistant to ciprofloxacin, a 
fluoroquinolone. We sought to describe outbreak magnitude and 
prevent additional cases. 
Methods: Probable cases were defined as having diarrhea 
lasting ≥1 day with onset during August 1–October 7 and 
known consumption of herdshare unpasteurized milk or an
epidemiologic link to a confirmed case; confirmed cases had 
Campylobacter isolation. Cases were identified through passive 
surveillance and by contacting herdshareholder households. The 
CDPHE laboratory cultured stool specimens from ill persons and 
4 milk samples, and performed pulsed-field gel electrophoresis 
(PFGE) on 10 patient and 2 milk isolates. CDC performed 
antimicrobial susceptibility testing on 3 patient isolates. 
Results: Ninety-one (53%) of 171 shareholder households 
responded to telephone interviews. We identified 5 probable 
and 12 confirmed cases; 1 patient was hospitalized. Confirmed 
cases were among patients aged 12–68 years (median: 58 years); 
9 (75%) were male. C. jejuni with the outbreak PFGE pattern was 
confirmed in 10 patient isolates and 2 milk samples. All 3 isolates 
tested for antibiotic resistance were resistant to ciprofloxacin. 
Conclusions: This fluoroquinolone-resistant Campylobacter
outbreak was caused by unpasteurized milk from a dairy 
herdshare. CDPHE notified herdshareholders and cautioned 
against consuming unpasteurized milk on 3 occasions. Because 
unpasteurized milk remains available, public health’s role is 
































11:20 Salmonella Javiana Infections Linked to a Restaurant in Maricopa County — Arizona 2016
 
Authors: Heather Venkat, T. Sylvester, R. Klein, J. Matthews,  
J. Collins, N. LaMantia, M. Kellis, M. Tewell, J. Weiss, S. Zusy,  
P. Lumadao, M. Ricca, B. Caballero, R. Penev, S. Gower,
K. Komatsu, R. Sunenshine 
Background: On August 10, 2016, the Maricopa County 
Department of Public Health was notified of culture-confirmed 
Salmonella Javiana isolates from 2 persons who reported eating at
Restaurant A. We identified 6 additional cases by August 15, and 
investigated to identify a source and prevent further illness. 
Methods: We interviewed all persons with laboratory-reported 
S. Javiana infection. Pulsed-field gel electrophoresis (PFGE) and 
whole genome sequencing (WGS) of isolates were performed.
A case was defined as diarrheal illness in a person during
July–September 2016; confirmed cases had S. Javiana isolate 
yielding outbreak-related PFGE patterns; probable cases had 
an epidemiological link to a confirmed case. Case-finding was 
through surveillance and inquiring about ill dining companions. 
An unmatched nested case-control study assessed risk factors
for S. Javiana infection. Food and environmental samples were
collected and tested. 
Results: We identified 50 S. Javiana cases (40 confirmed, 10 
probable); illness onsets July 22–September 17. No restaurant
workers were reported ill. Four of 5 tested isolates with outbreak-
related PFGE patterns were highly related by WGS. Thirty-three 
(73%) of 45 patients interviewed reported eating at Restaurant
A. Shrimp was delivered frozen to Restaurant A, then thawed for 
preparations. S. Javiana was isolated from prepared uncooked 
shrimp and halibut, and a freezer door handle. We included 
25 cases and 31 controls; unfried shrimp consumption was 
associated with illness (odds ratio, 6.5; 95% confidence interval 
1.6–33.01, P = 0.01). 
Conclusions: Highly WGS-related S. Javiana indicates a 
commonly supplied food item, possibly shrimp, was the outbreak 
source; cross-contamination with other foods likely amplified 
illness among restaurant diners. We hypothesize that higher 
Salmonella loads, following preparation, likely survived the 145°F 
recommended shrimp cooking temperature. 
11:40 Salmonella Typhimurium Outbreak Associated with Cheese from a Local Creamery — 







Authors: Jessica L. Rinsky, E. Berl, J. MacFarquhar,
H. Dubendris, C. Harris, J. Marshall, D. Gaines, R. Converse,  
K. Heiman Marshall, C. Schwensohn, L. Gieraltowski, Z. Moore,
A. Fleischauer 
Background: Contaminated dairy products are common sources 
of foodborne outbreaks. In June 2016, the North Carolina 
Division of Public Health detected a cluster of Salmonella
Typhimurium isolates with indistinguishable pulsed-field gel 
electrophoresis (PFGE) patterns. In July, a routine sample of raw 
milk from a local creamery (Creamery A) yielded Salmonella
Typhimurium with an indistinguishable PFGE pattern. We
investigated to identify opportunities for product contamination 
and prevent further illnesses. 
Methods: We defined a case as isolation of the outbreak strain 
from a specimen collected during April 24–August 15, 2016, 
from a North Carolina resident or visitor. We completed 
outbreak questionnaires for cases identified before August and 
conducted an on-site visit and product sampling with the North 
Carolina Department of Agriculture. 
Results: We identified 109 cases; 16 (15%) were hospitalized.
Median patient age was 29 years (range: 1–92). We interviewed 
46 of 61 (75%) patients identified before August; 26 (57%) 
respondents reported eating ≥1 Creamery A cheese. The 
creamery produced raw-milk cheeses aged ≥60 days and 
pasteurized cheeses in a 3-room, on-site facility. Few physical 
barriers existed between milking, production, and processing 
rooms; the same staff handled unfinished and finished products. 
The outbreak strain was isolated from a sample of a raw-milk 
cheese commonly consumed by patients (n = 21; 46%). Creamery
A recalled all products on July 27 and began working with food
safety experts to remediate and re-open. 
Conclusions: Consumption of cheeses produced from
contaminated raw milk resulted in a substantial Salmonella
outbreak. Contamination likely resulted from a cheese aging-
process failure or cross-contamination at the creamery. Physical 
barriers and adherence to good hygiene practices are necessary
to reduce the risk for product contamination. 









CONCURRENT SESSION O2: Child Health 
10:15 AM–12:00 PM 
Concurrent Session Room 
Moderators: Georgina Peacock and Andrea Sharma 
10:20 Acute Flaccid Myelitis in Pediatric Patients — Maricopa County, Arizona, 2016 
Authors: Sally Ann Iverson, S. Ostdiek, S. Prasai, D. Engelthaler, 
M. Kretschmer, N. Fowle, H. Tokhie, J. Routh, J. Sejvar, T. Ayers, 
K. Komatsu, S. Brady, T. Sylvester, J. Bowers, V. Harrison,  
J. Heim, S. Robinson, K. Fitzpatrick, G. Ostovar, R. Sunenshine 
Background: Acute flaccid myelitis (AFM) is a type of acute 
flaccid paralysis reported most commonly among children. 
In 2014, AFM was reported to be temporally associated with
enterovirus (EV)-D68, but no definitive etiology has been 
identified. In September 2016, the Maricopa County Department
of Public Health investigated a cluster of 11 suspected cases 
of AFM during a 6-week period to determine if cases met 
the standardized case definition and identify risk factors and 
potential etiologies. 
Methods: AFM CDC patient summary forms were completed 
by medical record abstraction and reviewed by a clinical team. A 
confirmed case of AFM was defined as acute focal limb weakness 
with MRI revealing spinal cord lesions of gray matter at >1 
spinal segments; a probable case was acute focal limb weakness 
and cerebrospinal fluid white blood cell count >5 cells/mm3. 
Interviews were conducted to determine risk factors. Clinical 
specimens were distributed to partner laboratories for further 
testing. 
Results: Four cases were confirmed and 1 was probable. Among 
confirmed cases, illness onset was August 20–September 15; 
ages were 3.5–10 years and 75% were female. All 4 confirmed 
cases had preceding respiratory or gastrointestinal illness. 
Nasopharyngeal swabs were available from 6 of 11 patients; 3 
confirmed cases and 1 noncase tested positive for EV-D68 by
polymerase chain reaction (PCR) at Translational Genomics 
Research Institute. Coxsackivirus A10 was detected by PCR in 
stool from the remaining confirmed case. 
Conclusions: No single etiology or risk factor was associated 
with all confirmed cases. Continued surveillance and reporting 
of cases is critical to better characterize this disease. Expanded 
testing for both infectious and noninfectious etiologies might
provide further insight into the mechanism of AFM.segments; a 
probable case was acute focal limb weakness and cerebrospinal 
fluid white blood cell count >5 cells/mm3. Interviews were
conducted to determine risk factors. Clinical specimens were
distributed to partner laboratories for further testing. 























10:40 Worsening Childhood Health in Conflict-Affected Areas of Borno State — Northeastern 
Nigeria, October–November 2016 
Authors: Erin E. Tromble, E. Leidman 
Background: Since 2012, ongoing conflict with Boko Haram 
has caused a humanitarian emergency, with reports of measles 
outbreaks and malnutrition, in northeastern Nigeria. The 
Nigerian government and UNICEF requested CDC assistance in 
assessing measles vaccine coverage and prevalence of diarrhea, 
acute respiratory illness, and malaria, the major causes of
childhood morbidity and mortality in humanitarian emergencies. 
Methods: To determine the health status among children <5 
years, from October-November, 2016, we conducted a household 
survey using two-stage cluster sampling design in Borno State,
northeastern Nigeria. For each eligible child, primary caregivers
answered questions about symptoms and clinical management of
fever (malaria proxy), cough with rapid breathing (pneumonia 
proxy), and diarrhea in the past two weeks and measles 
vaccination history. We conducted data analysis in Epi Info using 
complex sample procedures. 
Results:  We surveyed 627 households (491 children). Two-week 
prevalence of fever, cough with rapid breathing, and diarrhea 
among children was 27.1% (95% confidence interval [95% CI] 
21.5–32.7), 8.8% (95% CI, 4.8–12.8), and 17.9% (95% CI, 10.9– 
24.9), respectively. Among children with fever, 5.3% (95% CI 
0.7–9.8) and 28.6% (95% CI 13.2–43.9) received malaria testing 
and therapy, respectively. Measles vaccine coverage was 62.3% 
(95% CI 51.1–73.4) in children aged 9–59 months. Children aged 
24–59 months had greater odds (OR=1.6; 95% CI 1.1–2.2) of
vaccination versus children aged 9–23 months. 
Conclusions: Based on prior survey data from northeastern
Nigeria, these findings suggest a worsening in childhood health. 
Only a small proportion of children with fever were tested 
or provided treatment for malaria. Measles vaccine coverage
was significantly below the 95% threshold despite ongoing 
campaigns. These findings indicate an urgent need for improved 
access to malaria treatment and laboratory services and 
expanded measles vaccination. 
11:00 How Infants Die in Ohio: Comparison of Two Methods to Ascertain Cause of Death, 
2009–2013 
Authors: Martha Montgomery, J. Paulson, A. Davis, J. Mott,  
E. Conrey 
Background: Ohio has the 11th highest infant mortality rate in 
the United States as of 2015. Two sources are used to ascertain 
how infants die in Ohio, vital statistics (VS) and child fatality 
review (CFR). CFR determines cause of death through a 
multidisciplinary board that reviews medical, law enforcement, 
death scene investigation, and social work records. We sought to
use CFR findings to improve VS reporting. 
Methods: Infant mortality was defined as a death of an Ohio 
resident in Ohio before age 1 year. We linked CFR and VS
datasets by infant during 2009–2013 using personal identifying 
information. We grouped causes of death into 11 categories 
on the basis of CFR classification. Kappa statistic was used to
measure concordance. 
Results: Records were linked for 96% (4,985) of all VS infant
deaths. Concordance was excellent for asphyxia (kappa 0.95), 
moderate for congenital anomalies (kappa 0.64), and weak 
(kappa <0.6) for 9 remaining categories. The largest discordance 
occurred where 1,100 (22%) infants were assigned prematurity 
by CFR and perinatal condition by VS. Cause of death was 
missing from 359 CFRs, compared with 0 from VS; 64% of these 
were coded as sudden infant death syndrome by VS. 
Conclusions: Concordance between CFR and VS was low for 
the majority of categories. Although CFR is often considered 
the gold standard in Ohio, it is limited by missing data and 
insufficient detail for premature deaths. By using cause of death 
ICD-10 codes from VS additional detail on underlying causes of
prematurity was added. Linking CFR and VS provides a more
complete understanding of infant deaths in Ohio and may lead to



























11:20 Breastfeeding and Autism Spectrum Disorder in Preschool Children Enrolled in the Study to 
Explore Early Development — United States, 2008–2011 
Authors: Gnakub N. Soke, M. Maenner, G. Windham, E. Moody,
C. DiGuiseppi, L. Schieve 
Background: The prevalence estimate of autism spectrum 
disorder (ASD) has increased, and perinatal risk and protective
factors, including breastfeeding, may relate to ASD etiology. Few 
studies have assessed the relationship between breastfeeding 
and ASD, and these have reported inconsistent findings. Most 
studies had small samples and other methodological limitations. 
We evaluated associations between breastfeeding initiation and 
duration and ASD. 
Methods: We used data from the Study to Explore Early 
Development, a case-control study of children aged 2-5 years at
six sites in the United States. ASD cases (n=707), recruited from
clinics and schools, were classified by trained researchers using 
standardized developmental assessments. Controls (n=1,223) 
were randomly sampled from birth records. Breastfeeding 
initiation (yes/no), and among those who were breastfed, duration
(months) were obtained through maternal interviews. Association 
between breastfeeding initiation and ASD was assessed using 
logistic regression, and association with breastfeeding duration
[highest tertile (>12 months) versus lowest tertile (<=3 months)] 
using multinomial logistic regression. We adjusted for child and 
maternal characteristics (e.g., child sex, maternal race). 
Results: We did not find an association between breastfeeding 
initiation and ASD (adjusted odds ratio [aOR]: 0.92 [95% 
confidence interval (CI): 0.65, 1.30]). However, breastfeeding 
duration was shorter in cases versus controls (aOR: 0.60 [95% CI: 
0.42, 0.87]). 
Conclusions: Although breastfeeding initiation was not 
significantly different between the two groups, its duration was 
shorter among cases than controls. More studies are needed to
assess whether longer duration of breastfeeding is protective
against ASD, or shorter duration of breastfeeding could be
due to challenging behaviors that may have negatively affected 
breastfeeding. Nevertheless, longer duration of breastfeeding 
has other beneficial effects and is supported by the American
Academy of Pediatrics. 
11:40 Epidemiology and Trends of Pertussis Among Infants — United States, 2000–2015
 
Authors: Catherine Bozio, T. Skoff, T. Pondo, J. Liang 
Background: Pertussis, a cyclic disease, causes greatest morbidity 
and mortality among infants, particularly those too young to
be vaccinated.  In the context of a recent resurgence of pertussis 
and a 2012 recommendation to vaccinate for pertussis during
every pregnancy to prevent infant disease, we describe US infant
pertussis trends between 2000 and 2015. 
Methods: We analyzed nationally-reported infant pertussis cases 
(age groups: <2, 2–<4, 4–<6, and 6–<12 months) with cough 
onset between 2000 and 2015.  Incidence (per 100,000) was 
calculated using National Center for Health Statistics population
estimates.  Proportion of affected infants hospitalized and case-
fatality ratios (CFRs) were calculated using cases with known 
outcomes; relative percent changes were calculated.  Linear
trends were assessed using negative binomial regression; P<.05 
was significant. 
Results: From 2000–2015, 48,909 infant pertussis cases were
reported, including 255 deaths; infants aged <2 months accounted 
for 38.7% of cases.  Overall, annual incidence was highest 
among <2-month-olds (range: 112.7–282.1 per 100,000).  The 
proportion of infants hospitalized decreased 47.6% overall, from
64.5% in 2000 to 33.8% in 2015 (P<.0001); cases among 4–<6 
and 6–<12-month-olds had the largest annual relative decreases 
(-5.1% and -5.9%, respectively) while <2-month-olds had the 
smallest relative decline (-1.5%) (P<.0001 for all).  Although the 
CFR was highest among <2-month-olds (1.6%), CFRs decreased 
significantly over time among <2 and 2–<4-month-olds (P<.05). 
Conclusions: Pertussis incidence remains highest among infants 
aged <2 months.  While declines in hospitalization and case
fatality may represent a decrease in disease severity, these changes 
may also reflect increased reporting of non-severe cases.  Ongoing 
monitoring of infant pertussis is needed to better understand the 

























CONCURRENT SESSION P1: Drug-Related Illness 
1:35–3:20 PM 
Frieden Plenary 
Moderators: Debbie Dowell and Andrea Winquist 
1:40 Qualitative Description of Suspected Illicitly Manufactured Fentanyl-Related Overdose — 
Massachusetts, 2016
 
Authors: Nicholas J. Somerville, J. O’Donnell,
J. Kuramoto-Crawford, S.J. Zibbell, M. Younkin, M. Shang,  
T. Green, M. Chan, S. Ruiz, H. Babakhanlou-Chase, M. Gladden, 
H. Nields, A. Walley 
Background: Annual opioid-related overdose deaths in 
Massachusetts increased 138% during 2012–2015. Massachusetts 
law enforcement seizures of illicitly manufactured fentanyl
(IMF), a short-acting synthetic opioid with 50x–100x the potency 
of morphine, increased from 16 in 2013 to 630 in 2014. We
investigated factors associated with IMF use and overdose in 
Massachusetts through interviews with illicit opioid users during
April 2016. 
Methods: A purposive sample of illicit opioid users was recruited 
from harm reduction organizations in three Massachusetts 
counties with high rates of opioid overdose death. Trained team
members conducted semistructured, face-to-face interviews 
with adults who used illicit opioids during the previous year and 
experienced or witnessed an opioid overdose during the previous 
6 months. Investigated themes included IMF availability, overdose 
signs, and naloxone rescue. Interviews were audio recorded, 
transcribed, and thematically coded. Themes were tallied by
number of respondents. 
Results: Sixty-four respondents were interviewed; 28 (44%) 
had experienced an opioid overdose and 61 (95%) witnessed an
overdose during the previous 6 months. Respondents reported 
that suspected IMF was sold mixed with heroin or by itself, 
and 56 (88%) attributed the increase in opioid-related overdose 
deaths to IMF. Forty-eight (75%) respondents who witnessed 
a suspected IMF-related overdose described it as occurring
within minutes of use. Reported signs of suspected IMF-related 
overdose included blue discoloration of lips, rapid breathlessness, 
and seizure-like activity. Forty (63%) respondents reported that
rescues by laypeople and health professionals required ≥2 nasal-
administered doses of naloxone per suspected  
IMF-related overdose. 
Conclusions: Suspected IMF-related overdose occurs rapidly,
but can be reversed with naloxone by laypeople if quickly 
administered in sufficient dosage. Public health messaging about 
IMF is needed to educate users on its risks. 












2:00 Fentanyl Overdose Deaths in New Mexico During 2015–2016
 
Authors: Nicole Middaugh, L.E. Tomedi, N. Greene, L. Petersen, 
J. Davis, H. Kastenbaum, K.B. Nolte, M. Landen 
Background: Since 2013, illicitly manufactured fentanyl (IMF) 
has contributed to an epidemic of overdose deaths in the United 
States. Despite having the nation’s second highest drug overdose 
death rate in 2014, New Mexico had not experienced a similar 
increase. In August 2016, after multiple IMF-related overdose 
deaths, the New Mexico Department of Health initiated a 
statewide investigation of overdose deaths in New Mexico during
2015–2016 to characterize fentanyl-related deaths. 
Methods: Death data were obtained from the New Mexico Office 
of the Medical Investigator. A case was defined as any drug 
overdose death among a New Mexico resident during January 
1, 2015–October 31, 2016, with fentanyl or fentanyl analogs on
toxicology results. Demographic, circumstantial, and toxicological 
data were abstracted. Scene and toxicological information
were used to classify exposures by likely type of fentanyl (IMF, 
pharmaceutical fentanyl [PF], or unknown fentanyl [UF]). 
Results:  We identified 39 cases (21 in 2015, 18 in 2016); IMF 
was found in 8 (21%), PF in 18 (46%), and UF in 13 (33%). All 
IMF cases occurred in 2016; 17/18 PF cases occurred in 2015. 
Approximately 80% of IMF and UF cases were among men; 
>50% of PF cases were among women. Median age was 23 years 
among IMF cases; among PF and UF cases, median age was 43 
and 42 years, respectively. Half of IMF cases were white, whereas 
90% of PF and UF cases were white. 
Conclusions: During 2015–2016 in New Mexico, IMF overdose 
deaths increased, whereas PF overdose deaths decreased.
While New Mexico did not experience a substantial increase in 
fentanyl-related overdose deaths, maintaining surveillance for 
fentanyl-related overdose deaths to rapidly identify potential 
outbreaks is essential.
2:20 Deaths Associated with Opioid Use and Possible Infectious Disease Etiologies Among 
Persons in the Unexplained Death (UNEX) Surveillance System — Minnesota, 2006–2015 
Authors: Victoria Hall, R. Lynfield, N. Wright, L. Hiber, J. Palm, 
J. Christensen, K. Smith, S. Holzbauer 
Background: During 2006–2015, the Minnesota Department
of Health (MDH) identified 2,253 opioid toxicity deaths
in Minnesota through death certificate surveillance using 
International Classification of Diseases, Tenth Edition codes 
(ICD-10). Research has shown opioid users are at increased risk 
for pneumonia. MDH’s Unexplained Death surveillance system 
(UNEX) identifies unexplained deaths with possible infectious 
cause for additional pathogen testing. We described UNEX-
identified deaths with toxic opioid levels found at autopsy during
2006–2015. 
Methods: UNEX-identified deaths among Minnesota residents 
aged >12 years during 2006–2015 were reviewed for opioid 
toxicity identified by postmortem toxicological screening. Cause 
of death, clinical signs, preexisting conditions, and toxicology 
results were extracted from autopsy reports. Deaths with
hospitalization >24 hours antemortem and those without autopsy 
reports were excluded.
Results: Fifty-nine (3.5%) of 1,676 UNEX deaths had evidence 
of opioid use. Median age was 43 years (range: 16–82 years); 
31 (53%) were female. Twenty-two deaths involved toxic 
opioid levels, but lacked correct ICD-10 codes to be reported 
by statewide opioid death surveillance. Thirty-two (54%) of 59 
UNEX deaths with opioid use had pneumonia. A pathogen was 
identified in 20 (63%) pneumonia cases, including Streptococcus 
pneumoniae (n = 6), Haemophilus influenza (n = 3), and 
influenza A (n = 2). Of 20 pneumonia cases, 9 (45%) had a 
drug abuse history, 6 (30%) had chronic pain, and 1 (5%) was 
receiving methadone drug therapy.   
Conclusions: UNEX identified deaths missed by opioid death 
surveillance, indicating that the total burden of opioid-associated 
deaths was underestimated in Minnesota. The contributions of
opioid toxicity, infectious disease, or their interactions to death 
are challenging to disentangle; understanding these interactions 



























2:40 Electronic Surveillance System for the Early Notification (ESSENCE) for Marijuana-
Associated Visits to One Hospital Emergency Department — Denver, Colorado, 2016 
Authors: Grace E. Marx, Y. Chen, B. Albanese 
Background: Legalization of recreational marijuana in Colorado 
created a need to monitor adverse outcomes from marijuana 
use. Syndromic surveillance by using the Electronic Surveillance 
System for the Early Notification of Community-based Epidemics 
(ESSENCE) might serve to monitor trends in marijuana-
associated emergency department (ED) visits. We sought to
detect marijuana-associated ED visits by developing algorithms
of diagnostic codes and key words and evaluated algorithm 
performance in ESSENCE compared with physician-performed 
medical record reviews. 
Methods: Algorithms representing various combinations
of marijuana-specific International Classification of Diseases
Tenth Revision (ICD-10) diagnostic codes or key words 
were applied to ED visits submitted through the syndromic 
surveillance system at 1 hospital during June 1–September 30, 
2016. We reviewed medical records detected by ≥1 ESSENCE 
algorithms and defined a case as an ED visit that met an acute 
marijuana-associated adverse health outcome case definition as 
determined by the ED physician’s clinical impression. Positive
predictive values (PPVs) of each algorithm were calculated by
using the medical record as the ultimate standard. 
Results: Of 28,446 total ED visits, ESSENCE algorithms detected 
281 (1%) as potentially marijuana-associated. Two-hundred fifty 
(89% of 281) record reviews identified 114 cases (46% of 250) of
an acute marijuana-associated adverse health outcome. Median
case age was 31 (range 16–69) years; 59 (52%) were male. The 
ICD-10 algorithm identified 69 visits; 59 met the case definition
(PPV, 86%). The key word algorithm identified 212 visits; 85 met 
the case definition (PPV, 40%). 
Conclusions: ICD-10 code algorithms applied to ESSENCE data
more accurately detected ED visits for marijuana-associated 
adverse health outcomes at this hospital, compared with key 
words. ESSENCE can be used to monitor adverse outcomes of
recreational marijuana use. 








Authors: Amy E. Seitz, M. Eberhardt, S. Lukacs 
Background: Marijuana use in the United States has been 
increasing. Understanding population subgroups with increased 
marijuana use is of public health importance as the relationship
between marijuana use and health has not been fully described. 
Our objective was to describe marijuana use prevalence among 
adults with select health conditions. 
Methods: We examined data from 6,406 adults aged 20–59 
years who participated in the 2011–2014 National Health and 
Nutrition Examination Survey (NHANES). The prevalence of
self-reported marijuana use within the last 30 days is presented 
by demographic characteristics and by health conditions
available in NHANES with known or plausible associations
with marijuana use (i.e. depression, laboratory-confirmed HIV, 
respiratory disease, and cancer). Sample weights and design 
variables accounted for complex survey design, producing 
nationally representative prevalence estimates. 
Results: Overall, 14% of persons aged 20–59 reported marijuana 
use within the last 30 days. Males (17%) and persons aged 20–29 
(22%) were most likely to report marijuana use within the last 
30 days. There was a high prevalence of marijuana use among 
persons with depression (23%), HIV (53%), and respiratory
disease (18%). After adjusting for age and sex, persons with
depression (adjusted odds ratio [aOR]: 2.5; 95% confidence 
interval [CI]: 1.83, 3.30), HIV (aOR: 8.4; 95% CI: 3.08, 22.68)  
and respiratory disease (aOR: 1.6; 95% CI: 1.18, 2.04) had  
higher odds of marijuana use compared to persons not reporting 
the condition.   
Conclusions: In a nationally representative sample, 14% of adults 
aged 20-59 reported using marijuana within the last 30 days. 
Having depression, HIV, or respiratory disease was associated 
with marijuana use. Health care providers should be aware of
increased odds of marijuana use among patients with these 
health conditions. 










CONCURRENT SESSION P2: Water-Related Illness 
1:35–3:20 PM 
Concurrent Session Room 
Moderators: Michael Beach and Stacey Bosch 
1:40 	 Shigella sonnei Outbreak Investigation in the Setting of a Municipal Water Crisis — 
Genesee and Saginaw Counties, Michigan, 2016 
Authors: Robert Paul McClung, C. Castillo, A. Miller,  
S. Brandon, S. Collier, E. Adam, H. Reses, J. Hurd, V. Morrill,  
D. Wagner, S. Dietrich, M. Soehnlen, S. Lyon-Callo, J. Collins,  
V. Hill, M. Beach, J. Yoder, K. Yates, K. Fullerton, J. McFadden, 
M. Karwowski 
Background: On October 7, 2016, the Michigan Department of
Health and Human Services (MDHHS) requested CDC assistance 
investigating an outbreak of Shigella sonnei in Genesee County 
(GC), including City of Flint, and Saginaw County (SC) amid 
public concern regarding the City of Flint municipal water system. 
Objectives were to characterize the outbreak, identify risk factors
for transmission, and engage an array of community stakeholders. 
Methods: Iterative dialogue with community stakeholders 
and local health officials informed design and implementation
of the investigation. With this input, a hypothesis-generating
questionnaire was developed to identify risk factors for acquiring 
shigellosis and assess secondary transmission among households 
containing ≥1 ill persons reported to MDHHS from March 1– 
October 25. 
Results: We interviewed 66% (83/126) of affected households 
and identified 158 ill persons (56% female, 54% African-
American) among 353 household residents. Ill persons were
more likely to be children (P<.02) and to self-identify as African-
American (P<.0001) compared to the population in each county. 
In the week preceding illness, 55% of household index cases wore
or had direct contact with a person wearing diapers and 22% 
reported contact with a person with diarrhea outside the home. 
No point source exposure was identified. Households receiving
Flint water were less likely to have consumed tap water (33%) 
than those from greater GC (63%; P=.03) or SC (100%; P<.0001).
During the investigation, 10 stakeholder groups were engaged  
via 14 meetings, 10 communications products, and 2  
formal presentations. 
Conclusions: Preliminary findings suggest that shigellosis 
transmission occurred by person-to-person contact and not 
via a municipal water system. Early and recurrent community 
engagement was essential to the development, implementation, 
and acceptability of this investigation. 



























2:00 Shigella sonnei Outbreak Among Homeless Persons after Substantial Rainfal — Oregon, 
2015–2016 
Authors: Jonas Z. Hines, M. Jagger, T. Jeanne, N. West,  
R. Leman, K. Hedberg 
Background: The largest outbreak of shigellosis in Oregon state 
history occurred from July 2015–June 2016. In November, the 
outbreak strain spread among Portland’s homeless population, 
coinciding with onset of the wettest rainy season on record. 
Shigella transmission occurs through fecal-oral contact, and 
outbreaks tend to occur in overcrowded settings where personal 
hygiene is challenging; we hypothesized that substantial rainfall 
might have led to increased congregation and breakdown of
hygienic conditions among homeless persons, facilitating Shigella
transmission. We investigated whether rainfall was associated 
with shigellosis during this outbreak. 
Methods: A case was defined as a Shigella sonnei infection
in an Oregonian with a pulsed-field gel electrophoresis 
pattern indistinguishable from outbreak strain occurring
7/1/2015–6/30/2016. We interviewed patients and reviewed 
medical charts. Using Poisson regression, we analyzed the 
association between daily case count and cumulative rainfall 
during the period 8–14 days prior to each patient’s symptom 
onset. We stratified by homelessness status and controlled for 
temperature. 
Results: One-hundred and five shigellosis cases were identified 
during the outbreak; 79 (75%) were among men; all occurred 
among persons aged ≥18 years. Forty-five (43%) infections were
reported among homeless persons. Among homeless persons, the 
risk ratio (RR) for shigellosis was 1.46 (95% confidence interval 
[CI] = 1.28–1.68) for each additional inch of cumulative rainfall; 
the association was not significant for housed persons (RR = 
1.05; 95% CI = 0.88–1.26). 
Conclusions: Rainfall was associated with increased reports 
of shigellosis among homeless persons during this outbreak. 
Substantial rainfall might have caused behavior changes that
facilitated Shigella transmission. During forecasted heavy 
rainstorms, public health departments might take proactive 
measures to mitigate the spread of infectious disease among 
homeless persons. 








Authors: Alean A. Frawley, I.J. Schafer, R. Galloway, A. Artus,  
R. Ratard 
Background: Leptospirosis is an acute febrile illness caused by
infection with Leptospira species, a bacteria increasingly prevalent 
in Louisiana deer and feral swine. Infected animals can transmit 
Leptospira species to humans through urine-contaminated water,
often during flooding. In August 2016, Louisiana experienced 
widespread flooding; hospital laboratories subsequently reported 
2 initial leptospirosis cases in patients with flood-water exposure.
We investigated to determine burden of flood-related leptospirosis 
in Louisiana. 
Methods: We queried the Louisiana Early Events Detection 
System (LEEDS), a state-wide syndromic surveillance system, 
to identify patients with chief complaints or diagnoses clinically
compatible with leptospirosis from flooded areas from 2 
days after flooding onset to 30 days after water recession. We
performed medical record reviews and applied the Council of
State and Territorial Epidemiologists’ (CSTE) case definition; 
patients with laboratory evidence supporting an alternate 
diagnosis were excluded. Patients were interviewed to determine 
floodwater exposure. Blood and urine specimens were tested for 
leptospirosis with polymerase chain reaction (PCR); serum was 
tested by microscopic agglutination test (MAT) for initial cases 
and patients with floodwater exposure. 
Results: LEEDS query yielded 69 patients warranting medical 
record review. Of 18 patients meeting the CSTE case definition, 
13 were interviewed; 4 reported floodwater exposure and 
submitted blood and urine specimens; however, MAT and 
PCR were negative for Leptospira infection. Initial cases were
confirmed by MAT; urine PCR in 1 case identified Leptospira
kirschneri as the infecting species. 
Conclusions: No additional confirmed cases of postflooding 
leptospirosis were identified. However, Leptospira species 
endemicity in Louisiana wildlife and 2 laboratory-confirmed 
cases of leptospirosis postflooding warrants a high index of
suspicion for leptospirosis in patients with compatible symptoms
and exposure to untreated water, especially during flooding. 



















2:40 Access To Safe Water In Haiti: Have We Made Progress?
 
Authors: Alaine Knipes, A. Martinsen, J. Darius, T. Alerte,
T. Palmer, L. Templin, T. Handzel 
Background: In 2010, Haiti experienced a devastating earthquake
followed by an unprecedented cholera outbreak. Despite years 
of interventions directed toward improving access to safe water,
cholera cases have increased in 2016; with Artibonite being one 
of the most heavily affected departments. We conducted an
assessment of access to water, sanitation, hygiene, and household
water treatment (HWT) products in Artibonite, as a follow-up,
and for comparison to, a 2012 CDC assessment. 
Methods: In August 2016 we conducted a two-stage cluster 
survey among rural and urban residents in Artibonite. Data were
collected on cholera knowledge and access to improved water 
sources, sanitation and HWT products. Water sources were
tested for microbiological indicators. 
Results: We surveyed 709 households (416 rural, 293 
urban). Access to improved water sources was 59.1% in rural 
communities and 94.0% in urban communities; 56 of 131 
(42.7%) improved water sources tested positive for E. coli. One 
third of rural households reported disinfecting their current 
drinking water, and 44.6% of those had positive free chlorine 
residual at the time of the visit. From 2012 to 2016, access to
improved water sources in rural communities increased (43.1% 
to 59.1%, p=0.02), and there was no change in reported use of
HWT products (p=0.37). Access to improved sanitation did not 
change in rural communities between 2012 and 2016 (p=0.09); 
however, open defecation decreased (50.9% to 24.5%, p<0.0001). 
A majority of respondents (80.7%) cited the role of contaminated 
water in cholera transmission. 
Conclusions: Preliminary findings suggest that shigellosis 
transmission occurred by person-to-person contact and not 
via a municipal water system. Early and recurrent community 
engagement was essential to the development, implementation, 
and acceptability of this investigation. 
3:00 Cryptosporidiosis Associated with Recreational Water — Maricopa County, Arizona, 2016
 
Authors: Sally Ann Iverson, N. Fowle, J. Collins, G. Epperson,  
S. Zusy, R. Sunenshine 
Background: Cryptosporidium is the leading cause of U.S. 
outbreaks associated with recreational water venues (RWVs) 
(e.g., swimming pools) because of the parasite’s extreme 
chlorine tolerance. Diarrheal events in RWVs are high-risk 
Cryptosporidium contamination events. Maricopa County’s
climate allows for an extended “summer” swimming season
at >9,000 public RWVs. On August 3, 2016, a common RWV 
exposure among reported cryptosporidiosis cases was detected.
Together with environmental health practitioners, epidemiologists 
sought to control the outbreak with efforts including 
identification and remediation of affected RWVs. 
Methods: A confirmed case was defined as a person with onset 
of diarrhea, abdominal cramping, or vomiting during June 1– 
October 31 and laboratory-based evidence of Cryptosporidium 
infection; a probable case required the same clinical presentation
and an epidemiologic link to a confirmed case. We interviewed 
patients with confirmed cases about RWV and other exposures; 
public RWV remediation was based on interview data. 
Results: We identified 294 confirmed and 126 probable cases; 
patients were aged 0–75 years, and 258 (61%) were aged ≤19 
years. Incidence decreased by half ~2 weeks after schools 
reopened in early August. Of 247 patients interviewed, 198 
(80%) reported RWV exposure and 45 (18%) swam while ill with
diarrhea. Patients reporting RWV exposure visited a mean of 1.4 
(range: 1–5) RWVs during 2 weeks before symptom onset; 75 
public RWVs were associated with confirmed cases. 
Conclusions: Remediation of RWVs effectively prevents 
Cryptosporidium transmission; however, focal outbreaks can 
become communitywide outbreaks when patients experience 
diarrhea in and contaminate RWVs. Although the timing of
school reopening precludes assessing control efforts here, 
investigation findings underscore the need to engage
swimmers and parents of young swimmers in prevention















SESSION Q: Awards and Late-Breaking Reports 
3:35–5:15 PM 
Frieden Plenary 
Presentation of Awards and Moderator:  Tracie Gardner 
Moderators: Stephen Redd and Tracie Gardner 
• Outstanding Poster Presentation Award 
• Donald C. Mackel Memorial Award 
• J. Virgil Peavy Memorial Award 
• Paul C. Schnitker International Health Award 
• Iain C. Hardy Award\ 
• James H. Steele Veterinary Public Health Award 
• Mitch Singal Excellence in Occupational and Environmental Health Award 
3:55 	 Evaluating the Utility of rRT-PCR Testing in Whole Blood Compared to Other Specimens 
and IgM Testing to Optimize the Diagnosis of Zika Virus Infection among Asymptomatic 







Authors: Asher Yoel Rosinger, C. Pedati, B. Schroeder,  
J. Perez-Padilla, S. Ellington, C. Shapiro-Mendoza, L. Adams,  
R. Galang, R.M. Simeone, C. Colon, M. Goodwin,  
J.L. Munoz-Jordan, D. Meaney-Delman, J.S. Read, M.A. Honein, 
B. Rivera 
Background: Zika virus (ZIKV) infection during pregnancy is 
a cause of microcephaly and birth defects. According to current 
testing guidelines, asymptomatic pregnant women in Puerto
Rico are screened each trimester for ZIKV IgM antibodies in 
serum and, if detected, tested by real-time reverse transcription 
polymerase chain reaction (rRT-PCR) for confirmation.
Preliminary reports suggested rRT-PCR whole blood testing may 
detect ZIKV RNA in more symptomatic patients and for a longer 
duration than serum testing. We compared rRT-PCR testing 
performance of whole blood, serum, and urine with serum IgM 
antibody testing for asymptomatic women in Puerto Rico to
optimize diagnosis of ZIKV from October–November, 2016. 
Methods: Pregnant women provided serum, urine, and whole 
blood specimens for ZIKV rRT-PCR and IgM testing. McNemar’s 
χ2 was used to test for statistical differences in diagnostic utility. 
Results: Of 519 asymptomatic pregnant women, 44 (8.5%) had 
laboratory evidence of possible ZIKV infection: 26 (5.0%) had 
positive ZIKV rRT-PCR results on one or more specimens (19 
serum, 10 urine, and 5 whole blood) and negative IgM results. 
Seventeen women (3.3%) had positive IgM test results but 
negative rRT-PCR results. One (0.2%) woman tested positive by
rRT-PCR and IgM. Whole blood rRT-PCR testing detected fewer 
ZIKV infections than other specimens (p < 0.001). 
Conclusions: Compared to testing guidelines, performance 
of rRT-PCR and IgM testing at a single time-point detected 
an additional 26 asymptomatic women with ZIKV infection. 
rRT-PCR testing of whole blood did not detect additional ZIKV 
infections compared to other specimens. Findings suggest 
testing serum and urine from asymptomatic pregnant women 
by rRT-PCR, followed by serology if negative, would increase
identification of ZIKV-infected pregnant women in areas with
local ZIKV transmission. 
Awards presented during session. 




















4:05 Identification of Cat-to-Human Transmission During an Outbreak of Influenza A (H7N2) 
Among Cats in an Animal Shelter — New York City, 2016 
Authors: Christopher T. Lee, S.A. Slavinski, C. Schiff,  
D. Daskalakis, J.L. Rakeman, D. Liu, F. Havers, A. Fry, T. Davis, 
J.K. Varma, M.C. Layton 
Background: On December 14, 2016, the New York City
Department of Health (DOH) was notified of an influenza 
A (H7N2) outbreak (an avian-lineage virus) among cats at a 
Manhattan animal shelter. We conducted surveillance to assess
risk for H7N2 transmission to humans. 
Methods: We defined a suspected case as illness in a person
who adopted a cat from (adopter) or worked at (worker) the 
shelter during November 12–December 29, 2016, and developed 
conjunctivitis or ≥2 symptoms of sore throat, fever, myalgia, or
cough ≤10 days postexposure to a shelter cat. We interviewed 
adopters by telephone and workers in person, and collected 
nasopharyngeal specimens for H7N2 ribonucleic acid (RNA) 
detection by real-time polymerase chain reaction (RT-PCR). 
Results: We interviewed 185/382 (48.4%) adopters; 10 (5.4%) 
met the case definition and 4 were tested. We interviewed 
and tested 165/265 (62.3%) workers; 23 (13.9%) met the case
definition. H7N2 RNA was not detected in any specimen. 
On December 19, a previously untested worker who had 
collected oropharyngeal specimens from cats without using a 
respirator or mask reported to DOH sore throat, myalgia, and 
cough with onset December 18. H7N2 RNA was detected in a 
nasopharyngeal specimen collected on December 19, and not 
detected in a specimen collected on December 20. The patient 
recovered without hospitalization. Tracing of contacts with
exposure to the patient during December 17–20, including 
persons onboard a domestic flight, identified no additional cases. 
Conclusions: We identified the first case of cat-to-human
transmission of an influenza A virus, but no evidence of
additional cat-to-human or human-to-human transmission. 
Rapid transmission risk assessment was critical to evaluate
pandemic potential, craft public messaging, and implement 
control measures. 
4:15 Investigation of Salmonella Enteritidis Harboring the mcr-1 Resistance Gene — 
Connecticut, 2017 
Authors: Vivian H. Leung, N. Montero, M. Maloney,
L.F. Watkins, J. Chen, L. Sosa 
Background: In December 2016, routine surveillance identified 
the first mcr-1 gene in a Salmonella Enteritidis (SE) isolate in the 
United States. The isolate was from a stool specimen collected 
in May 2016 from a Connecticut patient experiencing diarrhea. 
Mcr-1 is located on a plasmid potentially capable of spreading 
among bacteria and confers resistance to colistin, a last-line 
antibiotic used to treat multidrug-resistant infections. We assessed 
possible routes of exposure to mcr-1, determined whether mcr-1
spread to the patient’s close contacts, and evaluated prevalence of
mcr-1 among similar SE isolates. 
Methods: We interviewed the patient and 4 close contacts about 
symptoms, travel, and exposure to foods, animals, and health
care settings. Rectal swabs collected in January 2017 from the 
patient and contacts were cultured for Salmonella and tested for 
mcr-1 by polymerase chain reaction. Genomes of 170 U.S. SE
isolates collected during October 2015–December 2016 with
the same pulse-field gel electrophoresis (PFGE) pattern were
screened for mcr-1. 
Results: The patient had travelled abroad during the 
salmonellosis incubation period, and had no substantial exposure 
to health care settings before her illness. Rectal swabs from the 
patient, 2 travel companions who had diarrhea during travel, 
and 2 asymptomatic household contacts tested negative for 
Salmonella and mcr-1. Mcr-1 was not identified in the sequences 
of any of the 170 PFGE-matching SE isolates. 
Conclusions: The patient might have acquired mcr-1 abroad, 
adding to evidence that acquisition of this gene is associated with
international travel. Continued screening of bacterial genomes 
for mcr-1 and investigations using these methods might delay the 
emergence of untreatable infections by identifying individuals 



























4:25 Investigation of a Nationally Distributed Contaminated Organ Transplant Preservation 
Solution — United States, 2016–2017 
Authors: Matthew J. Stuckey, S. Novosad, N. Wilde,  
P. Annambhotla, S.V. Basavaraju, H. Moulton-Meissner, K. Seiber, 
J. Perz, P. Quinlisk, A. Garvey, S. Conrad, S. Fewell, S. Hill,  
M.B. Edmond, B. Ford, A. Reed, I. Benowitz, M. Walters 
Background: In December 2016, bacterial contamination of an
organ preservation solution (OPS) was reported by Transplant
Center A in Iowa. Annually, >20,000 abdominal organs are 
transplanted in the U.S.; OPS is used for organ storage. We
investigated the scope of OPS contamination and its association 
with adverse events in patients. 
Methods: We assessed infection control practices related to OPS 
at Center A, Transplant Center B in Iowa, and the local organ 
procurement organization. We issued national notifications 
about OPS contamination and requested transplant centers
to report potential patient harm or product-related concerns. 
Among transplant recipients at Center A, we compared adverse 
events (fever, bacteremia, surgical site infection, peritonitis, or
pyelonephritis within 14 days of transplantation) from October– 
December 2016, when contaminated OPS was distributed, and 
October–December 2015. Isolates from OPS were characterized. 
4:35 Mumps Outbreak — Colorado, 2017 
Results: No infection control deficiencies were identified. In
January 2017, contaminated OPS from the same manufacturer 
was reported by Transplant Center C in Texas. Nationally, there 
were no reports of patient harm definitively linked to OPS. 
Post-transplant adverse events at Center A did not increase
between fourth quarter 2015 (5/14 [35%]) and 2016 (2/13 [15%]). 
Organisms recovered from OPS included Pantoea agglomerans
and Enterococcus gallinarum (Center A) and Pseudomonas 
koreensis (Center C). Five Pantoea isolates from ≥3 OPS bags 
were indistinguishable by pulsed-field gel electrophoresis. The 
manufacturer issued recalls and suspended production pending 
further investigation. 
Conclusions: Bacterial contamination of a nationally-distributed 
product was identified by astute clinicians and confirmed by this 
investigation; no illnesses were directly linked to the product. 
Prompt reporting of concerns about potentially contaminated 
healthcare products, which might put patients at risk, is critical 
for swift public health action. 
Authors: Grace E. Marx, A. Burakoff, D. Hite, T. Ayers, J. Chase,
K. Miller, M. Barnes, C. McDonald, L. Miller, B. Albanese 
Background: During 2016, an unusually high number (>5,000) of
mumps cases were reported in the United States. On January 20, 
2017, we identified a mumps outbreak in the Denver metropolitan
area among the Marshallese community. We performed 
active surveillance to assess outbreak magnitude and guide 
implementation of control measures. 
Methods: On January 22, local and state health departments 
initiated active case surveillance by using church-based 
community rosters. Each household was contacted by telephone 
≥3 times to identify mumps cases, according to the 2012 CDC/ 
Council of State and Territorial Epidemiologists case definition, 
and risk factors (e.g., household size). Measles, mumps, and 
rubella (MMR) vaccination status was reviewed in the Colorado 
Immunization Information System (CIIS). Church-based 
vaccination clinics (January 29 and February 12) were offered 
to bring participants up-to-date for MMR vaccination. Targeted 
messaging about mumps, MMR vaccine, and vaccination clinics 
was distributed through social media, churches, and Marshallese­
language radio. 
Results: Of the 17 households contacted, 13 (76%) provided data
for 70 persons (median household size: 6 persons; range: 4–12). 
Through household interviews and laboratory reporting, we
identified 33 mumps cases (16 confirmed; 17 probable); median
patient age was 21 years (range: 4–44 years), 17 (52%) were male, 
and 22 (67%) lacked prior MMR vaccine documentation in CIIS. 
During vaccination clinics, 118 (80%) of 148 persons received 
MMR vaccine; of those vaccinated, median age was 21 years 
(range: 1–55 years) and 104 (88%) had no prior MMR vaccine 
documentation. 
Conclusions: Active surveillance, facilitated through culturally 
appropriate communication with church leaders, helped identify
cases, disseminate materials, and promote MMR vaccination. 
Household interviews provided timely data to define outbreak 

























4:45 Shiga Toxin-Producing Escherichia coli O157:H7 Infections After Attendance 
at a Cider Festival — Kansas, 2016 
Authors: Jessica Nadeau Tomov, D. Neises, L. Webb, A. Barham, 
A. Inman 
Background: On October 21, 2016, the Kansas Department
of Health and Environment (KDHE) was notified of 6 Shiga 
toxin-producing Escherichia coli (STEC) O157:H7 isolates with
indistinguishable pulsed-field gel electrophoresis patterns from
attendees of a cider festival during September 24—25 and October 
1—2. KDHE and partner agencies investigated to identify the 
outbreak source and prevent illness. 
Methods: A press release requested festival attendees self-report 
illness to KDHE. A case was defined as diarrhea (>2 watery
stools per day) lasting >24 hours starting >1 day after festival 
attendance.  We conducted a matched case-control study; case-
patients were matched to one or more well persons who attended 
the festival with them.  Case-patients and control subjects were
interviewed about festival exposures.  We calculated odds ratios 
(ORs) and 95% confidence intervals (CIs) for associations
between illness and festival exposures. We observed the mill’s
food-handling processes and collected environmental samples. 
Results: Fifty-six persons reported illness meeting the case
definition; 9 (16%) were hospitalized, 2 (4%) developed hemolytic 
uremic syndrome, and 7 (13%) had laboratory-confirmed STEC 
O157:H7 infection. Thirty-eight case-patients and 46 control 
subjects were included in the analysis. Eating cider doughnuts 
(OR: 10.3; CI: 1.1–94.8) and drinking cold cider (exact OR: 
6.6; CI: 1.2–infinity) were associated with illness. Written 
policy was to serve pasteurized cider but onsite inspection
identified food-handlers unknowingly obtained cider from an
unpasteurized cider storage tank to serve customers and possibly
prepare doughnuts. Testing revealed no STEC O157 among 
environmental samples. 
Conclusions: The process evaluation, particularly on-site
evaluation of the mill’s processes, identified use of unpasteurized 
cider as the likely infection source. KDHE recommended labeling 
unpasteurized cider tanks and educating employees to prevent 
further illness. 
4:55 Immune Response Following Reactive Vaccination Campaign Using Fractional Dose Yellow 
Fever Vaccine — Kinshasa, Democratic Republic of Congo, 2016 
Authors: Rebecca M. Casey, J. Harris, S. Ahuka, M. Dixon,  
K. Mbunsu, P. Mutantu, J. Laven, G. Paluku, A. Gueye, T. Hyde,  
E. Staples, J. Muyembe 
Background: In 2016, several large outbreaks of yellow fever (YF) 
led to a global YF vaccine shortage. To vaccinate 7.6 million people 
in Kinshasa in response to an outbreak, fractional (1/5; 0.1 ml) 
dose of 17DD YF vaccine was provided to children age ≥2 years 
and non-pregnant adults via subcutaneous injection. We assessed 
the effectiveness of this novel control strategy. 
Methods: Participants were recruited in four age strata at
six vaccination sites. We assessed the presence of YF virus 
specific neutralizing antibodies from blood samples collected 
pre vaccination and 28 days post vaccination using the plaque 
reduction neutralization test (PRNT50). The World Health
Organization defines seroprotection as a PRNT50 titer ≥10. 
The study criteria for immune response were seroconversion 
(seronegative on pre-vaccination blood to titer ≥10 at follow-up), 
or ≥4 fold increase in titer. 
Results: Of 764 participants recruited, 492 have preliminary 
results available; 483 (98%; 95% confidence interval: 97%–99%) 
participants were seroprotected against YF at follow-up. Of these,
439 (91%) met criteria for immune response and 44 (9%) had 
preexisting immunity and did not meet the criteria. Stratified by
age group, the proportion seroprotected at follow-up was 97% in 
2–5 year olds; 100% in 6–12 year olds; 97% in 13–49 year olds; 
and 98% in those 50 and older. For the same age groups, the 
proportions meeting immune response criteria were 79%, 94%, 
93% and 88% respectively. 
Conclusions: In our cohort, fractional dose YF vaccine was  
highly effective at providing protective immunity. These findings 
support the use of fractional dose vaccination for outbreak 
control, which is important to address the ongoing global YF 
vaccine shortage. Additional studies are needed to assess

























5:05 Determining the End Date of Routine Screening of Asymptomatic Pregnant Women for 
Zika Virus Infection — American Samoa, 2016–2017 
Authors: Ruth Link-Gelles, M.S. Anesi, M. Matai’a, A. Uso,
B. Sili, J. Solaita, A.J. Tufa, M. Evans, C. Gould, T. Hancock,  
S. Hills, N. Krishna, M. Reynolds, K.A. Toews, W. Walker,  
P. Weidle, J. Wilken, W.R. Daley, W.K. Gallo, E. Irvin-Barnwell,
A. Koneru, R.L. Laws, D. Meaney-Delman, H. Soeters,  
P.M. Talboy, E. Piercefield 
Background: Zika virus (ZIKV) infection can cause birth defects 
in infants born to women infected during pregnancy. The first
individuals with ZIKV disease in American Samoa had symptom 
onset in January 2016 prompting initiation of routine screening 
for ZIKV infection among asymptomatic pregnant women. Case
counts increased rapidly before gradually declining by March 
2016. To guide resource allocation and inform decisions about 
whether asymptomatic pregnant women should continue to be
screened, we sought to determine if and when active mosquito-
borne transmission ended. 
Methods: Transmission end date criteria were finalized in 
January 2017 and included: (1) implementing enhanced ZIKV 
disease surveillance, (2) identifying symptom onset date for 
last polymerase chain reaction (PCR)-positive, locally-acquired 
case, (3) defining the period after which active mosquito-borne 




transmission could be considered over (3 extrinsic incubation
periods [45 days] after initiating enhanced surveillance), and (4) 
ongoing monitoring of enhanced surveillance data. 
Results: Enhanced surveillance was fully implemented by August 
31, 2016. No additional PCR-positive cases were identified and 
the last symptomatic, PCR-positive patient had symptom onset 
on June 19, 2016. The end date of transmission was therefore 
determined as October 15, 2016. Enhanced surveillance from
August 31, 2016 through February 1, 2017 included testing of
118 symptomatic individuals and 627 asymptomatic pregnant
women; none was ZIKV PCR-positive. Based on guidance 
to delay attempting conception until ≥8 weeks after possible 
ZIKV exposure, screening was recommended for asymptomatic 
pregnant women with estimated conception before December 11, 
2016. 
Conclusions: We used evidence-based criteria to determine 
when to discontinue routine screening of asymptomatic pregnant
women for ZIKV infection, which could allow for optimal use 
of public health resources and guide others dealing with similar 
epidemiologic situations. 
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Salinas, Jorge Luis MD – NCHHSTP 
Schicker, Rebekah Stewart* MSN, MPH, APRN – NCIRD 
Schmit, Kristine M.* MD, MPH – NCHHSTP 
Self, Julie L.* PhD, MPH – NCEZID 
Shah, Minesh* MD, MPH – NCIRD 
Shang, Mei* MBBS, MSc, MPH – NCIRD 
Sircar, Anita Devi* MD, MPH, DTM&H – CGH 
Soke, Gnakub Norbert* PhD, MPH, MD – NCBDDD 
Somerville, Nicholas J.* MD, MPH – DSEPD/EWB-MA 
Springer, Yuri P.* PhD – DSEPD/EWB-AK 
Straily, Anne* DVM, MPH, DACVPM – NCEZID 
Styczynski, Ashley Renee MD, MPH – NCEZID 
Su, Chia-Ping* MD, PhD, MSc – NIOSH 
Subaiya, Saleena* MD, MSc – CGH 
Surie, Diya MD – NCHHSTP 
Tanner, Mary MD – NCHHSTP 
Tomov, Jessica Nadeau* PhD – DSEPD/EWB-KS  
Tran, Cuc Hong PhD, MPH – NCEZID 
Ussery, Emily Neusel PhD, MPH – NCEH-ATSDR 
Vasquez, Amber* MD, MPH – NCEZID 
Venkat, Heather* DVM, MPH – DSEPD/EWB-AZ 
Wang, Alice* PhD – NCEH-ATSDR 
Wang, Teresa W.* MS, PhD – NCCDPHP 
Weiss, Debora DVM, MS, MPH – DSEPD/EWB-WI 
Yaffee, Anna Q.* MD, MPH – DSEPD/EWB-KY 
* Presenting EIS Officer 
EIS Officers, Class of 2016
 
Adebanjo, Tolulope* MD, MPH – NCIRD 
Agnew-Brune, Christine* PhD, MPH – NCHHSTP 
Agyemang, Elfriede MD, MPH – CGH 
Akelo, Victor* MPH, MBA, MBChB – NCCDPHP 
Anderson, Kayla N.* PhD, MA – NCBDDD 
Annor, Francis B.* MPH, PhD – NCIPC 
Ayers, Tracy* PhD, MS – NCIRD 
Bonwitt, Jesse H.* MSc, MRCVS – DSEPD/EWB-WA 
Boundy, Ellen O’Neal MS, ScD – NCCDPHP 
Bozio, Catherine* PhD, MPH – NCIRD 
Burakoff, Alexis W.* MD, MPH – DSEPD/EWB-CO 
Burke, Rachel M.* MPH, PhD – NCIRD 
Burrage, Amanda B.* MD, MPH – CGH 
Casey, Rebecca M.* MBBS, MPH, MRCS – CGH 
Castillo, Caroline Grady MD – DSEPD/EWB-MI 
Cha, Susan* PhD, MPH – NCHHSTP 
Chen, Meng-Yu* MD, MSc – NCBDDD 
Chi, Gloria C.* PhD, MPH – DSEPD/EWB-CA 
Cote, Andrea MPH, DVM – DSEPD/EWB-WY 
da Silva, Juliana de Fatima MD – CGH 
Davis, William W.* MA, MPH, DrPH – NCEZID 
Davlantes, Elizabeth MD – CGH 
Dawson, Erica L.* PhD, MS, MA – NCHHSTP 
Doshi, Reena H.* PhD, MPH – CGH 
Evans, Mary E. MD, MPH – NCHHSTP 
Frawley, Alean* DO, MPH – DSEPD/EWB-LA 
Fukunaga, Rena* PhD, MA – NCCDPHP 
Greene-Cramer, Blanche DrPH, MPH – CGH 
Grimes, George R. MD MPH – NIOSH 
Guagliardo, Sarah A.* PhD, MPH – NCEZID 
Hall, Noemi B.* PhD – DSEPD/EWB-TX 
Hall, Victoria L.* DVM, MS – DSEPD/EWB-MN 
Hatcher, Sarah M.* PhD – DSEPD/EWB-OR 
Hofmeister, Megan* MD, MS, MPH – NCHHSTP 
Issa, Asnindita Nanda Devanath MD – NCEH 
Iverson, Sally Ann* DVM, MPH – DSEPD/EWB-AZ 
Jarashow, Megan C. Dillavou* PhD, MPH – DSEPD/EWB-CA 
Kerins, Janna L.* VMD, MPH – DSEPD/EWB-IL 
Killerby, Marie E.* VetMB, MPH – NCIRD 
Krishnasamy, Vikram P. MD, MPH – NCEZID 
Laws, Rebecca* MPH, PhD – DSEPD/EWB-CA 
Leung, Vivian H.* MD – DSEPD/EWB-CT 
Link-Gelles, Ruth* PhD, MPH – NCHHSTP 
Liu, Eugene Wei-Kang MD – CGH 
Luna, Sarah V.* PhD – NCEZID 
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EIS Officers, Class of 2016 (continued)
 
Marx, Grace E.* MD, MPH – DSEPD/EWB-CO 
McAteer, Jarred B.* MD – NCEZID 
McClung, Robert Paul* MD – NCEZID 
Mitchell, Patrick K. ScD SM – DSEPD/EWB-PA 
Montgomery, Martha P.* MD, MHS – DSEPD/EWB-OH 
Mosites, Emily M.* MPH, PhD – NCEZID 
Murthy, Bhavini Patel MD, MPH – OPHPR 
Murthy, Neil Chandra* MD, MPH, MSc – NCIRD 
Patel, Jaymin C. PhD, MPH – NCIRD 
Poirot, Eugenie A.* PhD, MPH – DSEPD/EWB-NY 
Reynolds, Laura E.* MPH, RN – NIOSH 
Rozwadowski, Faye* MD – DSEPD/EWB-NJ 
Schnaubelt, Elizabeth R. MD – CGH 
Scholl, Lawrence MPH, PhD – NCIPC 
Schroeder, Betsy MPH, PhD, DVM – DSEPD/EWB-IN 
Seitz, Amy E.* MPH, PhD – NCHS 
Shih, David Chun-Ming* MD, MS, FACPM – NCCDPHP 
Siegel, David A.* MD, MPH – DSEPD/EWB-AL 
Siza, Charlene* DVM, MPH – DSEPD/EWB-OR 
Skrobarcek, Kimberly A.* MD – NCEZID 
Soda, Elizabeth A.* MD – NCIRD 
Stuckey, Matthew J.* PhD, MPH – NCEZID 
Tomasi, Suzanne E. DVM, MPH – NIOSH 
Tromble, Erin* MD – CGH 
Tsay, Sharon V.* MD – NCEZID 
Va, Puthiery DO, MS – NCCDPHP 
Van Dyne, Elizabeth MD, MPH – NCCDPHP 
Walker, William DVM, PhD – NCEZID 
Wansaula, Zimy MD, MPH – NCHHSTP 
Weng, Mark* MD, MSc – NCEZID 
Wilkinson, Amanda Lin* PhD – CGH 
Zambrano, Laura PhD MPH – NCEZID 
Zwald, Marissa L.* PhD, MPH – NCHS 
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LLS Fellows, Class of 2015
 
Araujo, Aufra MSc, PhD – NCEZID 
Keckler, Shannon PhD – NCEZID 
Llewellyn, Anna C.* PhD – NCIRD 
Mercante, Alexandra PhD – NCEZID 
Minchella, Peter PhD – CGH 
Okoth, Sheila PhD – NCHHSTP 
Weiner, Zachary PhD – NCEZID 
* Presenting LLS Fellow 
LLS Fellows, Class of 2016 
Clayton, April PhD – NCEZID 
Dietrich, Elizabeth PhD – NCEZID 
Kines, Kristine MSPH, PhD – CGH 
Pompey, Justine PhD – NCEZID 
Potts, Caelin PhD – NCIRD 
Ricaldi, Jessica N.* MD, PhD – NCIRD 
Riner, Diana* MS, PhD – NCEZID 
White, Brunilis* PhD – NCHHSTP 






Incoming EIS Officers, Class of 2017
 
Anand, Anjoli MD, MPH 
Alpren, Charles MBChB 
Bakhsh, Yasser MBBS, MPH 
Ballard, Sarah-Blythe MD, MPH, PhD 
Ben Hamida, Amen Allah MD, MPH 
Bergeron, Genevieve MD, MPH 
Bezold, Carla MPH, ScD 
Biedron, Caitlin MD, MS 
Billig, Erica MS, PhD 
Brennan, Julia MS 
Campbell, Stefanie MS, DVM 
Chancey, Rebecca MD 
Collins, Jennifer MD, MSc 
Cossaboom, Caitlin MPH, PhD, DVM 
Cotter, Caitlin DVM, MPH 
Cree, Robyn MPhil, PhD 
Curren, Emily DVM, MPH 
Doyle, Joshua PhD, MD 
Duwell, Monique MD, MPH 
Eboh, Victor MBBS, MSc 
Fay, Katherine MD 
Feldstein, Leora MSc, PhD 
Flak Pennington, Audrey MPH, PhD 
Free, Rebecca MD 
Goers, Matthew MD 
Harduar Morano, Laurel MPH, PhD 
Hartnett, Kathleen MPH, PhD 
Head, Sara MPH, PhD 
Herzig, Carolyn MS, PhD 
Hesse, Eizabeth MD, MTM&H 
Horth, Roberta MPH, PhD 
Hughes, Michelle MHS, PhD 
Imoisili, Omoye MPH, MD 
Jackson, David MD 
Keaton, Amelia MD, MSc 
Kofman, Aaron MD 
Kracalik, Ian MA, MPH, PhD 
Labuda, Sarah MD, MPH 
Lavery, Amy MSPH, PhD 
Logan, Naeemah MD 
Lucas, Todd MD, MPH 
Mandra, Anna DVM, MPH 
McCabe, Nancy PhD 
McDonald, Robert MPH, MD 
McKay, Susannah PhD, MPH 
Morawski, Bozena MPH, PhD 
Moritz, Erin MS, PhD 
Nabity, Scott MPH, MD 
N'cho, Hammad MS, MA, PhD 
Njuguna, Henry MBChB, MPH 
Peak, Corey SM, ScD 
Pickens, Cassandra MPH, PhD 
Pindyck, Talia MD 
Quilter, Laura MS, MPH, MD 
Richards, Jennifer MPH, PhD 
Robertson, Scott MPH, DVM, MS 
Schumacher, Amy MS, PhD 
Shaw, Kelly PhD 
Siegel, Miriam MPH, DrPH 
Sinatra, Jennifer DVM, MPH 
Strysko, Jonathan MD 
Swedo, Elizabeth MD, MPH 
Tiffany, Amanda MPH, PhD 
Toda, Mitsuru MS, PhD 
Udhayashankar, Kanagasabai MPH, MD 
Valenciano, Sandra MPH, MD 
Vannice, Kirsten MHS, PhD 
Weil, Lauren PhD, MPH 
Wilson, Erica MD, MPH 
Winstead, Alison MD 
Womack, Lindsay MPH, PhD 
Incoming LLS Fellows, Class of 2017
 
Fowler, Randal Christopher PhD Lowe, David Edward PhD
Hardy, Margaret C. MSc, PhD Marinova-Petkova, Atanaska DVM, MS, PhD
Kretz, Cecilia Batmalle PhD Stinnett, Rita Czako MHS, PhD 
Lawrence, Marlon G. PhD 
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